
<html lang="en"     class="pb-page"  data-request-id="1d77e093-df6e-4c8f-bd62-5f7f94951caf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm5006176;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-15;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase" /></meta><meta name="dc.Creator" content="Li-Fan  Zeng" /></meta><meta name="dc.Creator" content="Ruo-Yu  Zhang" /></meta><meta name="dc.Creator" content="Zhi-Hong  Yu" /></meta><meta name="dc.Creator" content="Sijiu  Li" /></meta><meta name="dc.Creator" content="Li  Wu" /></meta><meta name="dc.Creator" content="Andrea M.  Gunawan" /></meta><meta name="dc.Creator" content="Brandon S.  Lane" /></meta><meta name="dc.Creator" content="Raghuveer S.  Mali" /></meta><meta name="dc.Creator" content="Xingjun  Li" /></meta><meta name="dc.Creator" content="Rebecca J.  Chan" /></meta><meta name="dc.Creator" content="Reuben  Kapur" /></meta><meta name="dc.Creator" content="Clark D.  Wells" /></meta><meta name="dc.Creator" content="Zhong-Yin  Zhang" /></meta><meta name="dc.Description" content="The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interes..." /></meta><meta name="Description" content="The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interes..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 28, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5006176" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5006176" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5006176" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5006176" /></link>
        
    
    

<title>Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5006176" /></meta><meta property="og:title" content="Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0012.jpeg" /></meta><meta property="og:description" content="The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents. Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor 11a-1, with an IC50 value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs. Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β5–β6 loop contribute to 11a-1’s binding potency and selectivity. Evidence suggests that 11a-1 specifically attenuates the SHP2-dependent signaling inside the cell. Moreover, 11a-1 blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung cancer and breast cancer as well as leukemia cell lines." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5006176"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5006176">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5006176&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5006176&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5006176&amp;href=/doi/10.1021/jm5006176" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6594-6609</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500599s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500681z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Fan++Zeng">Li-Fan Zeng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruo-Yu++Zhang">Ruo-Yu Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhi-Hong++Yu">Zhi-Hong Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sijiu++Li">Sijiu Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Wu">Li Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea+M.++Gunawan">Andrea M. Gunawan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brandon+S.++Lane">Brandon S. Lane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raghuveer+S.++Mali">Raghuveer S. Mali</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingjun++Li">Xingjun Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+J.++Chan">Rebecca J. Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reuben++Kapur">Reuben Kapur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clark+D.++Wells">Clark D. Wells</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhong-Yin++Zhang">Zhong-Yin Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Biochemistry and Molecular Biology, <sup>‡</sup>Herman B. Wells Center for Pediatric Research, and <sup>§</sup>Chemical Genomics Core Facility, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (317) 274-8025. Fax: (317) 274-4686. E-mail: <a href="/cdn-cgi/l/email-protection#671d1e1d0f060900270e1249020312"><span class="__cf_email__" data-cfemail="c3b9bab9aba2ada483aab6eda6a7b6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5006176&amp;href=/doi/10.1021%2Fjm5006176" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6594–6609</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 8, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 April 2014</li><li><span class="item_label"><b>Published</b> online</span>28 July 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 August 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5006176" title="DOI URL">https://doi.org/10.1021/jm5006176</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5006176"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4267</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">64</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5006176" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li-Fan&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Ruo-Yu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhi-Hong&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Sijiu&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;M. Gunawan&quot;},{&quot;first_name&quot;:&quot;Brandon&quot;,&quot;last_name&quot;:&quot;S. Lane&quot;},{&quot;first_name&quot;:&quot;Raghuveer&quot;,&quot;last_name&quot;:&quot;S. Mali&quot;},{&quot;first_name&quot;:&quot;Xingjun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;J. Chan&quot;},{&quot;first_name&quot;:&quot;Reuben&quot;,&quot;last_name&quot;:&quot;Kapur&quot;},{&quot;first_name&quot;:&quot;Clark&quot;,&quot;last_name&quot;:&quot;D. Wells&quot;},{&quot;first_name&quot;:&quot;Zhong-Yin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;6594-6609&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5006176&quot;},&quot;abstract&quot;:&quot;The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents. Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor 11a-1, with an IC50 value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs. Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β5–β6 loop contribute to 11a-1’s binding potency and selectivity. Evidence suggests that 11a-1 specifically attenuates the SHP2-dependent signaling inside the cell. Moreover, 11a-1 blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5006176&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006176" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5006176&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006176" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5006176&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006176" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5006176&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006176&amp;href=/doi/10.1021/jm5006176" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5006176" /></input><a href="/doi/pdf/10.1021/jm5006176" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5006176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5006176%26sid%3Dliteratum%253Aachs%26pmid%3D25003231%26genre%3Darticle%26aulast%3DZeng%26date%3D2014%26atitle%3DTherapeutic%2BPotential%2Bof%2BTargeting%2Bthe%2BOncogenic%2BSHP2%2BPhosphatase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D15%26spage%3D6594%26epage%3D6609%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jmcmar.2014.57.issue-15/production/jmcmar.2014.57.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents. Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor <b>11a</b>-<b>1</b>, with an IC<sub>50</sub> value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs. Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β<sub>5</sub>–β<sub>6</sub> loop contribute to <b>11a</b>-<b>1</b>’s binding potency and selectivity. Evidence suggests that <b>11a</b>-<b>1</b> specifically attenuates the SHP2-dependent signaling inside the cell. Moreover, <b>11a</b>-<b>1</b> blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung cancer and breast cancer as well as leukemia cell lines.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proper levels of tyrosine phosphorylation, maintained by the reversible and coordinated actions of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), are critical for a wide range of cellular processes including growth, differentiation, metabolism, migration, and survival.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Aberrant tyrosine phosphorylation, as a result of perturbed balance between the activities of PTKs and PTPs, is linked to the pathogenesis of numerous human diseases, including cancer.<a onclick="showRef(event, 'ref1 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref4">(1, 3, 4)</a> Consequently, signaling events driven by tyrosine phosphorylation offer a rich source of molecular targets for therapeutic interventions.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> The success of such targeted approaches has been well demonstrated by the more than two dozen PTK inhibitors that are already approved for clinical uses.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, the therapeutic potential of modulating the PTPs is still underexplored despite the fact that several PTPs have also been identified as high-value targets.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">Excessive tyrosine phosphorylation is a hallmark of cancer, usually caused by abnormal expression and/or activation of receptor PTKs, such as epidermal growth factor receptor, and nonreceptor PTKs such as Src and Abl.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> By catalyzing the dephosphorylation of phosphotyrosine residues, PTPs are usually viewed as negative regulators of signal transduction and therefore perceived as products of tumor suppressor genes. Indeed, several PTPs, including PTEN, have been identified as tumor suppressors.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> However, recent genetic analyses of human tumors reveal that at least 22 PTPs are candidate oncoproteins.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> To this end, the Src homology 2 (SH2) domain containing protein tyrosine phosphatase-2 (SHP2), encoded by the <i>Ptpn11</i> gene, positively potentiates cellular signaling.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Biochemical and genetic studies establish that SHP2 promotes signaling downstream from almost all growth factor and cytokine receptors and upstream of Ras and is required for growth factor/cytokine-induced cell proliferation, migration, and survival. In addition, considerable evidence indicates that SHP2 is a bona fide oncoprotein. Germline gain-of-function SHP2 mutations cause 50% of Noonan syndrome, an autosomal dominant developmental disorder with increased risk of malignancy.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Moreover, somatic activating mutations in SHP2 are associated with juvenile myelomonocytic leukemia, acute myeloid leukemia, myelodysplastic syndrome, acute lymphoid leukemia, and several types of solid tumors including lung adenocarcinoma, colon cancer, neuroblastoma, glioblastoma, melanoma, hepatocellular carcinoma, and prostate cancer.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24">(15-24)</a> Furthermore, SHP2 has also been implicated as a therapeutic target for triple-negative and HER2<sup>+</sup> breast cancer.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Finally, given the obligatory requirement of SHP2 in multiple growth factor-mediated pathways, thwarting SHP2 activity may also prove effective for cancers caused by abnormal activation of receptor PTKs, some of which respond poorly to kinase inhibitor monotherapy.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This strong validation of SHP2 as an oncology target has generated considerable interest in the development of small molecule SHP2 inhibitors as potential therapeutic agents for hematologic malignancies and solid tumors.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41">(27-41)</a></div><div class="NLM_p last">Unfortunately, PTPs, including SHP2, have proven to be an extremely difficult target for drug discovery, due primarily to the highly conserved and positively charged nature of its PTP active site. Indeed, the majority of reported SHP2 inhibitors lack either appropriate selectivity or membrane permeability, limiting their utility in modulating the activity of the intracellular SHP2 phosphatase. We describe here a structure-guided and fragment-based focused library approach, which led to the development of a novel SHP2 inhibitor from the hydroxyindole carboxylic acid scaffold. This inhibitor has an IC<sub>50</sub> of 200 nM for SHP2 that is over 5-fold more selective for SHP2 than any of the over 20 tested PTPs. In addition, this inhibitor efficaciously blocks growth factor stimulated Erk1/2 activation and proliferation in a number of cancer cell lines, validating the concept that small molecule SHP2 inhibitors may be developed that effectively treat solid cancers and leukemias.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Structure-Guided and Fragment-Based Library Approach for Acquisition of SHP2 Inhibitors</h3><div class="NLM_p">The goal for this study was to combine structure-guided design and fragment-based focused library approach to obtain potent and selective SHP2 inhibitors for preclinical evaluation and pharmacological validation of SHP2 as an oncology drug target. However, targeting PTPs for therapeutic development has historically been shrouded with two major challenges. First, the similarities between their active sites (i.e., the pTyr-binding pockets) make it nearly impossible to develop small molecules capable of inhibiting just one of the 100 plus PTPs encoded by the human genome without inhibiting other closely related family members. Second, finding compounds with high affinity for the positively charged PTP active site while at the same time possessing favorable cell permeability also seems an insurmountable mountain to climb. To enhance both inhibitor potency and selectivity, we have advanced a novel paradigm to acquire compounds that interact not only with the pTyr-binding pocket but also nearby peripheral sites that are unique to particular PTPs.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> Application of this strategy has enabled the identification of a number of potent and selective PTP inhibitors.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> To address the bioavailability issue, we sought to identify nonhydrolyzable pTyr mimetics that possess sufficient polarity to bind the PTP active site yet still capable of penetrating cell membranes. We discovered that bicyclic salicylic acids could serve as novel nonphosphorus-containing pTyr mimetics and PTP inhibitors carrying a bicyclic salicylic acid scaffold have excellent cellular efficacies.<a onclick="showRef(event, 'ref35 ref45 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref35 ref45 ref46 ref47 ref48 ref49">(35, 45-49)</a></div><div class="NLM_p">To target both the active site and adjacent secondary binding cavities in SHP2, Click reaction was initially utilized to tether an alkyne-containing hydroxyindole carboxylic acid with 53 azide-containing amines and hydrazines.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This led to the identification of II-B08 (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), which exhibits an IC<sub>50</sub> of 5.5 μM for SHP2 and several-fold selectivity against a panel of mammalian PTPs. However, the potency and selectivity displayed by II-B08 are still modest and insufficient for further pharmacological investigation. Given its promising in vitro and in vivo activities,<a onclick="showRef(event, 'ref35 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref35 ref50 ref51">(35, 50, 51)</a> we envisioned that II-B08 could serve as an excellent starting point upon which more potent and selective SHP2 inhibitors can be developed. To guide the design of next-generation SHP2 inhibitors, we solved the X-ray crystal structure of SHP2 in complex with II-B08.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The co-crystal structure reveals that in addition to the hydroxyindole carboxylic acid-dependent interactions with the SHP2 active site, the distal phenyl ring in the biphenyl moiety is sandwiched between the side chains of R362 and K364 in the β<sub>5</sub>–β<sub>6</sub> loop (residues 362–365). Interestingly, the β<sub>5</sub>–β<sub>6</sub> loop is variable among the PTPs, and interactions between the terminal biphenyl group and residues R362 and K364 likely contribute to the observed potency and selectivity of II-B08.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Little interaction was observed between SHP2 and the 2-phenyl group (the α-ring) directly attached to the hydroxyindole carboxylic acid core. In addition, there was no significant contact between the triazol linker and SHP2. Molecular modeling indicated that appropriately functionalized substituents placed at the meta-position of the α-ring could increase inhibitor binding to SHP2 active site and the β<sub>5</sub>–β<sub>6</sub> loop. To this end, we devised a fragment-based focused library strategy (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) to transform the hydroxyindole carboxylic acid scaffold into highly potent and selective SHP2 inhibitors. The libraries contain (1) the hydroxyindole carboxylic acid core to target SHP2 active site, (2) proper linkers to connect the hydroxyindole carboxylic acid to (3) a structurally diverse collection of amines, intended to capture additional interactions with the adjacent β<sub>5</sub>–β<sub>6</sub> loop. In the interest of keeping the libraries to a manageable size, we chose 192 commercially available amines that differ in size, charge, hydrophobicity, polarity, solubility, and drug-like properties, which should provide a reasonable (albeit limited) structural diversity to increase the number and strength of noncovalent interactions between SHP2 and the inhibitor. To ensure that library components can optimally bridge both the active site cavity and the adjacent peripheral site in SHP2, a spacer of 0–3 methylene units was introduced between the two carbonyls in the amino-oxo acylamido phenyl linker (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Hydroxyindole Carboxylic Acid Based Libraries <b>11a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) FmocOSu, THF, reflux, 20 h, 81.4%; (b) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Na<sub>2</sub>CO<sub>3</sub>, DMF, 44%; (c) I<sub>2</sub>, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> or AcCN, rt, 86%; (d) 50% diethylamine in DCM, 3 h, 85%; (e) 5% LiOH/THF = 1:2, 80 °C, 2 h, 97.2%; (f) corresponding acyl chloride, Et<sub>3</sub>N, DMF, 0 °C, 80–90%; (g) 5% LiOH/THF = 1:2, rt, 2 h, 80–90%; (h) 192 amines, HOBT, HBTU, DIPEA, DMF, rt, overnigh,. 60–80%.</p></p></figure><div class="NLM_p">To construct the bidentate libraries (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), amine <b>1</b> was protected with FmocOSu to produce alkyne <b>2</b>. Alkyne <b>2</b> was coupled with iodide <b>3</b> by Sonogashira reaction to afford compound <b>4</b> with 44% yield.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Electrophilic cyclization of <b>4</b> by I<sub>2</sub> furnished compound <b>5</b> in 86% yield. Deprotection of <b>5</b> under 50% diethylamine in DCM afforded amine <b>6</b>. Compound <b>7</b> was obtained by hydrolysis of <b>6</b> in 5% LiOH under 80 °C for 2 h. Compound <b>7</b> upon treatment with acetyl chlorides <b>8a</b>–<b>d</b> yielded compounds <b>9a</b>–<b>d</b>, which were hydrolyzed in 5% LiOH at room temperature for 2 h to produce compounds <b>10a</b>–<b>d</b>. To assemble libraries <b>11a</b>–<b>d</b>, 192 structurally diverse amines were introduced, in equal quantities, into individual wells of two 96-well plates in the presence of HOBT, HBTU, and DIPEA in DMF to condense with the carboxylic acid in compounds <b>10a</b>–<b>d</b> overnight. The quality of the reactions in the wells was randomly monitored by LC-MS, indicating that 60–80% of compounds <b>10a</b>–<b>d</b> was converted to the desired products.</div><div class="NLM_p">Libraries <b>11a</b>–<b>d</b> were screened at ∼5 μM for SHP2 inhibitors without further purification. The ability of the library components to inhibit the SHP2-catalyzed hydrolysis of <i>p</i>-nitrophenyl phosphate (<i>p</i>NPP) was evaluated at pH 7 and 25 °C. It became immediately evident from the initial screening results that the linker length is of critical importance. In fact, all of the top hits were from library <b>11a</b>, which had the shortest oxalic linker. The top 20 hits from library <b>11a</b> were resynthesized, purified by HPLC, and their IC<sub>50</sub> values determined. As can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the IC<sub>50</sub> values matched well with the percent inhibition data measured at ∼5 μM compound concentration. The best hit compound <b>11a</b>-<b>1</b> identified from the screen also exhibited the lowest IC<sub>50</sub> value of 0.20 ± 0.02 μM against SHP2. Similar to <b>11a</b>-<b>1</b>, other compounds bearing a biaryl substituent (e.g., <b>11a</b>-<b>2</b> and <b>11a</b>-<b>5</b>) also strongly inhibited SHP2. Interestingly, compounds with the benzyloxyphenyl amino scaffold (e.g., <b>11a</b>-<b>3</b> and <b>11a</b>-<b>6</b>) also inhibited SHP2 at submicromolar concentration. To further establish biaryl substituents as privileged structures for SHP2 binding, we synthesized six additional biaryl substituted derivatives of <b>11a</b>-<b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As expected, the IC<sub>50</sub> values of compounds <b>11a</b>-<b>21</b> to <b>11a</b>-<b>26</b> are comparable to that of <b>11a</b>-<b>1</b>. To confirm the effectiveness of oxalic linker, we resynthesized and characterized 11 top hits from library <b>11c</b> (with a succinic linker). In agreement with the results from screening, the hits selected from library <b>11c</b> were less potent than their library <b>11a</b> counterparts (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). For example, <b>11c</b>-<b>1</b>, the top hit from library <b>11c</b>, had an IC<sub>50</sub> of 2.3 μM, more than 10 times higher than that of <b>11a</b>-<b>1</b> (IC<sub>50</sub> = 0.20 μM). Collectively, the structure and activity data indicate that the aromatic oxalic linker and biaryl substituents are preferred for enhanced inhibitor binding toward SHP2. Selectivity profiling revealed that <b>11a</b>-<b>1</b> exhibits over 5-fold selectivity for SHP2 over a large panel of 20 mammalian PTPs, including receptor-like PTPs, PTPμ, PTPε, PTPα, PTPσ, and PTPγ, cytosolic PTPs, PTP1B, Lyp, SHP1, PTPH1, HePTP, STEP, and PEZ, the dual specificity phosphatase VHR, VHZ, MKP5, CDC14A, UBLCP1, and Laforin, and the low-molecular-weight PTP and SSu72 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Of particular note, compound <b>11a</b>-<b>1</b> displayed a 7- and 11-fold preference for SHP2 over its closely related homologue SHP1 and PTP1B. To the best of our knowledge, <b>11a</b>-<b>1</b> is the most potent SHP2 inhibitor reported to date.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values (μM) of Top Hits from Library <b>11a</b> for SHP2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0008.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values (μM) of <b>11a</b>-<b>21</b> to <b>11a</b>-<b>26</b> for SHP2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0009.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values (μM) of Top Hits from Library <b>11c</b> for SHP2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0010.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selectivity of <b>11a</b>-<b>1</b> against a Panel of PTPs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0011.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PTP</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">PTP</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SHP2</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.02</td><td class="colsep0 rowsep0" align="left">VHR</td><td class="colsep0 rowsep0" align="center">3.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LYP</td><td class="colsep0 rowsep0" align="char" char="±">1.05 ± 0.02</td><td class="colsep0 rowsep0" align="left">PTPμ</td><td class="colsep0 rowsep0" align="center">3.3 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HePTP</td><td class="colsep0 rowsep0" align="char" char="±">1.03 ± 0.08</td><td class="colsep0 rowsep0" align="left">STEP</td><td class="colsep0 rowsep0" align="center">4.0 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTPH1</td><td class="colsep0 rowsep0" align="char" char="±">1.07 ± 0.07</td><td class="colsep0 rowsep0" align="left">PEZ</td><td class="colsep0 rowsep0" align="center">5.3 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SHP1</td><td class="colsep0 rowsep0" align="char" char="±">1.44 ± 0.04</td><td class="colsep0 rowsep0" align="left">PTPσ</td><td class="colsep0 rowsep0" align="center">8.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ssu72</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">UBLCP1</td><td class="colsep0 rowsep0" align="center">9.7 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTP1B</td><td class="colsep0 rowsep0" align="char" char="±">2.29 ± 0.03</td><td class="colsep0 rowsep0" align="left">laforin</td><td class="colsep0 rowsep0" align="center">12.2 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LMWPTP</td><td class="colsep0 rowsep0" align="char" char="±">2.34 ± 0.02</td><td class="colsep0 rowsep0" align="left">CDC14A</td><td class="colsep0 rowsep0" align="center">16 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VHZ</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">PTPε</td><td class="colsep0 rowsep0" align="center">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTPγ</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.4</td><td class="colsep0 rowsep0" align="left">PTPα</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKP5</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Structural Basis of SHP2 Inhibition by Compound <b>11a</b>-<b>1</b> and <b>11c</b>-<b>9</b></h3><div class="NLM_p">To elucidate the structural basis of SHP2 inhibition by <b>11a</b>-<b>1</b>, we sought to determine the crystal structure of the SHP2 PTP domain (residues 240–528) in complex with <b>11a</b>-<b>1</b>. Unfortunately, no diffraction quality crystals were obtained for the complex. Instead, we were able to cocrystallize SHP2 with <b>11c</b>-<b>9</b> and solved the crystal structure of SHP2 in complex with <b>11c</b>-<b>9</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, IC<sub>50</sub> = 14 μM). The SHP2·<b>11c</b>-<b>9</b> complex crystallized in space group <i>P</i>1 with one molecule in the asymmetric unit. The crystals of the SHP2·<b>11c</b>-<b>9</b> complex diffracted to 2.1 Å resolution, and the structure was solved by molecular replacement, using the apo-form of SHP2 catalytic domain (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B7O">3B7O</a>)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> as the search model. The three-dimensional structure of SHP2·<b>11c</b>-<b>9</b> was refined to a crystallographic <i>R</i>-factor of 18.7% (<i>R</i><sub>free</sub> = 22.1%), and the statistics for data collection and refinement are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The atomic model includes SHP2 residues 246–314 and 323–526, and all atoms of the compound <b>11c</b>-<b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">1</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure of SHP2 in complex with compound <b>11c</b>-<b>9</b>. (A) Overall structure of SHP2 in complex with <b>11c</b>-<b>9</b>. The P-loop is shown in pink, the WPD-loop in blue, the Q-loop in green, the pY-loop in orange, and the β<sub>5</sub>–β<sub>6</sub> loop in cyan. Compound <b>11c</b>-<b>9</b> is shown in stick model with unbiased <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map contoured at 2.5σ calculated before the ligand and water molecules were added to the model. (B) Detailed interactions between compound <b>11c</b>-<b>9</b> and SHP2. Polar interactions or H-bonds are shown by red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Data Collection and Refinement Statistics</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">SHP2·<b>11c</b>-<b>9</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">crystal parameters</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell dimensions</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i> (Å)</td><td class="colsep0 rowsep0" align="left">40.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>b</i> (Å)</td><td class="colsep0 rowsep0" align="left">40.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">48.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α (deg)</td><td class="colsep0 rowsep0" align="left">94.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β (deg)</td><td class="colsep0 rowsep0" align="left">109.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">γ (deg)</td><td class="colsep0 rowsep0" align="left">110.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">data collection</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution range (Å)</td><td class="colsep0 rowsep0" align="left">50.0–2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. of unique reflections</td><td class="colsep0 rowsep0" align="left">12808</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">82.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">redundancy</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.071</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">refinement</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution range (Å)</td><td class="colsep0 rowsep0" align="left">50.0–2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. of reflections used (<i>F</i> ≥ 2.0δ (<i>F</i>))</td><td class="colsep0 rowsep0" align="left">8843</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">94.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. of protein atoms</td><td class="colsep0 rowsep0" align="left">2219</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. of inhibitors</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>/<i>R</i><sub>free</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">18.7/22.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rms deviations from ideal geometry</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bond length (Å)</td><td class="colsep0 rowsep0" align="left">0.0079</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bond angle (deg)</td><td class="colsep0 rowsep0" align="left">1.33</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last"><i>R</i><sub>merge</sub> = ∑<sub><i>h</i></sub> ∑<sub><i>i</i></sub>|<i>I</i>(<i>h</i>)<sub><i>i</i></sub> – ⟨<i>I</i>(<i>h</i>)⟩|/∑<sub><i>h</i></sub>∑<sub><i>i</i></sub><i>I</i>(<i>h</i>)<sub><i>i</i></sub>.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last"><i>R</i><sub>work</sub> = ∑<sub><i>h</i></sub>|<i>F</i>(<i>h</i>)<sub>calcd</sub> – <i>F</i>(<i>h</i>)<sub>obsd</sub>|/∑<sub><i>h</i></sub><i>F</i>(<i>h</i>)<sub>obsd</sub>, where <i>F</i>(<i>h</i>)<sub>calcd</sub> and <i>F</i>(<i>h</i>)<sub>obsd</sub> were the refined calculated and observed structure factors, respectively.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last"><i>R</i><sub>free</sub> was calculated for a randomly selected 3.9% of the reflections that were omitted from refinement.</p></div></div></div><div class="NLM_p">The overall structure of SHP2·<b>11c</b>-<b>9</b> is similar to the ligand free SHP2 structure used for molecular replacement, with the root-mean-square-deviation (rmsd) for all α-carbon positions between the two being 0.53 Å. A major difference between the two structures are electron density in the SHP2 active site corresponding to <b>11c</b>-<b>9</b>, which was confirmed by the |<i>F</i><sub>o</sub>| – |<i>F</i><sub>c</sub>| difference map contoured at 2.5σ (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">1</a>A). As expected, the hydroxyindole carboxylic acid moiety in <b>11c</b>-<b>9</b> occupies the SHP2 active-site pocket and forms extensive interactions with residues in the P-loop (residues 458–465), the pY recognition loop (residues 277–284), and the Q loop (residues 501–507) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">1</a>B). Specifically, the phenolic oxygen O<sub>1</sub> within the hydroxyindole carboxylic acid core makes two hydrogen bonds with the side chain of R465 in the P-loop; the carboxylate O<sub>2</sub> is hydrogen bonded to the main chain amide of R465, and O<sub>3</sub> contributes one H-bond with the main chain amide of A461 and one polar interaction with the side chain of S460. The indole ring interacts favorably with the side chains of S460, A461, and R465 in the P-loop as well as the side chains of Q506, T507, and Q510 in the Q-loop, and the iodine atom at the 3-position of the indole ring has van der Waals contacts with the side chain of Y279. Interestingly, the distal benzodioxol ring in <b>11c</b>-<b>9</b> is also involved in polar and nonpolar interactions with the side chain of K364 in the β<sub>5</sub>–β<sub>6</sub> loop (residues 362–365). Finally, the succinic linker makes van der Waals contacts with both the side chain of R362 in the β<sub>5</sub>–β<sub>6</sub> loop and the side chain of H426 in the WPD loop (residues 421–431), whereas the carbonyl oxygen O<sub>4</sub> in the linker forms a polar interaction with the side chain of R362.</div><div class="NLM_p">Guided by our previous SHP2·II-B08 structure<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the current SHP2·<b>11c</b>-<b>9</b> structure, we sought to understand the molecular basis of compound <b>11a</b>-<b>1</b> mediated SHP2 inhibition by carrying out docking studies within the area that covers both II-B08 and <b>11c</b>-<b>9</b> around the SHP2 active site. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a>A, the overall SHP2 binding mode of <b>11a</b>-<b>1</b> (green carbon) is similar to those of II-B08 (cyan carbon) and <b>11c</b>-<b>9</b> (purple carbon). In all three cases, the hydroxyindole carboxylic acid motif penetrates into the active site, and the distal heterocycle tail interacts with a groove formed by residues in the β<sub>5</sub>–β<sub>6</sub> loop. However, unlike II-B08 or <b>11c</b>-<b>9</b>, which extend their heterocycle tail to the groove via their flexible linkers primarily along the Q-loop and WPD-loop, compound <b>11a</b>-<b>1</b> spreads its tail through the rigid oxalic linker along the pY recognition loop. Consequently, the hydroxyindole carboxylic acid in <b>11a</b>-<b>1</b> binds more deeply into the active site along the pY recognition cleft, occupies most of the active site pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a>B), and the adjacent α-phenyl ring forms strong π–π stacking interaction with Y279 in the pY recognition loop (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a>C), which is not observed in SHP2·II-B08 and SHP2·<b>11c</b>-<b>9</b> structures. In addition, the oxalamide linker properly places the phenylthiophene tail to be well sandwiched by R362 and K364 in the β<sub>5</sub>–β<sub>6</sub> loop (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a>D). In more detail (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a>E), the hydroxyindole carboxylic acid forms four H-bonds with the backbone amides of S460, I463, G464, and R465 in the P-loop, which anchors the indole core in the active site to be in van der Waals contacts with several P-loop residues, the 1-methyl group makes hydrophobic interactions with A461, Y279, and I282 and the α-phenyl ring π–π stacks with Y279, and one of the carbonyls within the oxalamide linker forms H-bond with the side chain of K364, which thus orients the phenylthiophene tail between R362 and K364 in the β<sub>5</sub>–β<sub>6</sub> loop. Collectively, the increased and more favorable interactions between <b>11a</b>-<b>1</b> and SHP2 likely contribute to <b>11a</b>-<b>1</b>’s enhanced inhibition potency and selectivity toward SHP2. To corroborate the proposed <b>11a</b>-<b>1</b> binding mode, we carried out site-directed mutagenesis to convert the β<sub>5</sub>–β<sub>6</sub> loop residues R362 and K364 to Ala and Ser, respectively. The R362A and K364S mutants displayed similar <i>k</i><sub>cat</sub> and <i>K</i><sub>m</sub> to those of the wild-type SHP2. However, the IC<sub>50</sub> values of <b>11a</b>-<b>1</b> for R363A and K364S were 2.2- and 1.5-fold higher than that of wild-type SHP2. These results are in agreement with the binding mode observed from the docking analysis, supporting the conclusion that interactions between <b>11a</b>-<b>1</b> and R362/K364 contribute to the enhanced potency of <b>11a</b>-<b>1</b> for SHP2.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SHP2 binding mode by <b>11a</b>-<b>1</b> revealed by molecular docking. (A) The overall binding mode of <b>11a</b>-<b>1</b> (green carbon stick) with SHP2 (represented by transparent surface). The binding modes of II-B08 (cyan carbon stick) and <b>11c</b>-<b>9</b> (purple carbon stick) from the complex structures are shown for comparison. (B) The hydroxyindole carboxylic acid motif (spheres) penetrating deeply into the SHP2 active site along the pY recognition cleft. (C) The α-phenyl ring (spheres) forms strong π–π stack interaction with Y279 (gray carbon stick with dotted surface). (D) The rigid oxalamide linker orients the phenylthiophene (spheres) to be well sandwiched by R362 and K364 (gray carbon stick). (E) The interaction details between <b>11a</b>-<b>1</b> (green carbon stick) with SHP2. Residues within 5 Å distance to <b>11a</b>-<b>1</b> are shown in stick. P-loop is highlighted in red, and the other three loops are in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SHP2 Inhibitor <b>11a</b>-<b>1</b> Displays Activity in Several Cancerous Cell Lines</h3><div class="NLM_p">Our goal is to develop potent and specific SHP2 inhibitors as novel anticancer and antileukemia agents. Previous studies have established that SHP2 promotes growth factor-mediated Ras-Erk1/2 activation and cell proliferation.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Given <b>11a</b>-<b>1</b>’s excellent potency and selectivity toward SHP2, we evaluated its ability to inhibit SHP2-dependent signaling and proliferation in a number of cancer cell lines. We previously demonstrated that SHP2 is required for growth of H1975,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> a nonsmall cell lung cancer (NSCLC) patient-derived cell line with secondary gatekeeper mutations in EGF receptor and showing resistance to EGF receptor inhibitors gefitinib and erlotinib.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> To determine the effect of SHP2 inhibition by <b>11a</b>-<b>1</b>, H1975 cells were treated with various concentrations of <b>11a</b>-<b>1</b> and the cell number was measured by the MTT assay. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a>A, <b>11a</b>-<b>1</b> inhibited H1975 cell proliferation in a dose-dependent manner with an IC<sub>50</sub> of 0.17 ± 0.02 μM.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SHP2 inhibitor <b>11a</b>-<b>1</b> reduced lung cancer cell proliferation and specifically blocked SHP2-dependent signaling. (A) <b>11a</b>-<b>1</b> dose dependently inhibited H1975 proliferation with an IC<sub>50</sub> of 0.17 ± 0.02 μM. (B) <b>11a</b>-<b>1</b> decreased EGF induced Erk1/2 phosphorylation and increased EGF induced paxillin (Y118) phosphorylation in a dose-dependent manner. (C) The structurally related negative control <b>10a</b> failed to block SHP2-dependent signaling at 2 μM. (D) the ability of <b>11a</b>-<b>1</b> to inhibit Erk1/2 activation was blunted in SHP2 knocked down cells, and (E) <b>11a</b>-<b>1</b> had no effect on PMA-stimulated Erk1/2 phosphorylation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because SHP2 phosphatase activity is required for the full activation of the Ras-Erk1/2 pathway,<a onclick="showRef(event, 'ref10 ref55'); return false;" href="javascript:void(0);" class="ref ref10 ref55">(10, 55)</a> we assessed the cellular effect of <b>11a</b>-<b>1</b> on EGF-induced Erk1/2 activation in H1975 cells. As expected, <b>11a</b>-<b>1</b> effectively reduced the EGF-induced Erk1/2 phosphorylation in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a>B). To provide direct evidence that <b>11a</b>-<b>1</b> can block the phosphatase activity of SHP2 inside the cell, we measured the phosphorylation level of Paxillin (pY118), a physiological substrate of SHP2 whose dephosphorylation by SHP2 enhances EGF-stimulated Erk1/2 activation.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a>B, treatment of H1975 cells with <b>11a</b>-<b>1</b> dose dependently increased Paxillin phosphorylation on Y118, which is consistent with the decreased EGF-induced Erk1/2 activation in the presence of <b>11a</b>-<b>1</b>.</div><div class="NLM_p">To ensure that the cellular activity of <b>11a</b>-<b>1</b> is manifested through SHP2 inhibition and not due to nonspecific effects, a structurally related but significantly less inhibitory compound <b>10a</b> (IC<sub>50</sub> of 14.4 μM for SHP2, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was also evaluated. As expected, at 2 μM compound <b>10a</b> exerted no effect on Paxillin and Erk1/2 phosphorylation while at the same concentration compound <b>11a</b>-<b>1</b> reduced Erk1/2 phosphorylation by 40% and augmented Paxillin phosphorylation by 30% (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a>C). Moreover, the ability of <b>11a</b>-<b>1</b> to attenuate EGF-mediated Erk1/2 activation was blunted when the level of SHP2 was knocked down with siRNA. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a>D, at 2 μM concentration <b>11a</b>-<b>1</b> reduced Erk1/2 phosphorylation by 2.2-fold in cells treated with scrambled siRNA but only 1.5-fold in cells treated with SHP2 siRNA. To provide further evidence that the observed cellular effect of <b>11a</b>-<b>1</b> is SHP2 dependent, we examined the effect of <b>11a</b>-<b>1</b> on PMA (phorbol 12-myristate 13-acetate)-induced Erk1/2 activation, which is SHP2 independent<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and instead depends on the activation of protein kinase C and Raf<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> in a Ras-independent manner.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Thus, SHP2 inhibitors would not be expected to affect PMA-induced Erk1/2 phosphorylation. Indeed, compound <b>11a</b>-<b>1</b> had no effect on PMA-induced Erk1/2 phosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a>E). Taken together, the results indicate that <b>11a</b>-<b>1</b> specifically inhibits SHP2-mediated cellular signaling events.</div><div class="NLM_p">The promising activity of <b>11a</b>-<b>1</b> in inhibiting H1975 lung cancer cell proliferation spurred an investigation into its effectiveness on inhibiting the growth of the ErbB2 positive SKBR3 breast cancer cell line. These cells through upregulation of ErbB2 strongly activate Ras, which then promotes either Akt signaling when grown on plastic or Erk1/2 signaling when grown in Matrigel.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Given the multitude of studies that show that cancer cells grow in Matrigel as a mass that much more closely models the formation and signaling properties of real human tumors,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> the effectiveness of <b>11a</b>-<b>1</b> in blocking the growth of these cells in Matrigel was determined. Consistently, SKBR3 cells formed tumor like growths in Matrigel treated with vehicle but their growth within 24 h was potently inhibited by 3 μM of <b>11a</b>-<b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">4</a>A). Further, while both control and <b>11a</b>-<b>1</b> treated cells showed equivalent levels of total Erk1/2 and Akt over 4 days, their levels of phosphorylation were concordantly inhibited by increasing concentrations <b>11a</b>-<b>1</b> from 1 to 10 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">4</a>B). Taken together, <b>11a</b>-<b>1</b> potently inhibits the growth of the ErbB2 positive SKBR3 cell line, most likely through its ability to block SHP2-dependent Erk1/2 and Akt activation.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>11a</b>-<b>1</b> inhibits Erk1/2 and Akt activity and ErbB2+ breast cancer cell growth in a 3D Matrigel environment. (A) SKBR3 cells were seeded into Matrigel, and their growth was then monitored over 4 days in the presence of vehicle or the indicated concentrations of <b>11a</b>-<b>1</b>. (B) Cells after 4 days of growth in Matrigel were recovered and the levels of the total and phospho forms of Erk1/2 and Akt were measured by immunoblot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Gain-of-function mutations in KIT receptor (KITD814V) in humans are associated with gastrointestinal stromal tumors, systemic mastocytosis, and acute myelogenous leukemia.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> We have previously shown that our first-generation SHP2 inhibitor II-B08 suppresses the growth of oncogenic KITD814V-induced ligand-independent growth.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> To further determine the efficacy of the new SHP2 inhibitor <b>11a</b>-<b>1</b>, we compared the growth of oncogenic KITD814V-bearing 32D myeloid cells in the presence of II-B08 and <b>11a</b>-<b>1</b>. As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">5</a>A, we did not see any significant suppression in the growth of wild-type KIT-bearing cells in the presence of II-B08 or <b>11a</b>-<b>1</b> at the tested concentrations. This was to be expected because SHP2 exists in an autoinhibited conformation in the absence of ligand stimulated KIT activation.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In contrast, treatment with II-B08 at 5 μM showed significant suppression in ligand-independent growth of KITD814V-bearing cells but not at 1 μM concentration. Furthermore, treatment with <b>11a</b>-<b>1</b> showed significant inhibition of ligand-independent growth of KITD814V-bearing cells at both 1 and 5 μM concentrations. To further determine the effect of II-B08 and <b>11a</b>-<b>1</b> on primary bone marrow cells bearing oncogenic KITD814V, we transduced primary low-density bone marrow cells from C57BL/6 mice with KITD814V and sorted cells were subjected to proliferation assay in the presence or absence of SHP2 inhibitors II-B08 and <b>11a</b>-<b>1</b>. Similar to 32D myeloid cells, primary bone marrow cells bearing KITD814V showed significant reduced growth in the presence of <b>11a</b>-<b>1</b> compared to II-B08 at both 1 and 5 μM concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">5</a>B). These results suggest that <b>11a</b>-<b>1</b> is more potent in inhibiting oncogenic KITD814V-induced constitutive growth compared to II-B08.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>11a</b>-<b>1</b> on 32D cells. (A) 32D myeloid cells bearing wild-type (WT) KIT or KITD814V were starved of serum and growth factors for 6 h and subjected to proliferation assay in the presence or absence of indicated concentration of II-B08 or <b>11a</b>-<b>1</b>. Assay was performed in the presence of IL-3 (10 ng/mL) for cells bearing WT KIT and in the absence of growth factors for cells bearing oncogenic KITD814V. Bars denote the mean thymidine incorporation (CPM ± SEM) consolidated from four independent experiments performed in triplicate. *<i>p</i> < 0.05. (B) WT hematopoietic stem and progenitor cells bearing KITD814V were starved of serum and growth factors for 6 h and subjected to proliferation assay in the presence or absence of indicated concentration of II-B08 or <b>11a</b>-<b>1</b>. Bars denote the mean thymidine incorporation (CPM ± SD) performed in triplicate from one experiment. *<i>p</i> < 0.05. (C) 32D myeloid cells bearing KITD814V were starved of serum and growth factors for 6 h and incubated with the indicated concentration of <b>11a</b>-<b>1</b> for 2 h. After treatment, cells were lysed and equal amount of protein lysates were subjected to Western blot analysis using indicated antibodies. Similar results were observed in two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Previous studies have shown that SHP2 controls the cell growth and survival through regulation of the activation of Akt and Erk1/2 signaling. We also found that SHP2 inhibitor II-B08 suppresses the activation of Akt in oncogenic KITD814V-bearing cells. To determine whether SHP2 inhibitor <b>11a</b>-<b>1</b> also suppress the ligand-independent activation of Akt and Erk1/2 signaling, we starved the 32D myeloid cells bearing wild-type KIT or KITD814V and treated them with <b>11a</b>-<b>1</b>. Consistent with our previous results, cells bearing wild-type KIT did not show any constitutive activation of Akt or Erk1/2 in the presence or absence of <b>11a</b>-<b>1</b> (data not shown). Likewise, constitutive phosphorylation of Akt and Erk1/2 was observed in oncogenic KITD814V-bearing cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">5</a>C, lane 1). There was dose-dependent inhibition of phosphorylation of Akt and Erk1/2 in the presence of <b>11a</b>-<b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">5</a>C, lanes 2–4). These results suggest that <b>11a</b>-<b>1</b> inhibits the activation of Akt and Erk1/2 signaling, leading to reduced growth of oncogenic KITD814V-bearing cells. Collectively, the results described above indicate that <b>11a</b>-<b>1</b> is highly efficacious in blocking SHP2 activity and cell proliferation in H1975 lung cancer cells, ErbB2 positive SKBR3 breast cancer cells, and oncogenic KITD814V-bearing 32D myeloid cells and primary low-density bone marrow cells.</div></div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we report a novel hydroxyindole carboxylic acid-based inhibitor for SHP2, an oncogenic phosphatase required for multiple growth factor receptor signaling and implicated in a broad-spectrum of cancer and leukemia. We took a structure-guided approach that targets the SHP2 active site with hydroxyindole carboxylic acid and relies on a fragment-based library strategy to introduce additional functionalities intended to interact with peripheral sites proximal to the catalytic pocket to increase binding affinity and selectivity for SHP2. This led to the transformation of a modest 5.5 μM hit II-B08 into a 200 nM SHP2 inhibitor <b>11a</b>-<b>1</b> with greater than 5-fold selectivity against a large panel of mammalian PTPs. Structural analysis and molecular modeling reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site while interactions of the oxalamide linker and phenylthiophene tail with residues in the β<sub>5</sub>–β<sub>6</sub> loop contribute significantly to <b>11a</b>-<b>1</b>’s binding potency and selectivity toward SHP2. We provide evidence that <b>11a</b>-<b>1</b> displays highly efficacious cellular activity and can specifically block the SHP2-dependent signaling inside the cell. Moreover, <b>11a</b>-<b>1</b> attenuates growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in nonsmall cell lung cancer cell line H1975, ErbB2 positive breast cancer cell line SKBR3, and oncogenic KITD814V expressing 32D myeloid cells and primary low-density bone marrow cells. Thus, compound <b>11a</b>-<b>1</b> not only serves as a promising candidate for the development of novel agents for a wide range of neoplastic disorders but also a useful tool to interrogate the function of SHP2 in normal physiology and to elucidate the events underlying SHP2-evoked transformation. Obtaining this knowledge is vital for understanding SHP2-mediated oncogenic mechanisms and for the development of novel anticancer and antileukemia therapies targeted to SHP2.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Materials</h3><div class="NLM_p last"><i>para</i>-Nitrophenyl phosphate (<i>p</i>NPP) was purchased from Fisher Scientific. For organic synthesis, reagents were used as purchased (Aldrich, Acros, Alfa Aesar, TCI) except where noted. Rabbit antiphospho-Akt, antitotal Akt, antiphospho-Erk1/2, antitotal Erk1/2, and anti-phospho-Paxillin (Tyr118) antibodies were purchased from Cell Signaling Technology (Beverly, MA). Anti-Paxilin antibodies were from BD Transduction Laboratories. Recombinant murine interleukin-3 (IL-3), murine stem cell factor (SCF), murine thrombopoietin (TPO), and murine FLT3 ligand (FLT3-L) were purchased from Peprotech (Rocky Hill, NJ). Iscove’s Modified Dulbecco’s Medium (IMDM) was purchased from Invitrogen (Carlsbad, CA). [<sup>3</sup>H] Thymidine was purchased from PerkinElmer (Boston, MA).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedures</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained on Bruker 500 spectrometers with TMS or residual solvent as standard. All column chromatography was performed using Dynamic Adsorbents 230–400 mesh silica gel (SiO<sub>2</sub>) with the indicated solvent system unless otherwise noted. TLC analysis was performed using 254 nm glass-backed plates and visualized using UV light (254 nm), and low-resolution mass spectra and purity data were obtained using an Agilent Technologies 6130 Quadrupole LC/MS. The purity of the compounds were assessed by analytical HPLC, with the solvent gradient started at 0% methanol in water and ended at 100% methanol after 8 min with 0.1% of TFA. The purity of all final tested compounds was determined to be >95% (UV, λ = 254 nm). High-resolution mass spectrum data were collected on an Agilent 6520 Accurate-Mass Q-TOF LC/MS. HPLC purification was carried out on a Waters Delta 600 equipped with a Sunfire Prep C18 OBD column (30 mm × 150 mm, 5 μm) with methanol–water (both containing 0.1% TFA) as mobile phase. The preparative HPLC gradient started at 50% methanol in water and ended at 100% methanol after 40 min with 0.1% of TFA.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (9<i>H</i>-Fluoren-9-yl)methyl (3-Ethynylphenyl)carbamate (<b>2</b>)</h4><div class="NLM_p last">Mixtures of compound <b>1</b> (0.75 mL, 7.18 mmol) and Fmoc-OSu (2.664 g, 7.89 mmol) in 200 mL of THF were refluxed overnight. The solution was partitioned between EtOAc and water. The residue was purified by flash silica chromatography (Hex/EtOAc = 8:1) to afford titled compound as white solid (1.98 g, 81.4%); mp 137–138 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (m, 2H), 7.61 (m, 2H), 7.54 (brs, 1H), 7.36 (m, 3H), 7.28 (m, 2H), 7.23 (m, 1H), 7.21 (m, 1H), 6.66 (brs, 1H), 4.57 (d, <i>J</i> = 6.6 Hz, 2H), 4.30 (t, <i>J</i> = 6.6 Hz, 1H), 3.08 (s, 1H). <sup>13</sup>C NMR (125 MHz, DMSO): δ 153.8, 144.1, 141.2, 139.8, 129.6, 128.1, 127.5, 126.2, 125.5, 122.5, 121.5, 120.6, 119.3, 83.5, 80.9, 66.1, 47.0. HRMS (ESI): (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>18</sub>NO<sub>2</sub>, 340.1332; found, 340.1341. LC-MS (ESI): 362.0 (M + Na)<sup>+</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Methyl 5-((3-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)phenyl)ethynyl)-4-(dimethylamino)-2-hydroxybenzoate (<b>4</b>)</h4><div class="NLM_p last">A mixture of methyl 4-(dimethylamino)-2-hydroxy-5-iodobenzoate <b>3</b> (5.13 g, 16 mmol), compound <b>2</b> (6.5 g, 19 mmol), Na<sub>2</sub>CO<sub>3</sub> (2.03 g, 19.2 mmol), bis(triphenylphosphine)palladium(II) chloride (0.576 g, 0.8 mmol), and CuI (304 mg, 1.6 mmol) were loaded in a flask, which was degassed and backfilled with nitrogen. then 15 mL of DMF were added. The resulting mixture was stirred under a nitrogen atmosphere at room temperature for 4 h. The reaction was monitored by TLC to establish completion. The solution was partitioned between EtOAc (200 mL) and brine (200 mL). The organic layers were washed with brine (3 × 200 mL), dried over sodium sulfate, and concentrated in vacuum. The residue was purified by flash silica chromatography (Hex/EtOAc = 4:1) to afford titled compound as viscous oil (3.74 g, 44%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.96 (s, 1H), 7.97 (s, 1H), 7.80 (m, 2H), 7.64 (m, 2H), 7.58 (brs, 1H), 7.45 (m, 2H), 7.20–7.31 (m, 6H), 6.72 (brs, 1H), 6.33 (s, 1H), 4.57 (d, <i>J</i> = 6.6 Hz, 2H), 4.30 (t, <i>J</i> = 6.6 Hz, 1H), 3.93 (s, 3H), 3.15 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 169.8, 162.6, 159.2, 153.2, 153.2, 143.6, 141.3, 137.8, 137.4, 129.0, 127.8, 127.6, 127.1, 126.1, 124.9, 124.7, 120.7, 120.0, 104.1, 103.9, 102.8, 92.1, 89.0, 66.9, 51.9, 47.1, 42.5. HRMS (ESI): (M + H)<sup>+</sup> calcd for C<sub>33</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>, 533.2071; found, 533.2072. LC-MS (ESI): 533.2 (M + H)<sup>+</sup>, 530.8 (M −H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Methyl 2-(3-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylate (<b>5</b>)</h4><div class="NLM_p last">To a solution of <b>4</b> (1.72 g, 3.23 mmol) and NaHCO<sub>3</sub> (0.408 g, 4.85 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) was added iodine (1.23 g, 4.85 mmol). The resulting mixture was stirred at room temperature for 4 h, then 100 mL of CH<sub>2</sub>Cl<sub>2</sub> was added, then washed with saturated aqueous Na<sub>2</sub>SO<sub>3</sub> solution (2 × 500 mL) and brine (500 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuum. The residue was purified by flash chromatography (hexane/THF = 1:1) to afford the title compound as colorless solid (1.79 g, 86%); mp 131–132 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.92 (s, 1H), 8.03 (s, 1H), 7.79 (m, 2H), 7.65 (m, 2H), 7.48 (m, 5H), 7.36 (m, 2H), 7.18 (m, 1H), 6.85 (s, 1H), 6.80 (s, 1H), 4.61 (m, 2H), 4.30 (m, 1H), 4.03 (s, 3H), 3.60 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.2, 158.2, 153.4, 143.6, 142.5, 142.2, 141.3, 137.9, 131.9, 129.2, 127.8, 127.1, 127.0, 125.8, 124.8, 124.3, 124.1, 120.0, 107.6, 96.2, 66.9, 60.0, 52.3, 47.1, 32.1. HRMS (ESI): (M + H)<sup>+</sup> calcd for C<sub>32</sub>H<sub>26</sub>IN<sub>2</sub>O<sub>5</sub>, 645.0881; found, 645.0851. LC-MS (ESI): 667.0 (M + Na)<sup>+</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methyl 2-(3-Aminophenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylate (<b>6</b>)</h4><div class="NLM_p last">Compound <b>5</b> (1.79 g, 2.77 mmol) was dissolved in 10 mL of CH<sub>2</sub>Cl<sub>2</sub>, and then 10 mL of diethylamine was added to the solution under room temperature for 3 h. The solution was concentrated in vacuum. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and brine (200 mL). The organic layer was dried over sodium sulfate and concentrated in vacuum. The residue was purified by flash silica chromatography (CH<sub>2</sub>Cl<sub>2</sub> as elution) to afford the title compound as white solid (1 g, 85.5%); mp 83–85 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.90 (s, 1H), 8.02 (s, 1H), 7.31 (m, 1H), 6.84 (s, 1H), 6.80 (m, 2H), 6.76 (m, 1H), 4.03 (s, 3H), 3.83 (brs, 2H), 3.60 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.2, 158.1, 146.4, 143.1, 142.4, 132.1, 129.4, 124.2, 124.1, 120.8, 117.1, 115.6, 107.4, 96.1, 59.4, 52.1, 32.1. HRMS (ESI): (M + H)<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>IN<sub>2</sub>O<sub>3</sub>, 423.0200; found, 423.0190. LC-MS (ESI): 423.0 (M + H)<sup>+</sup>, 420.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(3-Aminophenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>7</b>)</h4><div class="NLM_p last">Compound <b>6</b> (1 g, 2.37 mmol) was dissolved in 8 mL of THF. Then 5% LiOH (4 mL) solution was added. The mixture was heated to 80 °C for 2 h, cooled to room temperature, diluted by brine (200 mL), acidified by 2 N HCl to pH 5, and extracted with EtOAc (2 × 200 mL). The organic layers were combined, washed with brine, dried over sodium sulfate, and concentrated in vacuum to give the title compound as pale solid (940 mg, 97.2%); decomposed at 148 °C. <sup>1</sup>H NMR (500 MHz, DMSO): δ 7.85 (s, 1H), 7.46 (m, 1H), 7.11 (m, 3H), 7.04 (s, 1H), 4.11 (m, 2H), 3.59 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO): δ 173.0, 158.3, 142.6, 142.5, 140.9, 132.1, 130.0, 124.5, 124.0, 123.8, 120.9, 119.5, 108.1, 97.0, 60.6, 32.5. HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>16</sub>H<sub>12</sub>IN<sub>2</sub>O<sub>3</sub>, 406.9898; found, 406.9894. LC-MS (ESI): 409.0 (M + H)<sup>+</sup>, 407.0 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Method for the Synthesis of <b>9a</b>–<b>d</b></h3><div class="NLM_p last">Compound <b>7</b> (30 mg, 0.074 mmol) was dissolved in 1 mL of DMF under 0 °C, and then 1.5 equiv of corresponding acyl chloride <b>8a</b>–<b>d</b> was added to the solution for overnight. The solution was partitioned between EtOAc (200 mL) and brine (200 mL). The organic layers were washed with brine (3 × 200 mL), dried over sodium sulfate, and concentrated in vacuum to afford the title compounds as pale solids without purification for further use.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Method for the Synthesis of <b>10a</b>–<b>d</b></h3><div class="NLM_p">Compound <b>9a</b>–<b>d</b> (0.074 mmol) was dissolved in 2 mL of THF. Then 5% LiOH (2 mL) solution was added. The mixture was stirred under room temperature for overnight, acidified by 2 N HCl to pH 5, and extracted with EtOAc (2 × 200 mL). The organic layers were combined, washed with brine, dried over sodium sulfate, and concentrated in vacuum. This crude product was purified by Prep-HPLC to give the title compounds.</div><div id="sec3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(3-(Carboxyformamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>10a</b>)</h4><div class="NLM_p last">Pale solid (26 mg, 71%, two steps). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.38 (brs, 1H), 10.95 (s, 1H), 7.94 (m, 2H), 7.86 (s, 1H), 7.54 (m, 1H), 7.30 (m, 1H), 7.05 (s, 1H), 3.61 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO): δ 173.0, 162.4, 158.3, 157.4, 142.5, 142.4, 138.3, 131.5, 129.4, 127.1, 124.0, 123.8, 122.6, 121.1, 108.1, 97.0, 60.8, 32.5. HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>18</sub>H<sub>12</sub>IN<sub>2</sub>O<sub>6</sub>, 478.9746; found, 478.9762. LC-MS (ESI): 481.0 (M + H)<sup>+</sup>, 478.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(3-(2-Carboxyacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>10b</b>)</h4><div class="NLM_p last">Pale solid (30 mg, 82%, two steps). <sup>1</sup>H NMR (500 MHz, DMSO): δ 10.37 (s, 1H), 7.86 (s, 1H), 7.74 (m, 2H), 7.50 (m, 1H), 7.21 (m, 1H), 7.04 (s, 1H), 3.61 (s, 3H), 3.40 (s, 2H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>19</sub>H<sub>14</sub>IN<sub>2</sub>O<sub>6</sub>, 492.9902; found, 492.9933. LC-MS (ESI): 495.0 (M + H)<sup>+</sup>, 492.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(3-(3-Carboxypropanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>10c</b>)</h4><div class="NLM_p last">Pale solid (31 mg, 82%, two steps). <sup>1</sup>H NMR (500 MHz, DMSO): δ 12.16 (brs, 1H), 11.36 (brs, 1H), 10.19 (s, 1H), 7.84 (s, 1H), 7.42 (m, 2H), 7.47 (s, 1H), 7.16 (m, 1H), 7.04 (s, 1H), 3.58 (s, 3H), 2.60 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO): δ 174.2, 173.0, 170.8, 158.3, 142.8, 142.5, 139.9, 131.5, 129.4, 125.4, 123.9, 123.8, 121.2, 119.7, 108.0, 97.1, 60.6, 32.5, 31.5, 29.1. HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>20</sub>H<sub>16</sub>IN<sub>2</sub>O<sub>6</sub>, 507.0059; found, 507.0080. LC-MS (ESI): 509.0 (M + H)<sup>+</sup>, 507.0 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(3-(4-Carboxybutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>10d</b>)</h4><div class="NLM_p last">Pale solid (21 mg, 54%, two steps). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.38 (brs, 1H), 10.12 (s, 1H), 7.85 (s, 1H), 7.74 (m, 2H), 7.48 (m, 1H), 7.17 (m, 1H), 7.04 (s, 1H), 3.59 (s, 3H), 2.40 (m, 2H), 2.29 (m, 2H), 1.83 (m, 2H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>21</sub>H<sub>18</sub>IN<sub>2</sub>O<sub>6</sub>, 521.0215; found, 520.9139. LC-MS (ESI): 523.0 (M + H)<sup>+</sup>, 520.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Procedure for the Assembling of Library <b>11a</b>–<b>d</b></h4><div class="NLM_p last">Compound <b>10a</b>–<b>d</b> (65 mM, 3 μL) in DMF reacted with 192 amines (200 mM, 3 μL) in DMF respectively in the presence of HOBT (14 mM), HBTU (17 mM), and DIPEA (28 mM) in 14 μL of DMF overnight to assemble the combinatorial amide library <b>11a</b>–<b>d</b> in 96-well plates. Ten of the reactions were picked up randomly and monitored by LC-MS, which showed an average of 70% yield desired products.</div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Method for the Synthesis of (<b>11a</b>-<b>1</b> to <b>11a</b>-<b>26</b> and <b>11c</b>-<b>1</b> to <b>11c</b>-<b>11</b>)</h3><div class="NLM_p">Compound <b>11a</b> or <b>11c</b> (0.02 mmol) dissolved in 0.5 mL of DMF was added to a solution of corresponding amines (0.04 mmol), HOBT (3.06 mg, 0.02 mmol), HBTU (7.58 mg, 0.02 mmol), and DIPEA (5.16 μL, 0.04 mmol) in 1 mL of DMF. The mixture was stirred under room temperature for 4 h. This crude product was KJMM purified by Prep-HPLC to give titled compounds.</div><div id="sec3_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(2-oxo-2-((4-(thiophen-3-yl)phenyl)amino)acetamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>1</b>)</h4><div class="NLM_p last">Pale solid (3.8 mg, 29%); decomposed at 185 °C. <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.08 (s, 1H), 10.95 (s, 1H), 8.06 (s, 1H), 8.01 (m, 1H), 7.92 (m, 2H), 7.85 (m, 2H), 7.75 (m, 2H), 7.63 (m, 1H), 7.57 (m, 2H), 7.33 (m, 1H), 7.06 (s, 1H), 3.63 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO): δ 173.0, 159.2, 158.8, 158.3, 142.6, 142.5, 141.4, 138.3, 137.1, 132.0, 131.5, 129.5, 127.5, 127.2, 126.8, 126.5, 124.1, 123.9, 122.8, 121.3, 120.9, 108.1, 97.1, 60.9, 32.6. HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>28</sub>H<sub>19</sub>IN<sub>3</sub>O<sub>5</sub>S, 636.0096; found, 636.0098. LC-MS (ESI): 659.8 (M + Na)<sup>+</sup>, 635.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(3-(2-([1,1′-Biphenyl]-4-ylamino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>2</b>)</h4><div class="NLM_p last">Pale solid (3.5 mg, 27%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.11 (s, 1H), 11.02 (s, 1H), 8.08 (s, 1H), 8.03 (m, 1H), 7.99 (m, 2H), 7.87 (s, 1H), 7.70 (m, 4H), 7.59 (m, 1H), 7.37 (m, 2H), 7.33 (m, 2H), 7.06 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>30</sub>H<sub>21</sub>IN<sub>3</sub>O<sub>5</sub>, 630.0531; found, 630.0546. LC-MS (ESI): 653.8 (M + Na)<sup>+</sup>, 629.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(3-(2-((4-(Benzyloxy)-3-chlorophenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>3</b>)</h4><div class="NLM_p last">Pale solid (4.2 mg, 30%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.37 (s, 1H), 11.07 (s, 1H), 10.97 (s, 1H), 8.04 (m, 2H), 7.93 (m, 1H), 7.86 (s, 1H), 7.80 (m, 1H), 7.59–7.27 (m, 8H), 7.07 (s, 1H), 6.82 (m, 1H), 5.21 (s, 2H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>31</sub>H<sub>22</sub>ClIN<sub>3</sub>O<sub>6</sub>, 694.0247; found, 694.0233. LC-MS (ESI): 718.0 (M + Na)<sup>+</sup>, 693.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(3-(2-((6-Bromobenzo[<i>d</i>]thiazol-2-yl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>4</b>)</h4><div class="NLM_p last">Pale solid (3.4 mg, 24%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 13.16 (s, 1H), 11.37 (s, 1H), 11.27 (s, 1H), 8.37 (s, 1H), 8.02 (m, 2H), 7.87 (s, 1H), 7.78 (m, 1H), 7.63 (m, 2H), 7.34 (m, 1H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>25</sub>H<sub>15</sub>BrIN<sub>4</sub>O<sub>5</sub>S, 688.8997; found, 688.9008. LC-MS (ESI): 690.6 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(3-(2-([1,1′-Biphenyl]-3-ylamino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>5</b>)</h4><div class="NLM_p last">Pale solid (4.5 mg, 35%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.37 (s, 1H), 11.12 (s, 1H), 10.99 (s, 1H), 8.23 (s, 1H), 8.05 (m, 2H), 7.90 (m, 1H), 7.87 (s, 1H), 7.80 (m, 1H), 7.65 (m, 3H), 7.52 (m, 6H), 7.08 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>30</sub>H<sub>21</sub>IN<sub>3</sub>O<sub>5</sub>, 630.0531; found, 630.0533. LC-MS (ESI): 629.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(3-(2-((3-(Benzyloxy)phenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>6</b>)</h4><div class="NLM_p last">Pale solid (3.6 mg, 27%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.38 (s, 1H), 11.09 (s, 1H), 10.86 (s, 1H), 8.06 (s, 1H), 8.00 (m, 1H), 7.86 (s, 1H), 7.64 (s, 1H), 7.58–7.27 (m, 9H), 7.07 (s, 1H), 6.82 (m, 1H), 5.10 (s, 2H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>31</sub>H<sub>23</sub>IN<sub>3</sub>O<sub>6</sub>, 660.0637; found, 660.0627. LC-MS (ESI): 684.0 (M + Na)<sup>+</sup>, 659.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(3-(2-(5-Bromoindolin-1-yl)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>7</b>)</h4><div class="NLM_p last">Pale solid (4.6 mg, 34%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.36 (s, 1H), 11.09 (s, 1H), 8.06 (m, 1H), 7.92 (m, 1H), 7.89 (s, 1H), 7.86 (s, 1H), 7.57 (m, 2H), 7.46 (m, 1H), 7.31 (m, 1H), 7.07 (s, 1H), 4.39 (m, 2H), 3.64 (s, 3H), 3.18 (m, 2H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>26</sub>H<sub>18</sub>BrIN<sub>3</sub>O<sub>5</sub>, 657.9480; found, 657.9501.; LC-MS (ESI): 661.8 (M + H)<sup>+</sup>, 659.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Hydroxy-3-iodo-2-(3-(2-((4-iodophenyl)amino)-2-oxoacetamido)phenyl)-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>8</b>)</h4><div class="NLM_p last">Pale solid (3.5 mg, 25%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.36 (s, 1H), 11.08 (s, 1H), 11.01 (s, 1H), 8.05 (s, 1H), 8.01 (m, 1H), 7.86 (s, 1H), 8.01 (m, 1H), 7.73 (m, 4H), 7.58 (m, 1H), 7.33 (m, 1H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>24</sub>H<sub>16</sub>I<sub>2</sub>N<sub>3</sub>O<sub>5</sub>, 679.9185; found, 679.9183. LC-MS (ESI): 703.8 (M + Na)<sup>+</sup>, 679.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(3-(2-((2-(1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)phenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>9</b>)</h4><div class="NLM_p last">Pale solid (4.7 mg, 35%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.38 (s, 1H), 11.13 (s, 1H), 8.81 (m, 1H), 8.17 (m, 1H), 8.12 (s, 2H), 7.78 (s, 1H), 7.64 (m, 4H), 7.39 (m, 5H), 7.07 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>31</sub>H<sub>21</sub>IN<sub>5</sub>O<sub>5</sub>, 670.0593; found, 670.0594. LC-MS (ESI): 672.0 (M + H)<sup>+</sup>, 669.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(3-(2-(Benzo[<i>d</i>]thiazol-2-ylamino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>10</b>)</h4><div class="NLM_p last">Pale solid (3.5 mg, 28%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 13.02 (s, 1H), 11.37 (s, 1H), 11.28 (s, 1H), 8.12 (m, 1H), 8.06 (s, 2H), 7.85 (m, 2H), 7.60 (m, 1H), 7.52 (m, 1H), 7.38 (m, 2H), 7.06 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>25</sub>H<sub>16</sub>IN<sub>4</sub>O<sub>5</sub>S, 610.9892; found, 610.9884. LC-MS (ESI): 613.0 (M + H)<sup>+</sup>, 610.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(3-(2-((3-Chlorophenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>11</b>)</h4><div class="NLM_p last">Pale solid (4.1 mg, 34%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.36 (s, 1H), 11.11 (s, 1H), 11.10 (s, 1H), 8.03 (m, 3H), 7.85 (m, 2H), 7.57 (m, 1H), 7.42 (m, 1H), 7.34 (m, 1H), 7.24 (m, 1H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>24</sub>H<sub>16</sub>ClIN<sub>3</sub>O<sub>5</sub>, 587.9829; found, 587.9831. LC-MS (ESI): 587.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-(3-(2-((4-(1<i>H</i>-Imidazol-1-yl)phenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>12</b>)</h4><div class="NLM_p last">Pale solid (4.8 mg, 38%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.24 (s, 1H), 11.15 (s, 1H), 9.53 (s, 1H), 8.23 (s, 1H), 8.13 (m, 2H), 8.08 (s, 1H), 8.01 (m, 1H), 7.87 (s, 1H), 7.82 (m, 3H), 7.59 (m, 1H), 7.35 (m, 1H), 7.08 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>27</sub>H<sub>19</sub>IN<sub>5</sub>O<sub>5</sub>, 620.0436; found, 620.0442. LC-MS (ESI): 622.0 (M + H)<sup>+</sup>, 619.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(3-(2-((4-Chloro-3-(trifluoromethyl)phenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>13</b>)</h4><div class="NLM_p last">Pale solid (3.6 mg, 27%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.38 (s, 2H), 11.14 (s, 1H), 10.99 (s, 1H), 8.52 (s, 1H), 8.19 (m, 1H), 8.06 (s, 1H), 8.01 (m, 1H), 7.86 (s, 1H), 7.77 (m, 1H), 7.59 (m, 1H), 7.34 (m, 1H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>25</sub>H<sub>15</sub>ClF<sub>3</sub>IN<sub>3</sub>O<sub>5</sub>, 655.9702; found, 655.9720. LC-MS (ESI): 679.8 (M + Na)<sup>+</sup>, 655.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(2-oxo-2-((5-phenyl-1,3,4-thiadiazol-2-yl)amino)acetamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>14</b>)</h4><div class="NLM_p last">Pale solid (4.5 mg, 35%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 13.61 (s, 1H), 11.38 (s, 1H), 11.29 (s, 1H), 8.01 (m, 4H), 7.86 (s, 1H), 7.58 (m, 4H), 7.34 (m, 4H), 7.07 (s, 1H), 3.62 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>26</sub>H<sub>17</sub>ClIN<sub>5</sub>O<sub>5</sub>S, 638.0001; found, 638.0015. LC-MS (ESI): 637.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(3-(2-((4-Fluorophenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>15</b>)</h4><div class="NLM_p last">Pale solid (4.7 mg, 41%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.39 (s, 1H), 11.11 (s, 1H), 11.02 (s, 1H), 8.06 (s, 1H), 8.01 (m, 1H), 7.92 (m, 2H), 7.88 (s, 1H), 7.58 (m, 1H), 7.34 (m, 1H), 7.23 (m, 2H), 7.06 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>24</sub>H<sub>16</sub>FIN<sub>3</sub>O<sub>5</sub>, 572.0124; found, 572.0148. LC-MS (ESI): 571.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(2-oxo-2-(thiazol-2-ylamino)acetamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>16</b>)</h4><div class="NLM_p last">Pale solid (3.9 mg, 34%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 12.73 (s, 1H), 11.36 (s, 1H), 11.20 (s, 1H), 8.01 (s, 1H), 7.99 (s, 1H), 7.86 (s, 1H), 7.60 (m, 2H), 7.42 (m, 1H), 7.32 (m, 1H), 7.07 (s, 1H), 3.62 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>21</sub>H<sub>14</sub>IN<sub>4</sub>O<sub>5</sub>S, 560.9735; found, 560.9744. LC-MS (ESI): 563.0 (M + H)<sup>+</sup>, 560.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(2-oxo-2-((3-(trifluoromethoxy)phenyl)amino)acetamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>17</b>)</h4><div class="NLM_p last">Pale solid (3.3 mg, 25%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.37 (s, 1H), 11.21 (s, 1H), 11.13 (s, 1H), 8.05 (m, 3H), 7.90 (m, 1H), 7.87 (s, 1H), 7.76–7.51 (m, 2H), 7.33 (m, 1H), 7.17 (m, 1H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>25</sub>H<sub>16</sub>F<sub>3</sub>IN<sub>3</sub>O<sub>6</sub>, 638.0041; found, 638.0039. LC-MS (ESI): 661.8 (M + Na)<sup>+</sup>, 637.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(3-(2-((3-Bromophenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>18</b>)</h4><div class="NLM_p last">Pale solid (3.8 mg, 30%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.38 (s, 1H), 11.10 (s, 1H), 11.08 (s, 1H), 8.17 (s, 1H), 8.06 (s, 1H), 8.01 (m, 1H), 7.89 (m, 1H), 7.86 (s, 1H), 7.58 (m, 1H), 7.36 (m, 3H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>24</sub>H<sub>16</sub>BrIN<sub>3</sub>O<sub>5</sub>, 631.9323; found, 631.9326. LC-MS (ESI): 655.8 (M + Na)<sup>+</sup>, 631.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(3-(2-((3-Fluorophenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>19</b>)</h4><div class="NLM_p last">Pale solid (4.7 mg, 41%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.37 (s, 1H), 11.13 (s, 2H), 8.08 (s, 1H), 8.03 (m, 1H), 7.99 (m, 2H), 7.87 (s, 1H), 7.82 (m, 1H), 7.76 (m, 1H), 7.58 (m, 1H), 7.43 (m, 1H), 7.32 (m, 1H), 7.06 (s, 1H), 7.01 (m, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>24</sub>H<sub>16</sub>FIN<sub>3</sub>O<sub>5</sub>, 572.0124; found, 572.0136. LC-MS (ESI): 573.8 (M + H)<sup>+</sup>, 571.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 6-Hydroxy-3-iodo-2-(3-(2-((3-iodophenyl)amino)-2-oxoacetamido)phenyl)-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>20</b>)</h4><div class="NLM_p last">Pale solid (4.5 mg, 33%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.36 (s, 1H), 11.08 (s, 1H), 11.01 (s, 1H), 8.34 (s, 1H), 8.05 (s, 1H), 8.01 (m, 1H), 8.01 (m, 1H), 7.90 (m, 1H), 7.87 (s, 1H), 7.57 (m, 2H), 7.33 (m, 1H), 7.19 (m, 1H), 7.07 (s, 1H), 3.63 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>24</sub>H<sub>16</sub>I<sub>2</sub>N<sub>3</sub>O<sub>5</sub>, 679.9185; found, 679.9184. LC-MS (ESI): 679.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(3-(2-((4′-Cyano-[1,1′-biphenyl]-4-yl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>21</b>)</h4><div class="NLM_p last">Pale solid (2.3 mg, 17%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.37 (s, 1H), 11.12 (s, 1H), 11.10 (s, 1H), 8.14–8.04 (m, 4H), 7.93 (m, 4H), 7.87–7.81 (m, 3H), 7.59 (m, 1H), 7.35 (m, 1H), 7.07 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>31</sub>H<sub>20</sub>IN<sub>4</sub>O<sub>5</sub>, 655.0484; found, 655.0509. LC-MS (ESI): 654.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(3-(2-((3′-Cyano-[1,1′-biphenyl]-4-yl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>22</b>)</h4><div class="NLM_p last">Pale solid (2.9 mg, 21%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.37 (s, 1H), 11.11 (s, 1H), 11.07 (s, 1H), 8.18 (s, 1H), 8.03 (m, 5H), 7.87 (s, 1H), 7.82 (m, 3H), 7.67 (m, 1H), 7.59 (m, 1H), 7.34 (m, 1H), 7.08 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>31</sub>H<sub>20</sub>IN<sub>4</sub>O<sub>5</sub>, 655.0484; found, 655.0499. LC-MS (ESI): 654.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-Hydroxy-2-(3-(2-((2-(5-(hydroxymethyl)furan-2-yl)phenyl)amino)-2-oxoacetamido)phenyl)-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>23</b>)</h4><div class="NLM_p last">Pale solid (2.4 mg, 18%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.15 (s, 1H), 10.76 (s, 1H), 8.05 (m, 3H), 7.87 (s, 1H), 7.82 (s, 1H), 7.76 (m, 1H), 7.58 (m, 2H), 7.41 (m, 3H), 7.08 (s, 1H), 4.51 (s, 2H), 3.65 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>29</sub>H<sub>21</sub>IN<sub>3</sub>O<sub>7</sub>, 650.0430; found, 650.0422. LC-MS (ESI): 649.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(3-(2-((3-(Furan-2-yl)phenyl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>24</b>)</h4><div class="NLM_p last">Pale solid (4.6 mg, 37%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.36 (s, 1H), 11.10 (s, 1H), 10.98 (s, 1H), 8.29 (s, 1H), 8.07 (s, 1H), 8.03 (m, 1H), 7.94 (m, 1H), 7.87 (s, 1H), 7.77 (m, 2H), 7.50 (m, 4H), 7.34 (m, 1H), 7.07 (s, 1H), 6.90 (m, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>28</sub>H<sub>19</sub>IN<sub>3</sub>O<sub>6</sub>, 620.0324; found, 620.0327. LC-MS (ESI): 619.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(3-(2-((4′-Cyano-[1,1′-biphenyl]-3-yl)amino)-2-oxoacetamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>25</b>)</h4><div class="NLM_p last">Pale solid (3.4 mg, 26%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.12 (s, 1H), 11.05 (s, 1H), 8.29 (s, 1H), 8.08 (s, 1H), 8.03 (m, 4H), 7.87 (s, 1H), 7.86 (s, 1H), 7.56 (m, 3H), 7.33 (m, 1H), 7.09 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>31</sub>H<sub>20</sub>IN<sub>4</sub>O<sub>5</sub>, 655.0484; found, 655.0485. LC-MS (ESI): 654.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(2-oxo-2-((3-(thiophen-3-yl)phenyl)amino)acetamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11a</b>-<b>26</b>)</h4><div class="NLM_p last">Pale solid (3.1 mg, 24%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.12 (s, 1H), 10.92 (s, 1H), 8.22 (s, 1H), 8.08 (s, 1H), 8.02 (m, 4H), 7.87 (s, 1H), 7.84 (m, 2H), 7.68 (m, 1H), 7.59 (m, 1H), 7.52 (m, 2H), 7.43 (m, 1H), 7.34 (m, 1H), 7.08 (s, 1H), 3.64 (s, 3H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>28</sub>H<sub>19</sub>IN<sub>3</sub>O<sub>5</sub>S, 636.0096; found, 636.0102. LC-MS (ESI): 635.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(4-oxo-4-((4-(thiophen-3-yl)phenyl)amino)butanamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>1</b>)</h4><div class="NLM_p last">Pale solid (3.8 mg, 28%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.24 (s, 1H), 10.08 (s, 1H), 7.86 (s, 1H), 7.73 (m, 4H), 7.62 (m, 4H), 7.52 (m, 3H), 7.17 (m, 1H), 7.04 (s, 1H), 3.56 (s, 3H), 2.69 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>30</sub>H<sub>23</sub>IN<sub>3</sub>O<sub>5</sub>S, 664.0409; found, 664.0414. LC-MS (ESI): 663.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(4-oxo-4-((4-phenoxyphenyl)amino)butanamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>2</b>)</h4><div class="NLM_p last">Pale solid (1.6 mg, 11%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 10.22 (s, 1H), 10.04 (s, 1H), 7.83 (s, 1H), 7.76 (m, 2H), 7.60 (m, 2H), 7.47 (m, 1H), 7.35 (m, 2H), 7.09 (m, 3H), 6.96 (m, 4H), 3.58 (s, 3H), 2.67 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>32</sub>H<sub>25</sub>IN<sub>3</sub>O<sub>6</sub>, 674.0794; found, 664.0796. LC-MS (ESI): 673.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(3-(4-((4-(Benzyloxy)-3-chlorophenyl)amino)-4-oxobutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>3</b>)</h4><div class="NLM_p last">Pale solid (5.7 mg, 39%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 10.23 (s, 1H), 10.03 (s, 1H), 7.84 (s, 1H), 7.80 (m, 2H), 7.49–7.33 (m, 8H), 7.17 (m, 2H), 7.03 (s, 1H), 5.15 (s, 2H), 3.58 (s, 3H), 2.67 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>33</sub>H<sub>26</sub>ClIN<sub>3</sub>O<sub>6</sub>, 722.0560; found, 722.0563. LC-MS (ESI): 746.0 (M + Na)<sup>+</sup>, 721.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(3-(4-((3-(Benzyloxy)phenyl)amino)-4-oxobutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c-4</b>)</h4><div class="NLM_p last">Pale solid (2.2 mg, 15%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.22 (s, 1H), 9.99 (s, 1H), 7.84 (s, 1H), 7.73 (m, 2H), 7.50–7.32 (m, 7H), 7.15 (m, 3H), 7.04 (s, 1H), 6.68 (m, 1H), 5.05 (s, 2H), 3.58 (s, 3H), 2.67 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>33</sub>H<sub>27</sub>IN<sub>3</sub>O<sub>6</sub>, 688.0950; found, 688.0950. LC-MS (ESI): 687.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-(3-(4-([1,1′-Biphenyl]-3-ylamino)-4-oxobutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>5</b>)</h4><div class="NLM_p last">Pale solid (4.8 mg, 36%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.24 (s, 1H), 10.12 (s, 1H), 7.93 (m, 2H), 7.84 (s, 1H), 7.76 (m, 2H), 7.60–7.40 (m, 8H), 7.16 (m, 1H), 7.03 (s, 1H), 3.58 (s, 3H), 2.64 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>32</sub>H<sub>25</sub>IN<sub>3</sub>O<sub>5</sub>, 658.0844; found, 658.0861. LC-MS (ESI): 683.4 (M + H)<sup>+</sup>, 657.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(3-(4-(5-Bromoindolin-1-yl)-4-oxobutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>6</b>)</h4><div class="NLM_p last">Pale solid (3.2 mg, 23%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.25 (s, 1H), 7.97 (m, 1H), 7.84 (s, 1H), 7.76 (m, 2H), 7.47 (m, 1H), 7.42 (s, 1H), 7.29 (m, 1H), 7.17 (m, 1H), 7.04 (s, 1H), 4.16 (m, 2H), 3.56 (s, 3H), 3.17 (m, 2H), 2.77 (m, 2H), 2.71 (m, 2H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>28</sub>H<sub>22</sub>BrIN<sub>3</sub>O<sub>5</sub>, 685.9793; found, 685.9798. LC-MS (ESI): 687.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(4-oxo-4-((4-(trifluoromethoxy)phenyl)amino)butanamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>7</b>)</h4><div class="NLM_p last">Pale solid (6.1 mg, 45%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.23 (s, 1H), 10.22 (s, 1H), 7.84 (s, 1H), 7.71 (m, 5H), 7.48 (m, 1H), 7.30 (m, 2H), 7.16 (m, 1H), 7.03 (s, 1H), 3.58 (s, 3H), 2.70 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>27</sub>H<sub>20</sub>F<sub>3</sub>IN<sub>3</sub>O<sub>6</sub>, 666.0354; found, 666.0329. LC-MS (ESI): 665.8 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-Hydroxy-3-iodo-2-(3-(4-((4-isopropylphenyl)amino)-4-oxobutanamido)phenyl)-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>8</b>)</h4><div class="NLM_p last">Pale solid (2.1 mg, 16%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 9.91 (s, 1H), 7.70 (s, 1H), 7.50–7.45 (m, 5H), 7.15 (m, 5H), 6.66 (s, 1H), 3.58 (s, 3H), 2.82 (m, 1H), 2.64 (m, 4H), 1.17 (d, <i>J</i> = 6.9 Hz, 1H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>29</sub>H<sub>27</sub>IN<sub>3</sub>O<sub>5</sub>, 624.1001; found, 624.1037. LC-MS (ESI): 648.0 (M + Na)<sup>+</sup>, 624.0 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-(3-(4-((Benzo[<i>d</i>][1,3]dioxol-5-ylmethyl)amino)-4-oxobutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>9</b>)</h4><div class="NLM_p last">Pale solid (8.1 mg, 63%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.19 (s, 1H), 8.37 (m, 1H), 7.85 (s, 1H), 7.61 (s, 1H), 7.72 (m, 1H), 7.47 (m, 1H), 7.16 (m, 1H), 7.03 (s, 1H), 6.80 (m, 2H), 6.70 (m, 1H), 5.93 (s, 2H), 4.17 (m, 2H), 3.58 (s, 3H), 2.64 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO): δ 172.8, 171.8, 171.3, 158.2, 147.6, 146.3, 142.9, 142.5, 139.8, 133.9, 131.5, 129.4, 125.5, 123.9, 123.8, 121.2, 120.7, 119.8, 108.3, 108.2, 108.0, 101.1, 97.0, 60.5, 42.2, 32.5, 32.0, 30.6. HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>28</sub>H<sub>23</sub>IN<sub>3</sub>O<sub>7</sub>, 640.0586; found, 640.0569. LC-MS (ESI): 642.0 (M + H)<sup>+</sup>, 639.6 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(3-(4-((Cyclopropylmethyl)(propyl)amino)-4-oxobutanamido)phenyl)-6-hydroxy-3-iodo-1-methyl-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>10</b>)</h4><div class="NLM_p last">Pale solid (10.6 mg, 87%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 11.35 (brs, 1H), 10.16 (s, 1H), 7.85 (s, 1H), 7.73 (m, 2H), 7.48 (m, 1H), 7.16 (m, 1H), 7.04 (s, 1H), 3.58 (s, 3H), 3.33–3.14 (m, 4H), 2.64 (m, 2H), 1.59–1.46 (m, 2H), 0.88 (m, 4H), 0.50–0.10 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>27</sub>H<sub>29</sub>IN<sub>3</sub>O<sub>5</sub>, 602.1157; found, 602.1171. LC-MS (ESI): 604.0 (M + H)<sup>+</sup>, 602.0 (M – H)<sup>−</sup>. Purity: >95% (UV, λ = 254 nm).</div></div><div id="sec3_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 6-Hydroxy-3-iodo-1-methyl-2-(3-(4-oxo-4-(thiazol-2-ylamino)butanamido)phenyl)-1<i>H</i>-indole-5-carboxylic Acid (<b>11c</b>-<b>11</b>)</h4><div class="NLM_p last">Pale solid (0.9 mg, 7%). <sup>1</sup>H NMR (500 MHz, DMSO): δ 12.15 (s, 1H), 10.25 (s, 1H), 7.84 (s, 1H), 7.74 (m, 2H), 7.46 (m, 3H), 7.17 (m, 3H), 6.88 (s, 1H), 3.58 (s, 3H), 2.64 (m, 4H). HRMS (ESI): (M – H)<sup>−</sup> calcd for C<sub>23</sub>H<sub>18</sub>IN<sub>4</sub>O<sub>5</sub>S, 589.0048; found, 589.0056. LC-MS (ESI): 591.0 (M + H)<sup>+</sup>. Purity: >95% (UV, λ = 254 nm).</div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> SHP2 Crystallization and X-ray Data Collection</h3><div class="NLM_p last">Recombinant SHP2 expression and purification were described previously.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> All crystallization experiments were performed at room temperature using the sitting drop vapor diffusion method. For co-crystallization, 100 μL of SHP2 stock (7.0 mg/mL) in 20 mM MES (pH 6.0), 50 mM NaCl, 0.1 mM EDTA, and 4 mM DTT was mixed with 1 μL of compound <b>11a</b>-<b>1</b> or <b>11c</b>-<b>9</b> stock solution (50 mM in DMSO). Crystals of SHP2·<b>11c</b>-<b>9</b> complex were obtained at room temperature by vapor diffusion in sitting drops. Protein drops were equilibrated against a reservoir solution containing 20% w/v polyethylene glycol 3350, 200 mM magnesium acetate tetrahydrate, and 100 mM HEPES buffer (pH 7.7). For X-ray data collection, the crystals were transferred into 4 μL of cryoprotectant buffer containing 30% w/v polyethylene glycol 3350, 100 mM NaCl, 1 mM <b>11c</b>-<b>9</b>, and 100 mM HEPES (pH 7.7) and were allowed to soak for 30 min. The crystals were then flash-cooled by liquid nitrogen. X-ray data were collected at 19 μ<sub>B</sub> beamline at APS (Argonne, IL). Data were processed using the program HKL3000.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The space group of the crystals is <i>P</i>1. The statistics are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Structural Determination and Refinement</h3><div class="NLM_p last">The structure of SHP2·<b>11c</b>-<b>9</b> was solved by molecular replacement using the program MolRep.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The structure of SHP2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B7O">3B7O</a>),<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> without the solvent molecules, was used as a search model. The resulting difference Fourier map indicated the first 16 N-terminal residues has different conformation. The map also revealed the density for the compound <b>11c</b>-<b>9</b> in the active site of SHP2. The N-terminal peptide 246–261 was first rebuilt according to the <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> density map, then the structure was refined to 2.4 Å resolution with the program CNS1.1,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> using simulated annealing at 2500 K and then alternating positional and individual temperature factor refinement cycles. The density in the active site was interpreted to be <b>11c</b>-<b>9</b>. Then alternating positional and individual temperature factor refinement cycles were applied to the structure. The progress of the refinement was evaluated by improvement in the quality of the electron density maps, and the reduced values of the conventional <i>R</i> factor (<i>R</i> = ∑<sub><i>h</i></sub>||<i>F</i><sub>o</sub>| – |<i>F</i><sub>c</sub>||/∑<sub><i>h</i></sub>|<i>F</i><sub>o</sub>|) and the free <i>R</i> factor (3.7% of the reflections omitted from the refinement).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Electron density maps were inspected, and the model was modified on Coot.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Finally, water molecules were added gradually as the refinement progressed. They were assigned in the |<i>F</i><sub>o</sub>| – |<i>F</i><sub>c</sub>| difference Fourier maps with a 2.5σ cutoff level for inclusion in the model.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Docking Studies</h3><div class="NLM_p last">The 3D structure of <b>11a</b>-<b>1</b> was built and energy-minimized using Chem3D program, and three SHP2 catalytic domain structures, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B7O">3B7O</a>.pdb<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> (apo form SHP2 catalytic domain), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O5X">3O5X</a>.pdb<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (SHP2·II-B08 complex structure) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PVG">4PVG</a>.pdb (SHP2·<b>11c</b>-<b>9</b> complex structure), were used for ensemble docking in the AutoDock4.2.5 software suite.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The ligand and receptor were predocking processed as following in AutoDockTools1.4.6 program:<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> merge nonpolar hydrogens, add Gasteiger charges, set rotatable bond for ligand, add solvation parameter for receptor, and so on. To define the common docking area, the above two SHP2 complex structures were superimposed onto the apo form of SHP2, a rectangle docking area was visually set to adequately cover both II-B08 and <b>11c</b>-<b>9</b> around the active site, the energy grid size was set to 54 × 54 × 36 points with 0.375 Å spacing on each axis, and the energy grid maps for each atom type (i.e., A, C, I, OA, N, SA, and HD), as well as the electrostatics and desolvation maps were calculated using the AutoGrid4. The molecular docking were carried out using AutoDock4.2.5, the optimal binding conformation was determined by LGALS (Lamarckian Genetic Algorithm with Local Search) algorithm with the following parameters during each docking run: energy evaluations of 2500000, population size of 100, mutation rate of 0.02, crossover rate of 0.8, Solis and Wets local search iterations of 300 with probability of 0.06. For each SHP2 structure, 200 docking runs were performed and the resulted binding modes were conformation-clustered and energy-ranked. The final binding mode was determined by visual inspections, cluster analyses, and energy comparisons.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Inhibition Studies</h3><div class="NLM_p">The phosphatase activity of SHP2 was assayed using <i>p</i>-nitrophenyl phosphate (<i>p</i>NPP) as a substrate at 25 °C in 50 mM 3,3-dimethylglutarate buffer, pH 7.0, containing 1 mM EDTA with an ionic strength of 0.15 M adjusted by NaCl. The hydroxyindole carboxylic acid-based libraries were screened in a 384-well format at 5 μM compound concentration. The reaction was initiated by the addition of 20 μL of the enzyme to 30 μL of reaction mixture containing 5 μM library compound and 2.9 mM (the <i>K</i><sub>m</sub> value) <i>p</i>NPP and quenched after 10 min by the addition of 20 μL of 5N NaOH. The nonenzymatic hydrolysis of <i>p</i>NPP was corrected by measuring the control without the addition of enzyme. The amount of product <i>p</i>-nitrophenol was determined from the absorbance at 405 nm detected by a Spectra MAX340 microplate spectrophotometer (Molecular Devices) using a molar extinction coefficient of 18000 M<sup>–1</sup>cm<sup>–1</sup>. Inhibitor concentrations used for IC<sub>50</sub> measurements cover the range from 0.2 to 5× of the IC<sub>50</sub> value. IC<sub>50</sub> values for selected resynthesized and purified hits were calculated by fitting the absorbance at 405 nm versus inhibitor concentration to the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/jm-2014-006176_m001.gif" alt="" /></img></span>where <i>A</i><sub>I</sub> is the absorbance at 405 nm of the sample in the presence of inhibitor, <i>A</i><sub>0</sub> is the absorbance at 405 nm in the absence of inhibitor, and [I] is the concentration of the inhibitor.</div><div class="NLM_p last">For selectivity studies, the PTPs, including LYP, HePTP, PTPH1, SHP1, Ssu72, PTP1B, LMWPTP, VHZ, PTPγ, MKP5, VHR, PTPμ, STEP, PEZ, PTPσ, UBLCP1, Laforin, CDC14A, PTPε, and PTPα, were expressed and purified from <i>Escherichia coli</i>. The IC<sub>50</sub> determination for these PTPs was performed under the same conditions as for SHP2, except the <i>p</i>NPP concentrations used corresponded to the <i>K</i><sub>m</sub> values of the PTPs studied.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Effects of SHP2 Inhibitor <b>11a</b>-<b>1</b> on Lung Cancer Cell Line H1975</h3><div class="NLM_p last">Human nonsmall cell lung carcinoma cell line H1975 was obtained from the American Tissue Culture Collection and cultured at 37 °C and 5% CO<sub>2</sub> in RPMI-1640 (Corning) supplemented with 10% fetal bovine serum (HyClone). 3 ×10<sup>3</sup> cells were seeded in each well of 96-well plates. After treatment with <b>11a</b>-<b>1</b> for 2 days in RPMI-1640 supplement with 0.5% FBS, cells were incubated with 50 μg/mL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma) for 3–4 h. Then the culture medium was removed, and DMSO was added to dissolve the formazan crystals. Wells containing only media were used for background correction. The optical density was measured spectrophotometrically at 540 nm. For biochemical studies, H1975 cells were serum-starved overnight followed by treatment with vehicle or <b>11a</b>-<b>1</b> for 3 h, and then either left unstimulated or stimulated with 5 ng/mL EGF (Sigma) for 60 min. Lysates were then resolved by SDS-PAGE and the protein phosphorylation levels were detected by immunoblot analysis.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Effect of SHP2 Inhibitor <b>11a</b>-<b>1</b> on Breast Cancer Cells</h3><div class="NLM_p last">Approximately 300000 SKBR3 cells were seeded into 150 μL of growth factor reduced Matrigel (Corning) in 35 mm dishes. To three dishes for each condition, 2 mL of media containing either 10 μL of vehicle (DMSO) or <b>11a</b>-<b>1</b> at the indicated concentration was then added. Every 24 h, the cells were imaged with a NIKON SMZ1500 stereo microscope. The cross sectional area of individual colonies from each image were measured using Adobe Photoshop software. After 4 days, the cells were recovered from the Matrigel and lysed in PLC buffer containing protease inhibitor cocktail. Lysates were then resolved by SDS-PAGE, and relative levels of the indicated proteins were detected by immunoblot analysis.</div></div><div id="sec3_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Effect of SHP2 Inhibitor II-B08 and <b>11a</b>-<b>1</b> on D32 Myeloid Cells and Primary Hematopoietic Stem and Progenitor Cells</h3><div class="NLM_p">The WT KIT and KITD814V were inserted into the bicistronic retroviral vector, MIEG3, upstream of the internal ribosome entry site (IRES) and the enhanced green fluorescent protein (EGFP) gene as previously described.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Retroviral supernatants for transduction of 32D myeloid cells and primary hematopoietic stem and progenitor cells were generated using Phoenix ecotropic packaging cell line transfected with retroviral vector plasmids using a calcium phosphate transfection kit (Invitrogen, Carlsbad, CA). Supernatants were collected 48 h after transfection and filtered through 0.45 μm membranes. 32D myeloid cells were infected twice at 24 h intervals with 2 mL of high-titer virus supernatant in the presence of 10 ng/mL IL-3 and 8 μg/mL Polybrene. Forty-eight hours after infection, 32D cells expressing WT KIT or KITD814V receptors were sorted to homogeneity based on EGFP expression and utilized to perform all the experiments.</div><div class="NLM_p">To express WT KIT and KITD814V receptors in bone marrow cells, low-density bone marrow cells were collected from WT mice, and prestimulated in IMDM supplemented with 20% FBS, 2% penicillin/streptomycin, and cytokines (100 ng/mL SCF, 100 ng/mL TPO, 50 ng/mL FLT3-L, and 4 ng/mL IL-6) for 48 h prior to retroviral infection on fibronectin fragments (Retronectin) in nontissue culture plates. On the third day, cells were infected with 2 mL of high-titer retroviral supernatants for WT KIT or KITD814V prepared as described above. A second shot of viral infection was given 20 4 h later. Forty-eight hours after the second infection, cells expressing EGFP were sorted and utilized to perform all experiments.</div><div class="NLM_p last">Proliferation was assessed by conducting a thymidine incorporation assay as previously described (Mali et al., 2012<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>). Cells were washed and starved in IMDM containing 0.2% BSA without serum or any growth factors for 6–8 h. Cells (5 × 10<sup>4</sup>) were plated in replicates of three in a 96-well plate in 200 μL of complete medium (IMDM, 10% FBS, 2% penicillin–streptomycin) either in the presence or absence of indicated growth factors with or without SHP2 inhibitors. Cells were cultured for 48 h and subsequently pulsed with 1.0 μCi (0.037 MBq) [<sup>3</sup>H] thymidine (PerkinElmer, Shelton, CT) for 6 h. Cells were harvested using an automated 96-well cell harvester (Brandel, Gaithersburg, MD), and thymidine incorporation was determined as counts per minute (CPM).</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Immunoblot Analysis</h3><div class="NLM_p last">Cells were lysed in lysis buffer (1.0% Nonidet P-40, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 2 mM NaVO<sub>3</sub>, 10 mM NaF) plus a protease inhibitor mixture (Roche) and centrifuged at 10000 rpm for 5 min at 4 °C. Supernatants were collected and protein concentration was determined using the BCA protein assay (Thermo Fisher Scientific, Rockford, IL). Equal amount of protein extracts were mixed with gel loading buffer and separated on SDS-polyacrylamide gels. After electrophoresis, the proteins were transferred onto nitrocellulose membranes and nonspecific binding was blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween-20 (TBS-T). Membranes were then probed with various antibodies overnight at 4 °C on a rocker. After incubation, membranes were washed with TBS-T and incubated with appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature. Finally, the proteins on the membranes were detected using SuperSignal West Dura Luminol/Enhancer solution (Thermo Fisher Scientific, Rockford, IL) and membranes were analyzed using Bio-Rad ChemiDoc XRS Imaging System.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> RNA Interference Studies</h3><div class="NLM_p last">Small interfering RNA (siRNA) specific for SHP2 (5′-PCACGCAUGACGCCAUAUUCTT-3′) and scrambled SHP2 siRNA (5′-PGCACGACCGCCUUAUAACUTT-3′) were synthesized by Dharmacon Research. siRNAs were transfected into H1975 cells by using Lipofectamine 2000 reagent (Invitrogen Life Technologies) for 6 h and then recovered in RPMI1640 plus 10% FBS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/jm5006176">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H and <sup>13</sup>C NMR spectra for all of the intermediates (compounds <b>2</b>, <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b>) and final compounds (<b>10a</b>–<b>d</b>, <b>11a</b>-<b>1</b> to <b>11a</b>-<b>26</b> and <b>11c</b>-<b>1</b> to <b>11c</b>-<b>11</b>) tested for biological activity. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5006176/suppl_file/jm5006176_si_001.pdf">jm5006176_si_001.pdf (11.48 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates for the structure of the SHP2·<b>11c</b>-<b>9</b> complex (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PVG">4PVG</a>) have been deposited in the Protein Data Bank.</p><div class="testing" data-doi="10.1021/jm5006176" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhong-Yin Zhang</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#43393a392b222d24032a366d262736"><span class="__cf_email__" data-cfemail="32484b485a535c55725b471c575647">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Fan Zeng</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruo-Yu Zhang</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhi-Hong Yu</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sijiu Li</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Wu</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea M. Gunawan</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brandon S. Lane</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raghuveer S. Mali</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingjun Li</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca J. Chan</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reuben Kapur</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clark D. Wells</span> - <span class="hlFld-Affiliation affiliation">†Department of Biochemistry and
Molecular Biology, ‡Herman B. Wells Center for Pediatric
Research, and §Chemical Genomics Core Facility, Indiana
University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202 United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d935e4680-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Institutes of Health Grants RO1CA152194, R01CA151765, R01HL077177, R01HL081111, R01CA173852, and R01CA134777.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i79" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i79"> Abbreviations Used</h2><tr><td class="NLM_term">SHP2</td><td class="NLM_def"><p class="first last">Src homology-2 domain containing protein tyrosine phosphatase-2</p></td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">PTK</td><td class="NLM_def"><p class="first last">protein tyrosine kinase</p></td></tr><tr><td class="NLM_term">Erk</td><td class="NLM_def"><p class="first last">extracellular signal-regulated protein kinase</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Tyrosine phosphorylation: thirty years and counting</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.ceb.2009.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19269802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=140-146&author=T.+Hunter&title=Tyrosine+phosphorylation%3A+thirty+years+and+counting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine phosphorylation: thirty years and counting</span></div><div class="casAuthors">Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-146</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging.  Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a no. of which were approved for clin. use.  The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozf_yslNwApbVg90H21EOLACvtfcHk0liJxvQ-hcW10A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D&md5=ef5dbec53a41f9691317cc5b1b47b3cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DTyrosine%2520phosphorylation%253A%2520thirty%2520years%2520and%2520counting%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-846&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0lgLJ0-y-7UwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: prospects for therapeutics</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2FS1367-5931%2800%2900223-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11470605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=416-423&author=Z.-Y.+Zhang&title=Protein+tyrosine+phosphatases%3A+prospects+for+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: prospects for therapeutics</span></div><div class="casAuthors">Zhang, Z.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">416-423</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways.  Recent gene knockout studies in mice identify PTP1B as a promising target for anti-diabetes/obesity drug discovery.  PTPs are also implicated in a wide variety of other disorders, including cancer.  Significant progress has been made in identifying small mols. that simultaneously bind both the active site and a unique adjacent site that enables specific inhibition of individual PTP isoenzymes.  As a consequence, there are compelling reasons to believe that PTP inhibitors may ultimately serve as powerful therapeutic weapons in the authors' arsenal for battling human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgujWWYVWfjbVg90H21EOLACvtfcHk0lgLJ0-y-7UwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D&md5=eee42d18a57b314321cffca4e3892ac1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2800%2900223-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252800%252900223-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520prospects%2520for%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2001%26volume%3D5%26spage%3D416%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Julien, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M. L.</span><span> </span><span class="NLM_article-title">Inside the human cancer tyrosine phosphatome</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fnrc2980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=21179176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WisrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=35-49&author=S.+G.+Julienauthor=N.+Dub%C3%A9author=S.+Hardyauthor=M.+L.+Tremblay&title=Inside+the+human+cancer+tyrosine+phosphatome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inside the human cancer tyrosine phosphatome</span></div><div class="casAuthors">Julien, Sofi G.; Dube, Nadia; Hardy, Serge; Tremblay, Michel L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-49</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Members of the protein tyrosine phosphatase (Ptp) family dephosphorylate target proteins and counter the activities of protein tyrosine kinases that are involved in cellular phosphorylation and signalling.  As such, certain PTPs might be tumor suppressors.  Indeed, PTPs play an important part in the inhibition or control of growth, but accumulating evidence indicates that some PTPs may exert oncogenic functions.  Recent large-scale genetic analyses of various human tumors have highlighted the relevance of PTPs either as putative tumor suppressors or as candidate oncoproteins.  Progress in understanding the regulation and function of PTPs has provided insights into which PTPs might be potential therapeutic targets in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomjWFudpQjhLVg90H21EOLACvtfcHk0lgLJ0-y-7UwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WisrbM&md5=ffd5f76f3d0b2d0ef220e5d398794f2e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2980%26sid%3Dliteratum%253Aachs%26aulast%3DJulien%26aufirst%3DS.%2BG.%26aulast%3DDub%25C3%25A9%26aufirst%3DN.%26aulast%3DHardy%26aufirst%3DS.%26aulast%3DTremblay%26aufirst%3DM.%2BL.%26atitle%3DInside%2520the%2520human%2520cancer%2520tyrosine%2520phosphatome%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D35%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Krause, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinases as targets for cancer therapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1056%2FNEJMra044389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16014887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFClsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=172-187&author=D.+S.+Krauseauthor=R.+A.+Van+Etten&title=Tyrosine+kinases+as+targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinases as targets for cancer therapy</span></div><div class="casAuthors">Krause, Daniela S.; Van Etten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">172-187</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses the mechanisms of aberrant tyrosine kinase signaling and strategies to inhibit TKs in cancer.  It also summarizes the status of TK-directed cancer therapies, and discusses challenges and prospects for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq89QOl9E0UMLVg90H21EOLACvtfcHk0lgLJ0-y-7UwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFClsbs%253D&md5=0a98c8840a983300f6b0743673cf480c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMra044389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra044389%26sid%3Dliteratum%253Aachs%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D172%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ventura, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">Protein kinases and phosphatases as therapeutic targets in cancer</span> <span class="citation_source-journal">Clin. Transl. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1007%2Fs12094-006-0005-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16648114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFentb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=153-160&author=J.+J.+Venturaauthor=A.+R.+Nebreda&title=Protein+kinases+and+phosphatases+as+therapeutic+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases and phosphatases as therapeutic targets in cancer</span></div><div class="casAuthors">Ventura, Juan-Jose; Nebreda, Angel R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Translational Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-160</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Instituto de Investigaciones Biomedicas CSIC/UAM</span>)
        </div><div class="casAbstract">A review.  Protein phosphorylation plays key roles in many physiol. processes and is often deregulated in pathol. conditions.  Our current understanding of how protein kinases and phosphatases orchestrate the phosphorylation changes that control cellular functions has made these enzymes potential drug targets for the treatment of many diseases.  The success of the tyrosine kinase inhibitor Gleevec in the treatment of some cancers has further invigorated the development of kinase inhibitors as anti-cancer drugs.  A large no. of these compds. are currently undergoing clin. trials and there is much expectation on the therapeutic potential of these mols., as more specific and less toxic drugs than currently used generic chemotherapeutic agents.  In this manuscript, we review the current status of more than 30 protein kinase inhibitors with proven or potential therapeutic value for cancer treatment.  These include inhibitors of receptor and cytosolic tyrosine kinases as well as compds. that target different families of serine/threonine kinases involved in signalling and cell cycle regulation.  We also briefly touch on the prospects of phosphatase inhibitors.  The combination of kinase inhibitors to target different components of signalling pathways that are found deregulated in tumors is also emerging as an interesting approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdO6Up4gp6n7Vg90H21EOLACvtfcHk0lhiO0SNzU4ElQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFentb0%253D&md5=57a09f7b6916b45b1154b608cd1f17af</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs12094-006-0005-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-006-0005-0%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DJ.%2BJ.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DProtein%2520kinases%2520and%2520phosphatases%2520as%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2006%26volume%3D8%26spage%3D153%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Kinase Drug Discovery - What’s Next in the Field?</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300610s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=96-104&author=P.+Cohenauthor=D.+R.+Alessi&title=Kinase+Drug+Discovery+-+What%E2%80%99s+Next+in+the+Field%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcb300610s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300610s%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKinase%2520Drug%2520Discovery%2520-%2520What%25E2%2580%2599s%2520Next%2520in%2520the%2520Field%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D96%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podsypanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miliaresis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibshoosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title"><i>PTEN</i>, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1126%2Fscience.275.5308.1943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=9072974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=1943-1947&author=J.+Liauthor=C.+Yenauthor=D.+Liawauthor=K.+Podsypaninaauthor=S.+Boseauthor=S.+I.+Wangauthor=J.+Pucauthor=C.+Miliaresisauthor=L.+Rodgersauthor=R.+McCombieauthor=S.+H.+Bignerauthor=B.+C.+Giovanellaauthor=M.+Ittmannauthor=B.+Tyckoauthor=H.+Hibshooshauthor=M.+H.+Wiglerauthor=R.+Parsons&title=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span></div><div class="casAuthors">Li, Jing; Yen, Clifford; Liaw, Danny; Podsypanina, Katrina; Bose, Shikha; Wang, Steven I.; Puc, Janusz; Miliaresis, Christa; Rodgers, Linda; McCombie, Richard; Bigner, Sandra H.; Giovanella, Beppino C.; Ittmann, Michael; Tycko, Ben; Hibshoosh, Hanina; Wigler, Michael H.; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5308</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.  In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.  The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homol. to tensin, a protein that interacts with actin filaments at focal adhesions.  These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPNCE1bqsPNLVg90H21EOLACvtfcHk0lhiO0SNzU4ElQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D&md5=9b3810f68cbd7cbb882ff75e98a2f1bf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5308.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5308.1943%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DC.%26aulast%3DLiaw%26aufirst%3DD.%26aulast%3DPodsypanina%26aufirst%3DK.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%2BI.%26aulast%3DPuc%26aufirst%3DJ.%26aulast%3DMiliaresis%26aufirst%3DC.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DMcCombie%26aufirst%3DR.%26aulast%3DBigner%26aufirst%3DS.%2BH.%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DIttmann%26aufirst%3DM.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DHibshoosh%26aufirst%3DH.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%252C%2520a%2520putative%2520protein%2520tyrosine%2520phosphatase%2520gene%2520mutated%2520in%2520human%2520brain%252C%2520breast%252C%2520and%2520prostate%2520cancer%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sager, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijden, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmigiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Mutational analysis of the tyrosine phosphatome in colorectal cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1164</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1126%2Fscience.1096096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=15155950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVyit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1164-1166&author=Z.+Wangauthor=D.+Shenauthor=D.+W.+Parsonsauthor=A.+Bardelliauthor=J.+Sagerauthor=S.+Szaboauthor=J.+Ptakauthor=N.+Sillimanauthor=B.+A.+Petersauthor=M.+S.+van+der+Heijdenauthor=G.+Parmigianiauthor=H.+Yanauthor=T.+L.+Wangauthor=G.+Rigginsauthor=S.+M.+Powellauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=Mutational+analysis+of+the+tyrosine+phosphatome+in+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers</span></div><div class="casAuthors">Wang, Zhenghe; Shen, Dong; Parsons, D. Williams; Bardelli, Alberto; Sager, Jason; Szabo, Steve; Ptak, Janine; Silliman, Natalie; Peters, Brock A.; van der Heijden, Michiel S.; Parmigiani, Giovanni; Yan, Hai; Wang, Tian-Li; Riggins, Greg; Powell, Steven M.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5674</span>),
    <span class="NLM_cas:pages">1164-1167</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Tyrosine phosphorylation, regulated by protein tyrosine phosphatases (PTPs) and kinases (PTKs), is important in signaling pathways underlying tumorigenesis.  A mutational anal. of the tyrosine phosphatase gene superfamily in human cancers identified 83 somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14), affecting 26% of colorectal cancers and a smaller fraction of lung, breast, and gastric cancers.  Fifteen mutations were nonsense, frameshift, or splice-site alterations predicted to result in truncated proteins lacking phosphatase activity.  Five missense mutations in the most commonly altered PTP (PTPRT) were biochem. examd. and found to reduce phosphatase activity.  Expression of wild-type but not a mutant PTPRT in human cancer cells inhibited cell growth.  These observations suggest that the mutated tyrosine phosphatases are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9NQWiEUTTMbVg90H21EOLACvtfcHk0lgEwHFI8T79Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVyit7c%253D&md5=3466921b63561835ad9bf1f2f4f5d81e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096096%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSager%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DB.%2BA.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DM.%2BS.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DRiggins%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DMutational%2520analysis%2520of%2520the%2520tyrosine%2520phosphatome%2520in%2520colorectal%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1164%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span> </span><span class="NLM_article-title">The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span> </span><span class="NLM_article-title">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+first+identified+proto-oncogene+that+encodes+a+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520first%2520identified%2520proto-oncogene%2520that%2520encodes%2520a%2520tyrosine%2520phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Grossmann, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosário, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 in development and cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2FS0065-230X%2810%2906002-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=20399956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2010&pages=53-89&author=K.+S.+Grossmannauthor=M.+Ros%C3%A1rioauthor=C.+Birchmeierauthor=W.+Birchmeier&title=The+tyrosine+phosphatase+Shp2+in+development+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 in development and cancer</span></div><div class="casAuthors">Grossmann, Katja S.; Rosario, Marta; Birchmeier, Carmen; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-89</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Deregulation of signaling pathways, through mutation or other mol. changes, can ultimately result in disease.  The tyrosine phosphatase Shp2 has emerged as a major regulator of receptor tyrosine kinase (RTK) and cytokine receptor signaling.  In the last decade, germline mutations in the human PTPN11 gene, encoding Shp2, were linked to Noonan (NS) and LEOPARD syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation.  Somatic Shp2 mutations are also assocd. with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML).  Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be assocd. with LEOPARD syndrome.  Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2 function in disease, and shed light on the role of Shp2 in signaling pathways that control decisive events during embryonic development or during cellular transformation/tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgraxAD7u8HbVg90H21EOLACvtfcHk0lgEwHFI8T79Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVGjtr4%253D&md5=45bc842913f2ac8e0fec7c6e1ed8576a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2810%2906002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252810%252906002-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DK.%2BS.%26aulast%3DRos%25C3%25A1rio%26aufirst%3DM.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520in%2520development%2520and%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2010%26volume%3D106%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalidas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+encoding+the+protein+tyrosine+phosphatase+SHP-2%2C+cause+Noonan+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lgEwHFI8T79Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520encoding%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNature%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Noonan syndrome and related disorders: genetics and pathogenesis</span> <span class="citation_source-journal">Annu. Rev. Genomics Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1146%2Fannurev.genom.6.080604.162305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16124853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=45-68&author=M.+Tartagliaauthor=B.+D.+Gelb&title=Noonan+syndrome+and+related+disorders%3A+genetics+and+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Noonan syndrome and related disorders: Genetics and pathogenesis</span></div><div class="casAuthors">Tartaglia, Marco; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genomics and Human Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-68</span>CODEN:
                <span class="NLM_cas:coden">ARGHC4</span>;
        ISSN:<span class="NLM_cas:issn">1527-8204</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Noonan syndrome is a pleiomorphic autosomal dominant disorder with short stature, facial dysmorphia, webbed neck, and heart defects.  In the past decade, progress has been made in elucidating the pathogenesis of this disorder using a positional cloning approach.  Noonan syndrome is now known to be a genetically heterogeneous disorder with nearly one half of cases caused by gain-of-function mutations in PTPN11, the gene encoding the protein tyrosine phosphatase SHP-2.  Similar germ line mutations cause two related genetic disorders, Noonan-like disorder with multiple giant cell lesion syndrome and LEOPARD syndrome, and somatic PTPN11 mutations can underlie certain pediatric hematopoietic malignancies, including juvenile myelomonocytic, acute lymphoblastic, and acute myelogenous leukemias.  A mouse model of PTPN11-related Noonan syndrome was recently generated, providing a reagent for studying disease pathogenesis in greater depth as well as experimenting with novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXWUnHrGyprVg90H21EOLACvtfcHk0lhPntCF0dlJHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWisrrN&md5=6a16672446873326cc05a1d732e6bfb5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1146%2Fannurev.genom.6.080604.162305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.genom.6.080604.162305%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DNoonan%2520syndrome%2520and%2520related%2520disorders%253A%2520genetics%2520and%2520pathogenesis%26jtitle%3DAnnu.%2520Rev.%2520Genomics%2520Hum.%2520Genet.%26date%3D2005%26volume%3D6%26spage%3D45%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buechner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahlen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+Hahlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lhPntCF0dlJHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DHahlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNature%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzaniga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeddu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pession, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masera, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1182%2Fblood-2003-11-3876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=14982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=307-313&author=M.+Tartagliaauthor=S.+Martinelliauthor=G.+Cazzanigaauthor=V.+Cordedduauthor=I.+Iavaroneauthor=M.+Spinelliauthor=C.+Palmiauthor=C.+Cartaauthor=A.+Pessionauthor=M.+Aricoauthor=G.+Maseraauthor=G.+Bassoauthor=M.+Sorciniauthor=B.+D.+Gelbauthor=A.+Biondi&title=Genetic+evidence+for+lineage-related+and+differentiation+stage-related+contribution+of+somatic+PTPN11+mutations+to+leukemogenesis+in+childhood+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Cazzaniga, Giovanni; Cordeddu, Viviana; Iavarone, Ivano; Spinelli, Monica; Palmi, Chiara; Carta, Claudio; Pession, Andrea; Arico, Maurizio; Masera, Giuseppe; Basso, Giuseppe; Sorcini, Mariella; Gelb, Bruce D.; Biondi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">SHP-2 is a protein tyrosine phosphatase functioning as signal transducer downstream to growth factor and cytokine receptors.  SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.  SHP-2 plays a crucial role in hematopoietic cell development.  We recently demonstrated that somatic PTPN11 mutations are the most frequent lesion in juvenile myelomonocytic leukemia and are obsd. in a smaller percentage of children with other myeloid malignancies.  Here, we report that PTPN11 lesions occur in childhood acute lymphoblastic leukemia (ALL).  Mutations were obsd. in 23 of 317 B-cell precursor ALL cases, but not among 44 children with T-lineage ALL.  In the former, lesions prevalently occurred in TEL-AML1- cases with CD19+/CD10+/cyIgM- immunophenotype.  PTPN11, NRAS, and KRAS2 mutations were largely mutually exclusive and accounted for one third of common ALL cases.  We also show that, among 69 children with acute myeloid leukemia, PTPN11 mutations occurred in 4 of 12 cases with acute monocytic leukemia (FAB-M5).  Leukemia-assocd. PTPN11 mutations were missense and were predicted to result in SHP-2 gain-of-function.  Our findings provide evidence for a wider role of PTPN11 lesions in leukemogenesis, but also suggest a lineage-related and differentiation stage-related contribution of these lesions to clonal expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8ifPYTWa1LVg90H21EOLACvtfcHk0lhPntCF0dlJHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D&md5=d8a6592845c32adc35c9612bfa1d6a2f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-11-3876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-11-3876%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DIavarone%26aufirst%3DI.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DPalmi%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DArico%26aufirst%3DM.%26aulast%3DMasera%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DBiondi%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520lineage-related%2520and%2520differentiation%2520stage-related%2520contribution%2520of%2520somatic%2520PTPN11%2520mutations%2520to%2520leukemogenesis%2520in%2520childhood%2520acute%2520leukemia%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D307%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieuw, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtiss, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Beau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1182%2Fblood-2003-09-3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=14644997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=2325-2331&author=M.+L.+Lohauthor=S.+Vattikutiauthor=S.+Schubbertauthor=M.+G.+Reynoldsauthor=E.+Carlsonauthor=K.+H.+Lieuwauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=D.+Stokoeauthor=J.+M.+Bonifasauthor=N.+P.+Curtissauthor=J.+Gotlibauthor=S.+Meshinchiauthor=M.+M.+Le+Beauauthor=P.+D.+Emanuelauthor=K.+M.+Shannon&title=Mutations+in+PTPN11+implicate+the+SHP-2+phosphatase+in+leukemogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span></div><div class="casAuthors">Loh, Mignon L.; Vattikuti, Shashaank; Schubbert, Suzanne; Reynolds, Melissa G.; Carlson, Elaine; Lieuw, Kenneth H.; Cheng, Jennifer W.; Lee, Connie M.; Stokoe, David; Bonifas, Jeannette M.; Curtiss, Nicole P.; Gotlib, Jason; Meshinchi, Soheil; Le Beau, Michelle M.; Emanuel, Peter D.; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2325-2331</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2 (Src homol. 2 domain-contg. protein tyrosine Phosphatase), a non-receptor tyrosine protein tyrosine phosphatase (PTPase) that relays signals from activated growth factor receptors to p21Ras (Ras) and other signaling mols.  Mutations in PTPN11 cause Noonan syndrome (NS), a developmental disorder characterized by cardiac and skeletal defects.  NS is also assocd. with a spectrum of hematol. disorders, including juvenile myelomonocytic leukemia (JMML).  To test the hypothesis that PTPN11 mutations might contribute to myeloid leukemogenesis, we screened the entire coding region for mutations in 51 JMML specimens and in selected exons from 60 patients with other myeloid malignancies.  Missense mutations in PTPN11 were detected in 16 of 49 JMML specimens from patients without NS, but they were less common in other myeloid malignancies.  RAS, NF1, and PTPN11 mutations are largely mutually exclusive in JMML, which suggests that mutant SHP-2 proteins deregulate myeloid growth through Ras.  However, although Ba/F3 cells engineered to express leukemia-assocd. SHP-2 proteins cells showed enhanced growth factor-independent survival, biochem. anal. failed to demonstrate hyperactivation of the Ras effectors extracellular-regulated kinase (ERK) or Akt.  We conclude that SHP-2 is an important cellular PTPase that is mutated in myeloid malignancies.  Further investigation is required to clarify how these mutant proteins interact with Ras and other effectors to deregulate myeloid growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwm--W4OxYbVg90H21EOLACvtfcHk0lhGiqeLZ-yOeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D&md5=6c64eb186b172aef05f71c5d3dedbc8e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-09-3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-09-3287%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DLieuw%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DCurtiss%26aufirst%3DN.%2BP.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DMutations%2520in%2520PTPN11%2520implicate%2520the%2520SHP-2%2520phosphatase%2520in%2520leukemogenesis%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D2325%26epage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbing, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonzo, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Children’s Cancer Group</span><span> </span><span class="NLM_article-title">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children’s Cancer Group</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1831</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1831-1834&author=M.+L.+Lohauthor=M.+G.+Reynoldsauthor=S.+Vattikutiauthor=R.+B.+Gerbingauthor=T.+A.+Alonzoauthor=E.+Carlsonauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=B.+J.+Langeauthor=S.+Meshinchiauthor=Children%E2%80%99s+Cancer+Group&title=PTPN11+mutations+in+pediatric+patients+with+acute+myeloid+leukemia%3A+results+from+the+Children%E2%80%99s+Cancer+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLange%26aufirst%3DB.%2BJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3D%26atitle%3DPTPN11%2520mutations%2520in%2520pediatric%2520patients%2520with%2520acute%2520myeloid%2520leukemia%253A%2520results%2520from%2520the%2520Children%25E2%2580%2599s%2520Cancer%2520Group%26jtitle%3DLeukemia%26date%3D2004%26volume%3D18%26spage%3D1831%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kratz, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castleberry, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cetin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsträsser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stary, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zecca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span> </span><span class="NLM_article-title">The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2183</span><span class="NLM_x">–</span> <span class="NLM_lpage">2185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=2183-2185&author=C.+P.+Kratzauthor=C.+M.+Niemeyerauthor=R.+P.+Castleberryauthor=M.+Cetinauthor=E.+Bergstr%C3%A4sserauthor=P.+D.+Emanuelauthor=H.+Hasleauthor=G.+Kardosauthor=C.+Kleinauthor=S.+Kojimaauthor=J.+Staryauthor=M.+Treboauthor=M.+Zeccaauthor=B.+D.+Gelbauthor=M.+Tartagliaauthor=M.+L.+Loh&title=The+mutational+spectrum+of+PTPN11+in+juvenile+myelomonocytic+leukemia+and+Noonan+syndrome%2Fmyeloproliferative+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DC.%2BP.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DCastleberry%26aufirst%3DR.%2BP.%26aulast%3DCetin%26aufirst%3DM.%26aulast%3DBergstr%25C3%25A4sser%26aufirst%3DE.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DKardos%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DKojima%26aufirst%3DS.%26aulast%3DStary%26aufirst%3DJ.%26aulast%3DTrebo%26aufirst%3DM.%26aulast%3DZecca%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26atitle%3DThe%2520mutational%2520spectrum%2520of%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%2520and%2520Noonan%2520syndrome%252Fmyeloproliferative%2520disease%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D2183%26epage%3D2185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bentires-Alj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8816</span><span class="NLM_x">–</span> <span class="NLM_lpage">8820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=15604238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span></div><div class="casAuthors">Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.; Keilhack, Heike; Halmos, Balazs; Naoki, Katsuhiko; Maris, John M.; Richardson, Andrea; Bardelli, Alberto; Sugarbaker, David J.; Richards, William G.; Du, Jinyan; Girard, Luc; Minna, John D.; Loh, Mignon L.; Fisher, David E.; Velculescu, Victor E.; Vogelstein, Bert; Meyerson, Matthew; Sellers, William R.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8816-8820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SH2 domain-contg. protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential component of signaling pathways initiated by growth factors, cytokines, and extracellular matrix.  In many of these pathways, Shp2 acts upstream of Ras.  About 50% of patients with Noonan syndrome have germ-line PTPN11 gain of function mutations.  Assocns. between Noonan syndrome and an increased risk of some malignancies, notably leukemia and neuroblastoma, have been reported, and recent data indicate that somatic PTPN11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrome, B-cell acute lymphoblastic leukemia, and acute myelogenous leukemia (AML).  Juvenile myelomonocytic leukemia patients without PTPN11 mutations have either homozygotic NF-1 deletion or activating RAS mutations.  Given the role of Shp2 in Ras activation and the frequent mutation of RAS in human tumors, these data raise the possibility that PTPN11 mutations play a broader role in cancer.  The authors asked whether PTPN11 mutations occur in other malignancies in which activating RAS mutations occur at low but significant frequency.  Sequencing of PTPN11 from 13 different human neoplasms including breast, lung, gastric, and neuroblastoma tumors and adult AML and acute lymphoblastic leukemia revealed 11 missense mutations.  Five are known mutations predicted to result in an activated form of Shp2, whereas six are new mutations.  Biochem. anal. confirmed that several of the new mutations result in increased Shp2 activity.  The data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, esp. neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3taKvDtHXBLVg90H21EOLACvtfcHk0lhGiqeLZ-yOeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK&md5=f6f9fb8c6e9d5260901a03081db259c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+distinct+class+of+gain-of-function+SHP-2+mutants+with+oncogenic+RAS-like+transforming+activity+from+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0ljc9DGj-RQ1Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520distinct%2520class%2520of%2520gain-of-function%2520SHP-2%2520mutants%2520with%2520oncogenic%2520RAS-like%2520transforming%2520activity%2520from%2520solid%2520tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">The Cancer Genome Atlas Research Network</span><span> </span><span class="NLM_article-title">Comprehensive genomic characterization defines human glioblastoma genes and core pathways</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=1061-1068&author=The+Cancer+Genome+Atlas+Research+Network&title=Comprehensive+genomic+characterization+defines+human+glioblastoma+genes+and+core+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DComprehensive%2520genomic%2520characterization%2520defines%2520human%2520glioblastoma%2520genes%2520and%2520core%2520pathways%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D1061%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Taylor, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hieronymus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reva, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antipin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgalev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socci, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lash, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scardino, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald, W. L.</span><span> </span><span class="NLM_article-title">Integrative genomic profiling of human prostate cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=11-22&author=B.+S.+Taylorauthor=N.+Schultzauthor=H.+Hieronymusauthor=A.+Gopalanauthor=Y.+Xiaoauthor=B.+S.+Carverauthor=V.+K.+Aroraauthor=P.+Kaushikauthor=E.+Ceramiauthor=B.+Revaauthor=Y.+Antipinauthor=N.+Mitsiadesauthor=T.+Landersauthor=I.+Dolgalevauthor=J.+E.+Majorauthor=M.+Wilsonauthor=N.+D.+Socciauthor=A.+E.+Lashauthor=A.+Heguyauthor=J.+A.+Easthamauthor=H.+I.+Scherauthor=V.+E.+Reuterauthor=P.+T.+Scardinoauthor=C.+Sanderauthor=C.+L.+Sawyersauthor=W.+L.+Gerald&title=Integrative+genomic+profiling+of+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DB.%2BS.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DHieronymus%26aufirst%3DH.%26aulast%3DGopalan%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DCarver%26aufirst%3DB.%2BS.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DKaushik%26aufirst%3DP.%26aulast%3DCerami%26aufirst%3DE.%26aulast%3DReva%26aufirst%3DB.%26aulast%3DAntipin%26aufirst%3DY.%26aulast%3DMitsiades%26aufirst%3DN.%26aulast%3DLanders%26aufirst%3DT.%26aulast%3DDolgalev%26aufirst%3DI.%26aulast%3DMajor%26aufirst%3DJ.%2BE.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DSocci%26aufirst%3DN.%2BD.%26aulast%3DLash%26aufirst%3DA.%2BE.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DEastham%26aufirst%3DJ.%2BA.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DReuter%26aufirst%3DV.%2BE.%26aulast%3DScardino%26aufirst%3DP.%2BT.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DGerald%26aufirst%3DW.%2BL.%26atitle%3DIntegrative%2520genomic%2520profiling%2520of%2520human%2520prostate%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D11%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noushmehr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmulevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnholtz-Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vegesna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sougnez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Meir, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacocca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenberger, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TCGA Research Network</span><span> </span><span class="NLM_article-title">The somatic genomic landscape of glioblastoma</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2013&pages=462-477&author=C.+W.+Brennanauthor=R.+G.+Verhaakauthor=A.+McKennaauthor=B.+Camposauthor=H.+Noushmehrauthor=S.+R.+Salamaauthor=S.+Zhengauthor=D.+Chakravartyauthor=J.+Z.+Sanbornauthor=S.+H.+Bermanauthor=R.+Beroukhimauthor=B.+Bernardauthor=C.+J.+Wuauthor=G.+Genoveseauthor=I.+Shmulevichauthor=J.+Barnholtz-Sloanauthor=L.+Zouauthor=R.+Vegesnaauthor=S.+A.+Shuklaauthor=G.+Cirielloauthor=W.+K.+Yungauthor=W.+Zhangauthor=C.+Sougnezauthor=T.+Mikkelsenauthor=K.+Aldapeauthor=D.+D.+Bignerauthor=E.+G.+Van+Meirauthor=M.+Pradosauthor=A.+Sloanauthor=K.+L.+Blackauthor=J.+Eschbacherauthor=G.+Finocchiaroauthor=W.+Friedmanauthor=D.+W.+Andrewsauthor=A.+Guhaauthor=M.+Iacoccaauthor=B.+P.+O%E2%80%99Neillauthor=G.+Foltzauthor=J.+Myersauthor=D.+J.+Weisenbergerauthor=R.+Pennyauthor=R.+Kucherlapatiauthor=C.+M.+Perouauthor=D.+N.+Hayesauthor=R.+Gibbsauthor=M.+Marraauthor=G.+B.+Millsauthor=E.+Landerauthor=P.+Spellmanauthor=R.+Wilsonauthor=C.+Sanderauthor=J.+Weinsteinauthor=M.+Meyersonauthor=S.+Gabrielauthor=P.+W.+Lairdauthor=D.+Hausslerauthor=G.+Getzauthor=L.+Chinauthor=TCGA+Research+Network&title=The+somatic+genomic+landscape+of+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DVerhaak%26aufirst%3DR.%2BG.%26aulast%3DMcKenna%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DNoushmehr%26aufirst%3DH.%26aulast%3DSalama%26aufirst%3DS.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DSanborn%26aufirst%3DJ.%2BZ.%26aulast%3DBerman%26aufirst%3DS.%2BH.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBernard%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DC.%2BJ.%26aulast%3DGenovese%26aufirst%3DG.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DVegesna%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DS.%2BA.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DYung%26aufirst%3DW.%2BK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSougnez%26aufirst%3DC.%26aulast%3DMikkelsen%26aufirst%3DT.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DPrados%26aufirst%3DM.%26aulast%3DSloan%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DK.%2BL.%26aulast%3DEschbacher%26aufirst%3DJ.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DW.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DGuha%26aufirst%3DA.%26aulast%3DIacocca%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BP.%26aulast%3DFoltz%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeisenberger%26aufirst%3DD.%2BJ.%26aulast%3DPenny%26aufirst%3DR.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DHayes%26aufirst%3DD.%2BN.%26aulast%3DGibbs%26aufirst%3DR.%26aulast%3DMarra%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DLander%26aufirst%3DE.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DWeinstein%26aufirst%3DJ.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DHaussler%26aufirst%3DD.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DChin%26aufirst%3DL.%26aulast%3D%26atitle%3DThe%2520somatic%2520genomic%2520landscape%2520of%2520glioblastoma%26jtitle%3DCell%26date%3D2013%26volume%3D155%26spage%3D462%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Aceto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausgruber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhaus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidatzis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martiny-Baron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzarol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balwierz, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachkov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Nimwegen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentires-Alj, M.</span><span> </span><span class="NLM_article-title">Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=529-537&author=N.+Acetoauthor=N.+Sausgruberauthor=H.+Brinkhausauthor=D.+Gaidatzisauthor=G.+Martiny-Baronauthor=G.+Mazzarolauthor=S.+Confalonieriauthor=M.+Quartoauthor=G.+Huauthor=P.+J.+Balwierzauthor=M.+Pachkovauthor=S.+J.+Elledgeauthor=E.+van+Nimwegenauthor=M.+B.+Stadlerauthor=M.+Bentires-Alj&title=Tyrosine+phosphatase+SHP2+promotes+breast+cancer+progression+and+maintains+tumor-initiating+cells+via+activation+of+key+transcription+factors+and+a+positive+feedback+signaling+loop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAceto%26aufirst%3DN.%26aulast%3DSausgruber%26aufirst%3DN.%26aulast%3DBrinkhaus%26aufirst%3DH.%26aulast%3DGaidatzis%26aufirst%3DD.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DMazzarol%26aufirst%3DG.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DBalwierz%26aufirst%3DP.%2BJ.%26aulast%3DPachkov%26aufirst%3DM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3Dvan%2BNimwegen%26aufirst%3DE.%26aulast%3DStadler%26aufirst%3DM.%2BB.%26aulast%3DBentires-Alj%26aufirst%3DM.%26atitle%3DTyrosine%2520phosphatase%2520SHP2%2520promotes%2520breast%2520cancer%2520progression%2520and%2520maintains%2520tumor-initiating%2520cells%2520via%2520activation%2520of%2520key%2520transcription%2520factors%2520and%2520a%2520positive%2520feedback%2520signaling%2520loop%26jtitle%3DNature%2520Med.%26date%3D2012%26volume%3D18%26spage%3D529%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Stommel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmelman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabioullin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponugoti, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedemeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegh, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span> </span><span class="NLM_article-title">Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=287-290&author=J.+M.+Stommelauthor=A.+C.+Kimmelmanauthor=H.+Yingauthor=R.+Nabioullinauthor=A.+H.+Ponugotiauthor=R.+Wiedemeyerauthor=A.+H.+Steghauthor=J.+E.+Bradnerauthor=K.+L.+Ligonauthor=C.+Brennanauthor=L.+Chinauthor=R.+A.+DePinho&title=Coactivation+of+receptor+tyrosine+kinases+affects+the+response+of+tumor+cells+to+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStommel%26aufirst%3DJ.%2BM.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DNabioullin%26aufirst%3DR.%26aulast%3DPonugoti%26aufirst%3DA.%2BH.%26aulast%3DWiedemeyer%26aufirst%3DR.%26aulast%3DStegh%26aufirst%3DA.%2BH.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DCoactivation%2520of%2520receptor%2520tyrosine%2520kinases%2520affects%2520the%2520response%2520of%2520tumor%2520cells%2520to%2520targeted%2520therapies%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D287%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Noren-Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Correa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestweber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiewe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">10606</span><span class="NLM_x">–</span> <span class="NLM_lpage">10611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1073%2Fpnas.0601490103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16809424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10606-10611&author=A.+Noren-Mullerauthor=I.+Reis-Correaauthor=H.+Prinzauthor=C.+Rosenbaumauthor=K.+Saxenaauthor=H.+J.+Schwalbeauthor=D.+Vestweberauthor=G.+Cagnaauthor=S.+Schunkauthor=O.+Schwarzauthor=H.+Schieweauthor=H.+Waldmann&title=Discovery+of+protein+phosphatase+inhibitor+classes+by+biology-oriented+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span></div><div class="casAuthors">Noren-Muller Andrea; Reis-Correa Ivan Jr; Prinz Heino; Rosenbaum Claudia; Saxena Krishna; Schwalbe Harald J; Vestweber Dietmar; Cagna Guiseppe; Schunk Stefan; Schwarz Oliver; Schiewe Hajo; Waldmann Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10606-11</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Protein phosphatases have very recently emerged as important targets for chemical biology and medicinal chemistry research, and new phosphatase inhibitor classes are in high demand.  The underlying frameworks of natural products represent the evolutionarily selected fractions of chemical space explored by nature so far and meet the criteria of relevance to nature and biological prevalidation most crucial to inhibitor development.  We refer to synthesis efforts and compound collection development based on these criteria as biology-oriented synthesis.  For the discovery of phosphatase inhibitor classes by means of this approach, four natural product-derived or -inspired medium-sized compound collections were synthesized and investigated for inhibition of the tyrosine phosphatases VE-PTP, Shp-2, PTP1B, MptpA, and MptpB and the dual-specificity phosphatases Cdc25A and VHR.  The screen yielded four unprecedented and selective phosphatase inhibitor classes for four phosphatases with high hit rates.  For VE-PTP and MptpB the first inhibitors were discovered.  These results demonstrate that biology-oriented synthesis is an efficient approach to the discovery of new compound classes for medicinal chemistry and chemical biology research that opens up new opportunities for the study of phosphatases, which may lead to the development of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNf4ONKii5590Q2ypr7jHkfW6udTcc2eZ3wcH1cKqpLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D&md5=76f28f79227b8261fd23e7dbf3e2d8e7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601490103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601490103%26sid%3Dliteratum%253Aachs%26aulast%3DNoren-Muller%26aufirst%3DA.%26aulast%3DReis-Correa%26aufirst%3DI.%26aulast%3DPrinz%26aufirst%3DH.%26aulast%3DRosenbaum%26aufirst%3DC.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DSchwalbe%26aufirst%3DH.%2BJ.%26aulast%3DVestweber%26aufirst%3DD.%26aulast%3DCagna%26aufirst%3DG.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DO.%26aulast%3DSchiewe%26aufirst%3DH.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520protein%2520phosphatase%2520inhibitor%2520classes%2520by%2520biology-oriented%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10606%26epage%3D10611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Discovery of a novel shp2 protein tyrosine phosphatase inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16717135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-570&author=L.+W.+Chenauthor=S.+S.+Sungauthor=M.+L.+R.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+novel+shp2+protein+tyrosine+phosphatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor</span></div><div class="casAuthors">Chen, Liwei; Sung, Shen-Shu; Yip, M. L. Richard; Lawrence, Harshani R.; Ren, Yuan; Guida, Wayne C.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-570</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Shp2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene.  It is involved in growth factor-induced activation of mitogen-activated protein (MAP) kinases Erk1 and Erk2 (Erk1/2) and has been implicated in the pathogenicity of the oncogenic bacterium Helicobacter pylori.  Moreover, gain-of-function Shp2 mutations have been found in childhood leukemias and Noonan syndrome.  Thus, small mol. Shp2 PTP inhibitors are much needed reagents for evaluation of Shp2 as a therapeutic target and for chem. biol. studies of Shp2 function.  By screening the National Cancer Institute (NCI) Diversity Set chem. library, we identified 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877) as a potent Shp2 PTP inhibitor.  Mol. modeling and site-directed mutagenesis studies suggested that NSC-87877 binds to the catalytic cleft of Shp2 PTP.  NSC-87877 cross-inhibited Shp1 in vitro, but it was selective for Shp2 over other PTPs (PTP1B, HePTP, DEP1, CD45, and LAR).  It is noteworthy that NSC-87877 inhibited epidermal growth factor (EGF)-induced activation of Shp2 PTP, Ras, and Erk1/2 in cell cultures but did not block EGF-induced Gab1 tyrosine phosphorylation or Gab1-Shp2 assocn.  Furthermore, NSC-87877 inhibited Erk1/2 activation by a Gab1-Shp2 chimera but did not affect the Shp2-independent Erk1/2 activation by phorbol 12-myristate 13-acetate.  These results identified NSC-87877 as the first PTP inhibitor capable of inhibiting Shp2 PTP in cell cultures without a detectable off-target effect.  Our study also provides the first pharmacol. evidence that Shp2 mediates EGF-induced Erk1/2 MAP kinase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4XVGUjw3W7Vg90H21EOLACvtfcHk0lgdBlTNJb6zmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D&md5=a2ce03150ecbe6937876bb292ced30dc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520shp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dawson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhuiyan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tautz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waleh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span> </span><span class="NLM_article-title">Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5650</span><span class="NLM_x">–</span> <span class="NLM_lpage">5662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800456k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5650-5662&author=M.+I.+Dawsonauthor=Z.+Xiaauthor=T.+Jiangauthor=M.+Yeauthor=J.+A.+Fontanaauthor=L.+Farhanaauthor=B.+Patelauthor=L.+P.+Xueauthor=M.+Bhuiyanauthor=R.+Pellicciariauthor=A.+Macchiaruloauthor=R.+Nutiauthor=X.+K.+Zhangauthor=Y.+H.+Hanauthor=L.+Tautzauthor=P.+D.+Hobbsauthor=L.+Jongauthor=N.+Walehauthor=W.+R.+Chaoauthor=G.+S.+Fengauthor=Y.+Pangauthor=Y.+Su&title=Adamantyl-substituted+retinoid-derived+molecules+that+interact+with+the+orphan+nuclear+receptor+small+heterodimer+partner%3A+effects+of+replacing+the+1-adamantyl+or+hydroxyl+group+on+inhibition+of+cancer+cell+growth%2C+induction+of+cancer+cell+apoptosis%2C+and+inhibition+of+SRC+homology+2+domain-containing+protein+tyrosine+phosphatase-2+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantyl-Substituted Retinoid-Derived Molecules That Interact with the Orphan Nuclear Receptor Small Heterodimer Partner: Effects of Replacing the 1-Adamantyl or Hydroxyl Group on Inhibition of Cancer Cell Growth, Induction of Cancer Cell Apoptosis, and Inhibition of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Activity</span></div><div class="casAuthors">Dawson, Marcia I.; Xia, Zebin; Jiang, Tao; Ye, Mao; Fontana, Joseph A.; Farhana, Lulu; Patel, Bhaumik; Xue, Li Ping; Bhuiyan, Mohammad; Pellicciari, Roberto; Macchiarulo, Antonio; Nuti, Roberto; Zhang, Xiao-Kun; Han, Young-Hoon; Tautz, Lutz; Hobbs, Peter D.; Jong, Ling; Waleh, Nahid; Chao, Wan-ru; Feng, Gen-Sheng; Pang, Yuhong; Su, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5650-5662</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(E)-4-[3-(1-Adamantyl)-4'-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces the cell-cycle arrest and apoptosis of leukemia and cancer cells.  Studies demonstrated that 3-Cl-AHPC bound to the atypical orphan nuclear receptor small heterodimer partner (SHP).  Although missing a DNA-binding domain, SHP heterodimerizes with the ligand-binding domains of other nuclear receptors to repress their abilities to induce or inhibit gene expression.  3-Cl-AHPC analogs having the 1-adamantyl and phenolic hydroxyl pharmacophoric elements replaced with isosteric groups were designed, synthesized, and evaluated for their inhibition of proliferation and induction of human cancer cell apoptosis.  Structure-anticancer activity relationship studies indicated the importance of both groups to apoptotic activity.  Docking of 3-Cl-AHPC and its analogs to an SHP computational model that was based on the crystal structure of ultraspiracle complexed with 1-stearoyl-2-palmitoylglycero-3-phosphoethanolamine suggested why these 3-Cl-AHPC groups could influence SHP activity.  Inhibitory activity against Src homol. 2 domain-contg. protein tyrosine phosphatase 2 (Shp-2) was also assessed.  The most active Shp-2 inhibitor was found to be the 3'-(3,3-dimethylbutynyl) analog of 3-Cl-AHPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3EhNrmE1CAbVg90H21EOLACvtfcHk0lgdBlTNJb6zmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtbfE&md5=d083d7bfb6334fe98cf184b59af1dfec</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm800456k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800456k%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BI.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DFontana%26aufirst%3DJ.%2BA.%26aulast%3DFarhana%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DXue%26aufirst%3DL.%2BP.%26aulast%3DBhuiyan%26aufirst%3DM.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DNuti%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DX.%2BK.%26aulast%3DHan%26aufirst%3DY.%2BH.%26aulast%3DTautz%26aufirst%3DL.%26aulast%3DHobbs%26aufirst%3DP.%2BD.%26aulast%3DJong%26aufirst%3DL.%26aulast%3DWaleh%26aufirst%3DN.%26aulast%3DChao%26aufirst%3DW.%2BR.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26atitle%3DAdamantyl-substituted%2520retinoid-derived%2520molecules%2520that%2520interact%2520with%2520the%2520orphan%2520nuclear%2520receptor%2520small%2520heterodimer%2520partner%253A%2520effects%2520of%2520replacing%2520the%25201-adamantyl%2520or%2520hydroxyl%2520group%2520on%2520inhibition%2520of%2520cancer%2520cell%2520growth%252C%2520induction%2520of%2520cancer%2520cell%2520apoptosis%252C%2520and%2520inhibition%2520of%2520SRC%2520homology%25202%2520domain-containing%2520protein%2520tyrosine%2520phosphatase-2%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5650%26epage%3D5662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Geronikaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleftheriou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span> </span><span class="NLM_article-title">2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5221</span><span class="NLM_x">–</span> <span class="NLM_lpage">5228</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8004306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5221-5228&author=A.+Geronikakiauthor=P.+Eleftheriouauthor=P.+Viciniauthor=I.+Alamauthor=A.+Dixitauthor=A.+K.+Saxena&title=2-Thiazolylimino%2Fheteroarylimino-5-arylidene-4-thiazolidinones+as+new+agents+with+SHP-2+inhibitory+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm8004306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8004306%26sid%3Dliteratum%253Aachs%26aulast%3DGeronikaki%26aufirst%3DA.%26aulast%3DEleftheriou%26aufirst%3DP.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DAlam%26aufirst%3DI.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26atitle%3D2-Thiazolylimino%252Fheteroarylimino-5-arylidene-4-thiazolidinones%2520as%2520new%2520agents%2520with%2520SHP-2%2520inhibitory%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5221%26epage%3D5228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymanski, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span> </span><span class="NLM_article-title">Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4948</span><span class="NLM_x">–</span> <span class="NLM_lpage">4956</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8002526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4948-4956&author=H.+R.+Lawrenceauthor=R.+Piredduauthor=L.+W.+Chenauthor=Y.+T.+Luoauthor=S.+S.+Sungauthor=A.+M.+Szymanskiauthor=M.+L.+R.+Yipauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=J.+Wuauthor=N.+J.+Lawrence&title=Inhibitors+of+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28Shp2%29+based+on+oxindole+scaffolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds</span></div><div class="casAuthors">Lawrence, Harshani R.; Pireddu, Roberta; Chen, Liwei; Luo, Yunting; Sung, Shen-Shu; Szymanski, Ann Marie; Yip, M. L. Richard; Guida, Wayne C.; Sebti, Said M.; Wu, Jie; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4948-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the NCI diversity set of compds. has led to the identification of NSC-117199, which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM.  A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities.  Several compds. were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity.  A model for the binding of the active compds. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqLAauyGNBbVg90H21EOLACvtfcHk0lixDMP3XJ8EMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D&md5=572227c5a8cfffb108388616bd36fdfe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm8002526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002526%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DLuo%26aufirst%3DY.%2BT.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DSzymanski%26aufirst%3DA.%2BM.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DInhibitors%2520of%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528Shp2%2529%2520based%2520on%2520oxindole%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4948%26epage%3D4956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hellmuth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosskopf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kries, J. P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7275</span><span class="NLM_x">–</span> <span class="NLM_lpage">7280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1073%2Fpnas.0710468105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=18480264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7275-7280&author=K.+Hellmuthauthor=S.+Grosskopfauthor=C.+T.+Lumauthor=M.+Wurteleauthor=N.+Roderauthor=J.+P.+V.+Kriesauthor=M.+Rosarioauthor=J.+Rademannauthor=W.+Birchmeier&title=Specific+inhibitors+of+the+protein+tyrosine+phosphatase+Shp2+identified+by+high-throughput+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span></div><div class="casAuthors">Hellmuth, Klaus; Grosskopf, Stefanie; Lum, Ching Tung; Wuertele, Martin; Roeder, Nadine; von Kries, Jens Peter; Rosario, Marta; Rademann, Jorg; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7275-7280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase Shp2 is a pos. regulator of growth factor signaling.  Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene.  We performed a high-throughput in silico screen for small-mol.-wt. compds. that bind the catalytic site of Shp2.  We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1 B.  PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis.  PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin.  Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-assocd. Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.  The PHPS compd. class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGponh1kw_h7jrVg90H21EOLACvtfcHk0lixDMP3XJ8EMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D&md5=39c7dda94e32134c305e135e4c48b9d1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710468105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710468105%26sid%3Dliteratum%253Aachs%26aulast%3DHellmuth%26aufirst%3DK.%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DWurtele%26aufirst%3DM.%26aulast%3DRoder%26aufirst%3DN.%26aulast%3DKries%26aufirst%3DJ.%2BP.%2BV.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DSpecific%2520inhibitors%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520Shp2%2520identified%2520by%2520high-throughput%2520docking%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D7275%26epage%3D7280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guvench, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKerell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7396</span><span class="NLM_x">–</span> <span class="NLM_lpage">7404</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800229d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7396-7404&author=W.+M.+Yuauthor=O.+Guvenchauthor=A.+D.+MacKerellauthor=C.+K.+Qu&title=Identification+of+small+molecular+weight+inhibitors+of+Src+homology+2+domain-containing+tyrosine+phosphatase+2+%28SHP-2%29+via+in+silico+database+screening+combined+with+experimental+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Small Molecular Weight Inhibitors of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 (SHP-2) via in Silico Database Screening Combined with Experimental Assay</span></div><div class="casAuthors">Yu, Wen-Mei; Guvench, Olgun; MacKerell, Alexander D.; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7396-7404</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual screening methods combined with exptl. assays were used to identify low mol. wt. inhibitors for Src homol. 2 domain-contg. phosphatase 2 (SHP-2) that is mutated and hyperactivated in Noonan syndrome and a significant portion of childhood leukemias.  Virtual screening included multiple conformations of the protein, score normalization procedures, and chem. similarity considerations.  As the catalytic core of SHP-2 shares extremely high homol. to those of the related SHP-1 phosphatase and other tyrosine phosphatases, in order to identify selective inhibitors, we chose to target an adjacent protein surface pocket that is predicted to be important for binding to phosphopeptides and that has structural features unique to SHP-2.  From a database of 1.3 million compds., 9 out of 165 computationally selected compds. were shown to inhibit SHP-2 activity with IC50 values of ≈ 100 μM.  Two of the active compds. were further verified for their ability to inhibit SHP-2-mediated cellular functions.  Fluorescence titrn. expts. confirmed their direct binding to SHP-2.  Because of their simple chem. structures, these small org. compds. have the potential to act as lead compds. for the development of novel anti-SHP-2 drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Kw_2kNl-RbVg90H21EOLACvtfcHk0lixDMP3XJ8EMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI&md5=915691bc2e64243286cf305314b3a470</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm800229d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800229d%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DGuvench%26aufirst%3DO.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520small%2520molecular%2520weight%2520inhibitors%2520of%2520Src%2520homology%25202%2520domain-containing%2520tyrosine%2520phosphatase%25202%2520%2528SHP-2%2529%2520via%2520in%2520silico%2520database%2520screening%2520combined%2520with%2520experimental%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7396%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tautz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustelin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.-S.</span><span> </span><span class="NLM_article-title">A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e4914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e4914&author=D.+Wuauthor=Y.+Pangauthor=Y.+Keauthor=J.+Yuauthor=Z.+Heauthor=L.+Tautzauthor=T.+Mustelinauthor=S.+Dingauthor=Z.+Huangauthor=G.-S.+Feng&title=A+conserved+mechanism+for+control+of+human+and+mouse+embryonic+stem+cell+pluripotency+and+differentiation+by+shp2+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DTautz%26aufirst%3DL.%26aulast%3DMustelin%26aufirst%3DT.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DG.-S.%26atitle%3DA%2520conserved%2520mechanism%2520for%2520control%2520of%2520human%2520and%2520mouse%2520embryonic%2520stem%2520cell%2520pluripotency%2520and%2520differentiation%2520by%2520shp2%2520tyrosine%2520phosphatase%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De4914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Salicylic acid-based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.-X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.-Y.+Zhang&title=Salicylic+acid-based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.-X.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSalicylic%2520acid-based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Fatty acids as natural specific inhibitors of the proto-oncogenic protein Shp2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6833</span><span class="NLM_x">–</span> <span class="NLM_lpage">6837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6833-6837&author=D.+Liuauthor=G.+Kongauthor=Q.+C.+Chenauthor=G.+Wangauthor=J.+Liauthor=Y.+Xuauthor=T.+Linauthor=Y.+Tianauthor=X.+Zhangauthor=X.+Yaoauthor=G.+Fengauthor=Z.+Luauthor=H.+Chen&title=Fatty+acids+as+natural+specific+inhibitors+of+the+proto-oncogenic+protein+Shp2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DKong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DQ.%2BC.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DFatty%2520acids%2520as%2520natural%2520specific%2520inhibitors%2520of%2520the%2520proto-oncogenic%2520protein%2520Shp2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6833%26epage%3D6837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Scott, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs</span> <span class="citation_source-journal">Bioorg. Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.bmcl.2010.11.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=21193311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=730-733&author=L.+M.+Scottauthor=L.+Chenauthor=K.+G.+Danielauthor=W.+H.+Brooksauthor=W.+C.+Guidaauthor=H.+R.+Lawrenceauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Shp2+protein+tyrosine+phosphatase+inhibitor+activity+of+estramustine+phosphate+and+its+triterpenoid+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs</span></div><div class="casAuthors">Scott, Latanya M.; Chen, Liwei; Daniel, Kenyon G.; Brooks, Wesley H.; Guida, Wayne C.; Lawrence, Harshani R.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">730-733</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Shp2 protein tyrosine phosphate (PTP) is a novel target for anticancer drug discovery.  We identified estramustine phosphate as a Shp2 PTP inhibitor from the National Cancer Institute Approved Oncol. Drug set.  A focused structure-activity relationship study indicated that the 17-phosphate group is required for the Shp2 PTP inhibitor activity of estramustine phosphate.  A search for estramustine phosphate analogs led to identification of two triterpenoids, enoxolone, and celastrol, having Shp2 PTP inhibitor activity.  With the previously reported PTP1B inhibitor trodusquemine, our study reveals steroids and triterpenoids with neg. charged phosphate, carboxylate, or sulfonate groups as novel pharmacophores of selective PTP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo41pp4mYsX5rVg90H21EOLACvtfcHk0lgiRnK9sf9Zyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOjtA%253D%253D&md5=41e82922b4285fa0d45c9033d1257631</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.117%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDaniel%26aufirst%3DK.%2BG.%26aulast%3DBrooks%26aufirst%3DW.%2BH.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DShp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%2520activity%2520of%2520estramustine%2520phosphate%2520and%2520its%2520triterpenoid%2520analogs%26jtitle%3DBioorg.%2520Bioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D730%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Yu, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4238</span><span class="NLM_x">–</span> <span class="NLM_lpage">4242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4238-4242&author=Z.-H.+Yuauthor=L.+Chenauthor=L.+Wuauthor=S.+Liuauthor=L.+Wangauthor=Z.-Y.+Zhang&title=Small+molecule+inhibitors+of+SHP2+tyrosine+phosphatase+discovered+by+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.-H.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520SHP2%2520tyrosine%2520phosphatase%2520discovered%2520by%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4238%26epage%3D4242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">SHP2 is a target of the immunosuppressant tautomycetin</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.chembiol.2010.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=21276943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=101-110&author=S.+Liuauthor=Z.+Yuauthor=X.+Yuauthor=S.-X.+Huangauthor=Y.+Luoauthor=L.+Wuauthor=W.+Shenauthor=Z.+Yangauthor=L.+Wangauthor=A.+M.+Gunawanauthor=R.+J.+Chanauthor=B.+Shenauthor=Z.-Y.+Zhang&title=SHP2+is+a+target+of+the+immunosuppressant+tautomycetin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 is a Target of the Immunosuppressant Tautomycetin</span></div><div class="casAuthors">Liu, Si-Jiu; Yu, Zhi-Hong; Yu, Xiao; Huang, Sheng-Xiong; Luo, Ying-Gang; Wu, Li; Shen, Wei-Hua; Yang, Zhen-Yun; Wang, Li-Na; Gunawan, Andrea M.; Chan, Rebecca J.; Shen, Ben; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SHP2 phosphatase is a pos. transducer of growth factor and cytokine signaling.  SHP2 is also a bona fide oncogene; gain-of-function SHP2 mutations leading to increased phosphatase activity cause Noonan syndrome, as well as multiple forms of leukemia and solid tumors.  The authors report that tautomycetin (TTN), an immunosuppressor in organ transplantation, and its engineered analog TTN D-1 are potent SHP2 inhibitors.  TTN and TTN D-1 block T cell receptor-mediated tyrosine phosphorylation and ERK activation and gain-of-function mutant SHP2-induced hematopoietic progenitor hyperproliferation and monocytic differentiation.  Crystal structure of the SHP2·TTN D-1 complex reveals that TTN D-1 occupies the SHP2 active site in a manner similar to that of a peptide substrate.  Collectively, the data support the notion that SHP2 is a cellular target for TTN and provide a potential mechanism for the immunosuppressive activity of TTN.  Moreover, the structure furnishes mol. insights upon which therapeutics targeting SHP2 can be developed on the basis of the TTN scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfQx2ElYrqrVg90H21EOLACvtfcHk0ljiB02G43HT-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaku7c%253D&md5=2ecffe52d66725214426ddee18fe85f5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DS.-X.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSHP2%2520is%2520a%2520target%2520of%2520the%2520immunosuppressant%2520tautomycetin%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7212</span><span class="NLM_x">–</span> <span class="NLM_lpage">7221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400474r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7212-7221&author=W.+Liuauthor=B.+Yuauthor=G.+Xuauthor=W.+R.+Xuauthor=M.+L.+Lohauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Identification+of+cryptotanshinone+as+an+inhibitor+of+oncogenic+protein+tyrosine+phosphatase+SHP2+%28PTPN11%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)</span></div><div class="casAuthors">Liu, Wei; Yu, Bing; Xu, Gang; Xu, Wei-Ren; Loh, Mignon L.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7212-7221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are assocd. with Noonan syndrome, childhood leukemias, and sporadic solid tumors.  Virtual screening combined with exptl. assays was performed to identify inhibitors of SHP2 from a database of natural products.  This effort led to the identification of cryptotanshinone as an inhibitor of SHP2.  Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM.  Fluorescence titrn. expts. confirmed that it directly bound to SHP2.  Enzymic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.  This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions.  Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor.  Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-assocd. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYelS47QYHLVg90H21EOLACvtfcHk0ljiB02G43HT-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN&md5=3bbbae68159ae4227bbf74d5573ca77a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520cryptotanshinone%2520as%2520an%2520inhibitor%2520of%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520%2528PTPN11%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7212%26epage%3D7221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guvench, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1738</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1158%2F1535-7163.MCT-13-0049-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=23825065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1738-1748&author=B.+Yuauthor=W.+Liuauthor=W.+M.+Yuauthor=M.+L.+Lohauthor=S.+Alterauthor=O.+Guvenchauthor=A.+D.+Mackerellauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Targeting+protein+tyrosine+phosphatase+SHP2+for+the+treatment+of+PTPN11-associated+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11-Associated Malignancies</span></div><div class="casAuthors">Yu, Bing; Liu, Wei; Yu, Wen-Mei; Loh, Mignon L.; Alter, Shawn; Guvench, Olgun; MacKerell, Alexander D., Jr.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1738-1748</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activating mutations in PTPN11 (encoding SHP2), a protein tyrosine phosphatase (PTP) that plays an overall pos. role in growth factor and cytokine signaling, are directly assocd. with the pathogenesis of Noonan syndrome and childhood leukemias.  Identification of SHP2-selective inhibitors could lead to the development of new drugs that ultimately serve as treatments for PTPN11-assocd. diseases.  As the catalytic core of SHP2 shares extremely high homol. to those of SHP1 and other PTPs that play neg. roles in cell signaling, to identify selective inhibitors of SHP2 using computer-aided drug design, we targeted a protein surface pocket that is adjacent to the catalytic site, is predicted to be important for binding to phosphopeptide substrates, and has structural features unique to SHP2.  From computationally selected candidate compds., #220-324 effectively inhibited SHP2 activity with an IC50 of 14 μmol/L.  Fluorescence titrn. expts. confirmed its direct binding to SHP2.  This active compd. was further verified for its ability to inhibit SHP2-mediated cell signaling and cellular function with minimal off-target effects.  Furthermore, mouse myeloid progenitors with the activating mutation (E76K) in PTPN11 and patient leukemic cells with the same mutation were more sensitive to this inhibitor than wild-type cells.  This study provides evidence that SHP2 is a "druggable" target for the treatment of PTPN11-assocd. diseases.  As the small-mol. SHP2 inhibitor identified has a simple chem. structure, it represents an ideal lead compd. for the development of novel anti-SHP2 drugs.  Mol Cancer Ther; 12(9); 1738-48. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj3UZZIk5H7LVg90H21EOLACvtfcHk0ljiB02G43HT-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7M&md5=645bbea5d54c34844313f638b6fb0b7c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0049-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0049-T%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DAlter%26aufirst%3DS.%26aulast%3DGuvench%26aufirst%3DO.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DTargeting%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520for%2520the%2520treatment%2520of%2520PTPN11-associated%2520malignancies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1738%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Puius, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">13420</span><span class="NLM_x">–</span> <span class="NLM_lpage">13425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1073%2Fpnas.94.25.13420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=9391040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADyaK2sXotVamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=13420-13425&author=Y.+A.+Puiusauthor=Y.+Zhaoauthor=M.+Sullivanauthor=D.+S.+Lawrenceauthor=S.+C.+Almoauthor=Z.-Y.+Zhang&title=Identification+of+a+second+aryl+phosphate-binding+site+in+protein-tyrosine+phosphatase+1B%3A+A+paradigm+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design</span></div><div class="casAuthors">Puius, Yoram A.; Zhao, Yu; Sullivan, Michael; Lawrence, David S.; Almo, Steven C.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">13420-13425</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The structure of the catalytically inactive mutant (C215S) of the human protein-tyrosine phosphatase 1B (PTP1B) has been solved to high resoln. in two complexes.  In the first, crystals were grown in the presence of bis-(para-phosphophenyl) methane (BPPM), a synthetic high-affinity low-mol. wt. nonpeptidic substrate (Km = 16μM), and the structure was refined to an R-factor of 18.2% at 1.9 Å resoln.  In the second, crystals were grown in a satg. concn. of phosphotyrosine (pTyr), and the structure was refined to an R-factor of 18.1% at 1.85 Å.  Difference Fourier maps showed that BPPM binds PTP1B in two mutually exclusive modes, one in which it occupies the canonical pTyr-binding site (the active site), and another in which a phosphophenyl moiety interacts with a set of residues not previously obsd. to bind aryl phosphates.  The identification of a second pTyr mol. at the same site in the PTP1B/C215S-pTyr complex confirms that these residues constitute a low-affinity noncatalytic aryl phosphate-binding site.  Identification of a second aryl phosphate binding site adjacent to the active site provides a paradigm for the design of tight-binding, highly specific PTP1B inhibitors that can span both the active site and the adjacent noncatalytic site.  This design can be achieved by tethering together two small ligands that are individually targeted to the active site and the proximal noncatalytic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXZfTSWJNehLVg90H21EOLACvtfcHk0lgH7_n0cDML1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotVamtbs%253D&md5=663b390ee7851d389f8e045391bfe46b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.25.13420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.25.13420%26sid%3Dliteratum%253Aachs%26aulast%3DPuius%26aufirst%3DY.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DLawrence%26aufirst%3DD.%2BS.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DIdentification%2520of%2520a%2520second%2520aryl%2520phosphate-binding%2520site%2520in%2520protein-tyrosine%2520phosphatase%25201B%253A%2520A%2520paradigm%2520for%2520inhibitor%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D13420%26epage%3D13425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1146%2Fannurev.pharmtox.42.083001.144616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11807171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFKnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=209-234&author=Z.-Y.+Zhang&title=Protein+tyrosine+phosphatases%3A+structure+and+function%2C+substrate+specificity%2C+and+inhibitor+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development</span></div><div class="casAuthors">Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-234</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs) are signaling enzymes that control a diverse array of cellular processes.  Malfunction of PTP activity is assocd. with a no. of human disorders.  Recent genetic and biochem. studies indicate that PTPs represent a novel platform for drug discovery.  Detailed knowledge of PTP substrate specificity and the wealth of structural data on PTPs provide a solid foundation for rational PTP inhibitor design.  This review summarizes a correlation of PTP structure and function from mutagenesis expts.  The mol. basis for PTP1B and MKP3 substrate recognition is discussed.  A powerful strategy is presented for creating specific and high-affinity bidentate PTP inhibitors that simultaneously bind both the active site and a unique adjacent site.  Finally, recent advances in the development of potent and selective inhibitors for PTP1B and Cdc25 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKkHsDd9nAT7Vg90H21EOLACvtfcHk0lgH7_n0cDML1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFKnsbo%253D&md5=eb192ad4d7283c476947af0fbbcfcfb0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.42.083001.144616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.42.083001.144616%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520structure%2520and%2520function%252C%2520substrate%2520specificity%252C%2520and%2520inhibitor%2520development%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2002%26volume%3D42%26spage%3D209%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Small molecule tools for functional interrogation of protein tyrosine phosphatases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1111%2Fj.1742-4658.2012.08718.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=22816879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=731-750&author=R.+Heauthor=L.-F.+Zengauthor=Y.+Heauthor=S.+Zhangauthor=Z.-Y.+Zhang&title=Small+molecule+tools+for+functional+interrogation+of+protein+tyrosine+phosphatases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule tools for functional interrogation of protein tyrosine phosphatases</span></div><div class="casAuthors">He, Rongjun; Zeng, Li-Fan; He, Yantao; Zhang, Sheng; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">731-750</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The importance of protein tyrosine phosphatases (PTPs) in the regulation of cellular signalling is well established.  Malfunction of PTP activity is also known to be assocd. with cancer, metabolic syndromes and autoimmune disorders, as well as neurodegenerative and infectious diseases.  However, a detailed understanding of the roles played by the PTPs in normal physiol. and in pathogenic conditions has been hampered by the absence of PTP-specific small mol. agents.  In addn., the therapeutic benefits of modulating this target class are underexplored as a result of a lack of suitable chem. probes.  Potent and specific PTP inhibitors could significantly facilitate functional anal. of the PTPs in complex cellular signal transduction pathways and may constitute valuable therapeutics in the treatment of several human diseases.  We highlight the current challenges to and opportunities for developing PTP-specific small mol. agents.  We also review available selective small mol. inhibitors developed for a no. of PTPs, including PTP1B, TC-PTP, SHP2, lymphoid-specific tyrosine phosphatase, hematopoietic protein tyrosine phosphatase, CD45, PTPβ, PTPγ, PTPRO, Vaccinia H1-related phosphatase, mitogen-activated protein kinase phosphatase-1, mitogen-activated protein kinase phosphatase-3, Cdc25, YopH, mPTPA and mPTPB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokl-YBrjLX1bVg90H21EOLACvtfcHk0lgH7_n0cDML1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D&md5=a30f63b9e20bcff3b00bf61e77a95bce</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08718.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08718.x%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSmall%2520molecule%2520tools%2520for%2520functional%2520interrogation%2520of%2520protein%2520tyrosine%2520phosphatases%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D731%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudmon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">19767</span><span class="NLM_x">–</span> <span class="NLM_lpage">19772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19767-19772&author=X.+Yuauthor=J.-P.+Sunauthor=Y.+Heauthor=X.-L.+Guoauthor=S.+Liuauthor=B.+Zhouauthor=A.+Hudmonauthor=Z.-Y.+Zhang&title=Structure%2C+inhibitor%2C+and+regulatory+mechanism+of+Lyp%2C+a+lymphoid-specific+tyrosine+phosphatase+implicated+in+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DJ.-P.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.-L.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DHudmon%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DStructure%252C%2520inhibitor%252C%2520and%2520regulatory%2520mechanism%2520of%2520Lyp%252C%2520a%2520lymphoid-specific%2520tyrosine%2520phosphatase%2520implicated%2520in%2520autoimmune%2520diseases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19767%26epage%3D19772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Targeting Mycobacterium Protein Tyrosine Phosphatase B for Anti-Tuberculosis Agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">4573</span><span class="NLM_x">–</span> <span class="NLM_lpage">4578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=4573-4578&author=B.+Zhouauthor=Y.+Heauthor=X.+Zhangauthor=J.+Xuauthor=Y.+Luoauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=Z.+Yangauthor=R.+J.+Chanauthor=Y.+Liuauthor=J.+Zhengauthor=Z.-Y.+Zhang&title=Targeting+Mycobacterium+Protein+Tyrosine+Phosphatase+B+for+Anti-Tuberculosis+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DTargeting%2520Mycobacterium%2520Protein%2520Tyrosine%2520Phosphatase%2520B%2520for%2520Anti-Tuberculosis%2520Agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D4573%26epage%3D4578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">A Facile Hydroxyindole Carboxylic Acid-Based Focused Library Approach for Potent and Selective Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=904-908&author=L.-F.+Zengauthor=J.+Xuauthor=Y.+Heauthor=R.+Heauthor=L.+Wuauthor=A.+M.+Gunawanauthor=Z.-Y.+Zhang&title=A+Facile+Hydroxyindole+Carboxylic+Acid-Based+Focused+Library+Approach+for+Potent+and+Selective+Inhibitors+of+Mycobacterium+Protein+Tyrosine+Phosphatase+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DA%2520Facile%2520Hydroxyindole%2520Carboxylic%2520Acid-Based%2520Focused%2520Library%2520Approach%2520for%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Mycobacterium%2520Protein%2520Tyrosine%2520Phosphatase%2520B%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D904%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Discovery and Evaluation of Novel Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B from the 6-Hydroxy-Benzofuran-5-Carboxylic Acid Scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301781p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Oguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=832-842&author=Y.+Heauthor=J.+Xuauthor=Z.-H.+Yuauthor=A.+M.+Gunawanauthor=L.+Wuauthor=L.+Wangauthor=Z.-Y.+Zhang&title=Discovery+and+Evaluation+of+Novel+Inhibitors+of+Mycobacterium+Protein+Tyrosine+Phosphatase+B+from+the+6-Hydroxy-Benzofuran-5-Carboxylic+Acid+Scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of Novel Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic Acid Scaffold</span></div><div class="casAuthors">He, Yantao; Xu, Jie; Yu, Zhi-Hong; Gunawan, Andrea M.; Wu, Li; Wang, Lina; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">832-842</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis (Mtb) protein tyrosine phosphatase B (mPTPB) is a virulence factor secreted by the pathogen and mediates mycobacterial survival in macrophages by targeting host cell immune responses.  Consequently, mPTPB represents an exciting new target to combat tuberculosis (TB) infection.  We describe a medicinal chem. oriented approach that transforms a benzofuran salicylic acid scaffold into a highly potent (IC50 = 38 nM) and selective mPTPB inhibitor (>50 fold against a large panel of PTPs).  Importantly, the inhibitor is capable of reversing the altered host immune responses induced by the bacterial phosphatase and restoring the macrophage's full capacity to secrete IL-6 and undergo apoptosis in response to interferon-γ stimulation, validating the concept that chem. inhibition of mPTPB may be therapeutically useful for novel TB treatment.  The study further demonstrates that bicyclic salicylic acid pharmacophores can be used to deliver PTP inhibitors with high potency, selectivity, and cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPqxb8o40oqrVg90H21EOLACvtfcHk0lhdspdv9AuSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Oguw%253D%253D&md5=c9492d72c21adb7be4e74eb2f5d5860a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm301781p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301781p%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DZ.-H.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520and%2520Evaluation%2520of%2520Novel%2520Inhibitors%2520of%2520Mycobacterium%2520Protein%2520Tyrosine%2520Phosphatase%2520B%2520from%2520the%25206-Hydroxy-Benzofuran-5-Carboxylic%2520Acid%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D832%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrios, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cato, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">A potent and selective small molecular inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4990</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400248c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4990-5008&author=Y.+Heauthor=S.+Liuauthor=A.+Menonauthor=S.+Stanfordauthor=E.+Oppongauthor=A.+M.+Gunawanauthor=L.+Wuauthor=D.+J.+Wuauthor=A.+M.+Barriosauthor=N.+Bottiniauthor=A.+C.+Catoauthor=Z.-Y.+Zhang&title=A+potent+and+selective+small+molecular+inhibitor+for+the+lymphoid-specific+tyrosine+phosphatase+%28LYP%29%2C+a+target+associated+with+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm400248c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400248c%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DA.%26aulast%3DStanford%26aufirst%3DS.%26aulast%3DOppong%26aufirst%3DE.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DD.%2BJ.%26aulast%3DBarrios%26aufirst%3DA.%2BM.%26aulast%3DBottini%26aufirst%3DN.%26aulast%3DCato%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DA%2520potent%2520and%2520selective%2520small%2520molecular%2520inhibitor%2520for%2520the%2520lymphoid-specific%2520tyrosine%2520phosphatase%2520%2528LYP%2529%252C%2520a%2520target%2520associated%2520with%2520autoimmune%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4990%26epage%3D5008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Mali, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramdas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munugalavadla, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, R.</span><span> </span><span class="NLM_article-title">Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2669-2678&author=R.+S.+Maliauthor=P.+Maauthor=L.-F.+Zengauthor=H.+Martinauthor=B.+Ramdasauthor=Y.+Heauthor=E.+Simsauthor=J.+Goshauthor=S.+Nabingerauthor=S.+Liauthor=V.+Munugalavadlaauthor=A.+W.+Craigauthor=K.+D.+Buntingauthor=G.-S.+Fengauthor=R.+J.+Chanauthor=Z.-Y.+Zhangauthor=R.+Kapur&title=Role+of+SHP2+phosphatase+in+KIT-induced+transformation%3A+identification+of+SHP2+as+a+druggable+target+in+diseases+involving+oncogenic+KIT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMali%26aufirst%3DR.%2BS.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DMartin%26aufirst%3DH.%26aulast%3DRamdas%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DSims%26aufirst%3DE.%26aulast%3DGosh%26aufirst%3DJ.%26aulast%3DNabinger%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DCraig%26aufirst%3DA.%2BW.%26aulast%3DBunting%26aufirst%3DK.%2BD.%26aulast%3DFeng%26aufirst%3DG.-S.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26aulast%3DKapur%26aufirst%3DR.%26atitle%3DRole%2520of%2520SHP2%2520phosphatase%2520in%2520KIT-induced%2520transformation%253A%2520identification%2520of%2520SHP2%2520as%2520a%2520druggable%2520target%2520in%2520diseases%2520involving%2520oncogenic%2520KIT%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D2669%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turchi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Targeting SHP2 for EGFR inhibitor resistant non small cell lung carcinoma</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">439</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2013&pages=586-590&author=J.+Xuauthor=L.-F.+Zengauthor=W.+Shenauthor=J.+J.+Turchiauthor=Z.-Y.+Zhang&title=Targeting+SHP2+for+EGFR+inhibitor+resistant+non+small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTurchi%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DTargeting%2520SHP2%2520for%2520EGFR%2520inhibitor%2520resistant%2520non%2520small%2520cell%2520lung%2520carcinoma%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D439%26spage%3D586%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Barr, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugochukwu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess-Brown, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Large-scale structural analysis of the classical human protein tyrosine phosphatome</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.cell.2008.11.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19167335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Kiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=352-363&author=A.+J.+Barrauthor=E.+Ugochukwuauthor=W.+H.+Leeauthor=O.+N.+Kingauthor=P.+Filippakopoulosauthor=I.+Alfanoauthor=P.+Savitskyauthor=N.+A.+Burgess-Brownauthor=S.+Mullerauthor=S.+Knapp&title=Large-scale+structural+analysis+of+the+classical+human+protein+tyrosine+phosphatome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Large-scale structural analysis of the classical human protein tyrosine phosphatome</span></div><div class="casAuthors">Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Muller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">352-363</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs) play a crit. role in regulating cellular functions by selectively dephosphorylating their substrates.  Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive anal. of the classical PTP family.  Despite their largely conserved fold, surface properties of PTPs are strikingly diverse.  A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors.  Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure.  Enzymic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases.  We propose a "head-to-toe" dimerization model for RPTPγ/ζ that is distinct from the "inhibitory wedge" model and that provides a mol. basis for inhibitory regulation.  This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0kaabM4U0LLVg90H21EOLACvtfcHk0lhCkZQEc0lGEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Kiu7o%253D&md5=f47994736342cc0490609596d66fd03e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.11.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.11.038%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26aulast%3DUgochukwu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DKing%26aufirst%3DO.%2BN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DAlfano%26aufirst%3DI.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DBurgess-Brown%26aufirst%3DN.%2BA.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DLarge-scale%2520structural%2520analysis%2520of%2520the%2520classical%2520human%2520protein%2520tyrosine%2520phosphatome%26jtitle%3DCell%26date%3D2009%26volume%3D136%26spage%3D352%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1163-1167&author=R.+Sordellaauthor=D.+W.+Bellauthor=D.+A.+Haberauthor=J.+Settleman&title=Gefitinib-sensitizing+EGFR+mutations+in+lung+cancer+activate+anti-apoptotic+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DGefitinib-sensitizing%2520EGFR%2520mutations%2520in%2520lung%2520cancer%2520activate%2520anti-apoptotic%2520pathways%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1163%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riely, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakowski, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kris, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H.</span><span> </span><span class="NLM_article-title">Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain</span> <span class="citation_source-journal">PLoS Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=e73&author=W.+Paoauthor=V.+A.+Millerauthor=K.+A.+Politiauthor=G.+J.+Rielyauthor=R.+Somwarauthor=M.+F.+Zakowskiauthor=M.+G.+Krisauthor=H.+Varmus&title=Acquired+resistance+of+lung+adenocarcinomas+to+gefitinib+or+erlotinib+is+associated+with+a+second+mutation+in+the+EGFR+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DPoliti%26aufirst%3DK.%2BA.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26aulast%3DSomwar%26aufirst%3DR.%26aulast%3DZakowski%26aufirst%3DM.%2BF.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DAcquired%2520resistance%2520of%2520lung%2520adenocarcinomas%2520to%2520gefitinib%2520or%2520erlotinib%2520is%2520associated%2520with%2520a%2520second%2520mutation%2520in%2520the%2520EGFR%2520kinase%2520domain%26jtitle%3DPLoS%2520Med.%26date%3D2005%26volume%3D2%26spage%3De73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Dance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, P.</span><span> </span><span class="NLM_article-title">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</span> <span class="citation_source-journal">Cell Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.cellsig.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=17993263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=453-459&author=M.+Danceauthor=A.+Montagnerauthor=J.+P.+Sallesauthor=A.+Yartauthor=P.+Raynal&title=The+molecular+functions+of+Shp2+in+the+Ras%2FMitogen-activated+protein+kinase+%28ERK1%2F2%29+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</span></div><div class="casAuthors">Dance, Marie; Montagner, Alexandra; Salles, Jean-Pierre; Yart, Armelle; Raynal, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">453-459</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Shp2 is a ubiquitous tyrosine phosphatase contg. Src Homol. 2 domains which plays major biol. functions in response to various growth factors, hormones or cytokines.  This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway.  Recent progresses have been made in the understanding of the mol. mechanisms involved in this regulation.  We review here, and discuss the physiol. relevance, of the following mol. functions of Shp2 that have been proposed to couple the phosphatase to Ras activation: promoter of Grb2/Sos recruitment through direct binding to Grb2, binding partner and regulator of SHPS-1, neg. regulator of Sprouty, neg. regulator of RasGAP recruitment, and activator of Src through dephosphorylation of Src-regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF2Kpmuyw1urVg90H21EOLACvtfcHk0lhCkZQEc0lGEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D&md5=a512a7f588e669c4ea4bb8fcc3d872db</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDance%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DSalles%26aufirst%3DJ.%2BP.%26aulast%3DYart%26aufirst%3DA.%26aulast%3DRaynal%26aufirst%3DP.%26atitle%3DThe%2520molecular%2520functions%2520of%2520Shp2%2520in%2520the%2520Ras%252FMitogen-activated%2520protein%2520kinase%2520%2528ERK1%252F2%2529%2520pathway%26jtitle%3DCell%2520Signalling%26date%3D2008%26volume%3D20%26spage%3D453%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">(2004) Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">8497</span><span class="NLM_x">–</span> <span class="NLM_lpage">8505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=8497-8505&author=Y.+Renauthor=S.+Mengauthor=L.+Meiauthor=Z.+J.+Zhaoauthor=R.+Joveauthor=J.+Wu&title=%282004%29+Roles+of+Gab1+and+SHP2+in+paxillin+tyrosine+dephosphorylation+and+Src+activation+in+response+to+epidermal+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3D%25282004%2529%2520Roles%2520of%2520Gab1%2520and%2520SHP2%2520in%2520paxillin%2520tyrosine%2520dephosphorylation%2520and%2520Src%2520activation%2520in%2520response%2520to%2520epidermal%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D8497%26epage%3D8505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Yamauchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milarski, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltiel, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessin, J. E.</span><span> </span><span class="NLM_article-title">Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=664-668&author=K.+Yamauchiauthor=K.+L.+Milarskiauthor=A.+R.+Saltielauthor=J.+E.+Pessin&title=Protein-tyrosine-phosphatase+SHPTP2+is+a+required+positive+effector+for+insulin+downstream+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DK.%26aulast%3DMilarski%26aufirst%3DK.%2BL.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26aulast%3DPessin%26aufirst%3DJ.%2BE.%26atitle%3DProtein-tyrosine-phosphatase%2520SHPTP2%2520is%2520a%2520required%2520positive%2520effector%2520for%2520insulin%2520downstream%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D664%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Marquardt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stabel, S.</span><span> </span><span class="NLM_article-title">Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3213</span><span class="NLM_x">–</span> <span class="NLM_lpage">3218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=3213-3218&author=B.+Marquardtauthor=D.+Frithauthor=S.+Stabel&title=Signalling+from+TPA+to+MAP+kinase+requires+protein+kinase+C%2C+raf+and+MEK%3A+reconstitution+of+the+signalling+pathway+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarquardt%26aufirst%3DB.%26aulast%3DFrith%26aufirst%3DD.%26aulast%3DStabel%26aufirst%3DS.%26atitle%3DSignalling%2520from%2520TPA%2520to%2520MAP%2520kinase%2520requires%2520protein%2520kinase%2520C%252C%2520raf%2520and%2520MEK%253A%2520reconstitution%2520of%2520the%2520signalling%2520pathway%2520in%2520vitro%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D3213%26epage%3D3218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span> </span><span class="NLM_article-title">Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent of Raf</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">23512</span><span class="NLM_x">–</span> <span class="NLM_lpage">23519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23512-23519&author=Y.+Uedaauthor=S.+Hiraiauthor=S.+Osadaauthor=A.+Suzukiauthor=K.+Mizunoauthor=S.+Ohno&title=Protein+kinase+C+activates+the+MEK-ERK+pathway+in+a+manner+independent+of+Ras+and+dependent+of+Raf"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DOsada%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DOhno%26aufirst%3DS.%26atitle%3DProtein%2520kinase%2520C%2520activates%2520the%2520MEK-ERK%2520pathway%2520in%2520a%2520manner%2520independent%2520of%2520Ras%2520and%2520dependent%2520of%2520Raf%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23512%26epage%3D23519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Weigelt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissell, M. J.</span><span> </span><span class="NLM_article-title">HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1007%2Fs10549-009-0502-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19701706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2010&pages=35-43&author=B.+Weigeltauthor=A.+T.+Loauthor=C.+C.+Parkauthor=J.+W.+Grayauthor=M.+J.+Bissell&title=HER2+signaling+pathway+activation+and+response+of+breast+cancer+cells+to+HER2-targeting+agents+is+dependent+strongly+on+the+3D+microenvironment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment</span></div><div class="casAuthors">Weigelt, Britta; Lo, Alvin T.; Park, Catherine C.; Gray, Joe W.; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-43</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Development of effective and durable breast cancer treatment strategies requires a mechanistic understanding of the influence of the microenvironment on response.  Previous work has shown that cellular signaling pathways and cell morphol. are dramatically influenced by three-dimensional (3D) cultures as opposed to traditional two-dimensional (2D) monolayers.  Here, we compared 2D and 3D culture models to det. the impact of 3D architecture and extracellular matrix (ECM) on HER2 signaling and on the response of HER2-amplified breast cancer cell lines to the HER2-targeting agents Trastuzumab, Pertuzumab and Lapatinib.  We show that the response of the HER2-amplified AU565, SKBR3 and HCC1569 cells to these anti-HER2 agents was highly dependent on whether the cells were cultured in 2D monolayer or 3D laminin-rich ECM gels.  Inhibition of β1 integrin, a major cell-ECM receptor subunit, significantly increased the sensitivity of the HER2-amplified breast cancer cell lines to the humanized monoclonal antibodies Trastuzumab and Pertuzumab when grown in a 3D environment.  Finally, in the absence of inhibitors, 3D cultures had substantial impact on HER2 downstream signaling and induced a switch between PI3K-AKT- and RAS-MAPK-pathway activation in all cell lines studied, including cells lacking HER2 amplification and overexpression.  Our data provide direct evidence that breast cancer cells are able to rapidly adapt to different environments and signaling cues by activating alternative pathways that regulate proliferation and cell survival, events that may play a significant role in the acquisition of resistance to targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxkScWl2PzgrVg90H21EOLACvtfcHk0liGUf3fJgOSAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKlsr0%253D&md5=7f49c4af3b9f1ef0c5633e81f66368ff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2Fs10549-009-0502-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-009-0502-2%26sid%3Dliteratum%253Aachs%26aulast%3DWeigelt%26aufirst%3DB.%26aulast%3DLo%26aufirst%3DA.%2BT.%26aulast%3DPark%26aufirst%3DC.%2BC.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26atitle%3DHER2%2520signaling%2520pathway%2520activation%2520and%2520response%2520of%2520breast%2520cancer%2520cells%2520to%2520HER2-targeting%2520agents%2520is%2520dependent%2520strongly%2520on%2520the%25203D%2520microenvironment%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2010%26volume%3D122%26spage%3D35%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Muthuswamy, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, B.</span><span> </span><span class="NLM_article-title">Cell polarity as a regulator of cancer cell behavior plasticity</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=599-625&author=S.+K.+Muthuswamyauthor=B.+Xue&title=Cell+polarity+as+a+regulator+of+cancer+cell+behavior+plasticity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuthuswamy%26aufirst%3DS.%2BK.%26aulast%3DXue%26aufirst%3DB.%26atitle%3DCell%2520polarity%2520as%2520a%2520regulator%2520of%2520cancer%2520cell%2520behavior%2520plasticity%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2012%26volume%3D28%26spage%3D599%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isozaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad Tunio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span> </span><span class="NLM_article-title">Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=577-580&author=S.+Hirotaauthor=K.+Isozakiauthor=Y.+Moriyamaauthor=K.+Hashimotoauthor=T.+Nishidaauthor=S.+Ishiguroauthor=K.+Kawanoauthor=M.+Hanadaauthor=A.+Kurataauthor=M.+Takedaauthor=G.+Muhammad+Tunioauthor=Y.+Matsuzawaauthor=Y.+Kanakuraauthor=Y.+Shinomuraauthor=Y.+Kitamura&title=Gain-of-function+mutations+of+c-kit+in+human+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DIsozaki%26aufirst%3DK.%26aulast%3DMoriyama%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DHanada%26aufirst%3DM.%26aulast%3DKurata%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DMuhammad%2BTunio%26aufirst%3DG.%26aulast%3DMatsuzawa%26aufirst%3DY.%26aulast%3DKanakura%26aufirst%3DY.%26aulast%3DShinomura%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DY.%26atitle%3DGain-of-function%2520mutations%2520of%2520c-kit%2520in%2520human%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D577%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Longley, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reguera, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span> </span><span class="NLM_article-title">Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2FS0145-2126%2801%2900028-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11377682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslSisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=571-576&author=B.+J.+Longleyauthor=M.+J.+Regueraauthor=Y.+Ma&title=Classes+of+c-KIT+activating+mutations%3A+proposed+mechanisms+of+action+and+implications+for+disease+classification+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy</span></div><div class="casAuthors">Longley, B. J.; Reguera, M. J.; Ma, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">571-576</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Mutations causing constitutive activation of KIT have been shown to be causative in some forms of mastocytosis, and several types of mutations have been assocd. with myeloproliferative disorders (MPDs), acute myelogenous leukemia (AML), sinonasal lymphomas, and gastrointestinal stromal tumors (GIST).  We divide these activating mutation into two types - 'regulatory type' mutations, which affect regulation of the kinase mol., and 'enzymic pocket type' mutations, which alter the amino acid sequence directly forming the enzymic site.  KIT inhibitors have been suggested as therapeutic drugs for these conditions, but different types of activating mutations respond differentially to KIT inhibitors, so classification of individuals on the basis of specific mutations is necessary to guide therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCZqOKdaiUV7Vg90H21EOLACvtfcHk0ljsyNRi4z3BcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslSisbg%253D&md5=d902f401a5919da6bc558ccf100fd6d3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0145-2126%2801%2900028-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0145-2126%252801%252900028-5%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DB.%2BJ.%26aulast%3DReguera%26aufirst%3DM.%2BJ.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DClasses%2520of%2520c-KIT%2520activating%2520mutations%253A%2520proposed%2520mechanisms%2520of%2520action%2520and%2520implications%2520for%2520disease%2520classification%2520and%2520therapy%26jtitle%3DLeuk.%2520Res.%26date%3D2001%26volume%3D25%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cymborowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chruszcz, M.</span><span> </span><span class="NLM_article-title">HKL-3000: the integration of data reduction and structure solution–from diffraction images to an initial model in minutes</span> <span class="citation_source-journal">Acta. Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+integration+of+data+reduction+and+structure+solution%E2%80%93from+diffraction+images+to+an+initial+model+in+minutes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520integration%2520of%2520data%2520reduction%2520and%2520structure%2520solution%25E2%2580%2593from%2520diffraction%2520images%2520to%2520an%2520initial%2520model%2520in%2520minutes%26jtitle%3DActa.%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A.</span><span> </span><span class="NLM_article-title">MOLREP: an automated program for molecular replacement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1107%2FS0021889897006766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=1022-1025&author=A.+Vaginauthor=A.+Teplyakov&title=MOLREP%3A+an+automated+program+for+molecular+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">MOLREP: an automated program for molecular replacement</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement which uses effective new approaches in data processing and rotational and translational searching.  These include an automatic choice of all parameters, scaling by Patterson origin peaks and soft resoln. cutoff.  One of the cornerstones of the program is an original full-symmetry translation function combined with a packing function.  Information from the model already placed in the cell is incorporated in both translation and packing functions.  A no. of tests using exptl. data proved the ability of the program to find the correct soln. in difficult cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGXdZ-nTKxLVg90H21EOLACvtfcHk0ljsyNRi4z3BcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D&md5=96af64aedd8a8f018c3c18b57a6b4b21</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1107%2FS0021889897006766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897006766%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMOLREP%253A%2520an%2520automated%2520program%2520for%2520molecular%2520replacement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D1022%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Brünger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLano, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography and NMR system: a new software suite for macro-molecular structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Br%C3%BCngerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+DeLanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+and+NMR+system%3A+a+new+software+suite+for+macro-molecular+structure+determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520and%2520NMR%2520system%253A%2520a%2520new%2520software%2520suite%2520for%2520macro-molecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Brünger, A. T.</span><span> </span><span class="NLM_article-title">The free <i>R</i> value: a novel statistical quantity for assessing the accuracy of crystal structures</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1992&pages=472-475&author=A.+T.+Br%C3%BCnger&title=The+free+R+value%3A+a+novel+statistical+quantity+for+assessing+the+accuracy+of+crystal+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26atitle%3DThe%2520free%2520R%2520value%253A%2520a%2520novel%2520statistical%2520quantity%2520for%2520assessing%2520the%2520accuracy%2520of%2520crystal%2520structures%26jtitle%3DNature%26date%3D1992%26volume%3D355%26spage%3D472%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljsyNRi4z3BcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lgNc5wKqhCCAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span> </span><span class="NLM_article-title">Python: A programming language for software integration and development</span> <span class="citation_source-journal">Journal Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+A+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0lgNc5wKqhCCAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520A%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJournal%2520Mol.%2520Graphics%2520Modell.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 64 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Stephanie M. Stanford, Michael A. Diaz, Robert J. Ardecky, Jiwen Zou, Tarmo Roosild, Zachary J. Holmes, Tiffany P. Nguyen, Michael P. Hedrick, Socorro Rodiles, April Guan, Stefan Grotegut, Eugenio Santelli, Thomas D. Y. Chung, Michael R. Jackson, Nunzio Bottini, <span class="NLM_string-name hlFld-ContribAuthor">Anthony B. Pinkerton</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine Phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5645-5653. <a href="https://doi.org/10.1021/acs.jmedchem.0c02126" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02126%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BOrally%252BBioavailable%252BPurine-Based%252BInhibitors%252Bof%252Bthe%252BLow-Molecular-Weight%252BProtein%252BTyrosine%252BPhosphatase%26aulast%3DStanford%26aufirst%3DStephanie%2BM.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09122020%26date%3D29042021%26volume%3D64%26issue%3D9%26spage%3D5645%26epage%3D5653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual López-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew J. LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Homan Chan, Christine Hiu-Tung Chen, Ying-Nan Chen, Zhouliang Chen, Zhan Deng, Michael Dore, David Dunstan, Jianmei Fan, Peter Fekkes, Brant Firestone, Michelle Fodor, Jorge Garcia-Fortanet, Pascal D. Fortin, Cary Fridrich, John Giraldes, Meir Glick, Denise Grunenfelder, Huia-Xiang Hao, Martin Hentemann, Samuel Ho, Andriana Jouk, Zhao B. Kang, Rajesh Karki, Mitsunori Kato, Nick Keen, Robert Koenig, Laura R. LaBonte, Jay Larrow, Gang Liu, Shumei Liu, Dyuti Majumdar, Simon Mathieu, Matthew J. Meyer, Morvarid Mohseni, Rukundo Ntaganda, Mark Palermo, Lawrence Perez, Minying Pu, Timothy Ramsey, John Reilly, Patrick Sarver, William R. Sellers, Martin Sendzik, Michael D. Shultz, Joanna Slisz, Kelly Slocum, Troy Smith, Stanley Spence, Travis Stams, Christopher Straub, Victoriano Tamez, Jr., Bakary-Barry Toure, Christopher Towler, Ping Wang, Hongyun Wang, Sarah L. Williams, Fan Yang, Bing Yu, Ji-Hu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Suzanne Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13578-13594. <a href="https://doi.org/10.1021/acs.jmedchem.0c01170" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01170%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTNO155%25252C%252Ban%252BAllosteric%252BSHP2%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLaMarche%26aufirst%3DMatthew%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D24092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13578%26epage%3D13594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zachary Hartman, Werner J. Geldenhuys, <span class="NLM_string-name hlFld-ContribAuthor">Yehenew M. Agazie</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell Effects. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (39)
                                     , 25113-25124. <a href="https://doi.org/10.1021/acsomega.0c02746" title="DOI URL">https://doi.org/10.1021/acsomega.0c02746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c02746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c02746%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNovel%252BSmall-Molecule%252BInhibitor%252Bfor%252Bthe%252BOncogenic%252BTyrosine%252BPhosphatase%252BSHP2%252Bwith%252BAnti-Breast%252BCancer%252BCell%252BEffects%26aulast%3DHartman%26aufirst%3DZachary%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10062020%26date%3D14092020%26date%3D25092020%26volume%3D5%26issue%3D39%26spage%3D25113%26epage%3D25124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingliang Wang, Jianfeng Lu, Mi Wang, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7510-7528. <a href="https://doi.org/10.1021/acs.jmedchem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSHP2-D26%252Bas%252Ba%252BFirst%25252C%252BPotent%25252C%252Band%252BEffective%252BPROTAC%252BDegrader%252Bof%252BSHP2%252BProtein%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D21052020%26volume%3D63%26issue%3D14%26spage%3D7510%26epage%3D7528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michelle Fodor, Edmund Price, Ping Wang, Hengyu Lu, Andreea Argintaru, Zhouliang Chen, Meir Glick, Huai-Xiang Hao, Mitsunori Kato, Robert Koenig, Jonathan R. LaRochelle, Gang Liu, Eric McNeill, Dyuti Majumdar, Gisele A. Nishiguchi, Lawrence B. Perez, Gregory Paris, Christopher M. Quinn, Timothy Ramsey, Martin Sendzik, Michael David Shultz, Sarah L. Williams, Travis Stams, Stephen C. Blacklow, Michael G. Acker, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (3)
                                     , 647-656. <a href="https://doi.org/10.1021/acschembio.7b00980" title="DOI URL">https://doi.org/10.1021/acschembio.7b00980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDual%252BAllosteric%252BInhibition%252Bof%252BSHP2%252BPhosphatase%26aulast%3DFodor%26aufirst%3DMichelle%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D16112017%26date%3D05012018%26date%3D18012018%26date%3D05012018%26volume%3D13%26issue%3D3%26spage%3D647%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span> and <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 1069-1091. <a href="https://doi.org/10.1021/acs.chemrev.7b00105" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00105%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRegulatory%252BMechanisms%252Band%252BNovel%252BTherapeutic%252BTargeting%252BStrategies%252Bfor%252BProtein%252BTyrosine%252BPhosphatases%26aulast%3DYu%26aufirst%3DZhi-Hong%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D23022017%26date%3D25052017%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D1069%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjing  Xie</span>, <span class="hlFld-ContribAuthor ">Xiaojia  Si</span>, <span class="hlFld-ContribAuthor ">Shoulai  Gu</span>, <span class="hlFld-ContribAuthor ">Mingliang  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Haoyan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yanjia  Fang</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>, and <span class="hlFld-ContribAuthor ">Jidong  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10205-10219. <a href="https://doi.org/10.1021/acs.jmedchem.7b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BInhibitors%252Bof%252BSHP2%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BCancer%252BTreatment%26aulast%3DXie%26aufirst%3DJingjing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11102017%26date%3D07122017%26date%3D28122017%26date%3D20112017%26volume%3D60%26issue%3D24%26spage%3D10205%26epage%3D10219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2017,</strong> <em>50 </em>
                                    (1)
                                     , 122-129. <a href="https://doi.org/10.1021/acs.accounts.6b00537" title="DOI URL">https://doi.org/10.1021/acs.accounts.6b00537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.6b00537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.6b00537%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDrugging%252Bthe%252BUndruggable%25253A%252BTherapeutic%252BPotential%252Bof%252BTargeting%252BProtein%252BTyrosine%252BPhosphatases%26aulast%3DZhang%26aufirst%3DZhong-Yin%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D27102016%26date%3D15122016%26date%3D17012017%26volume%3D50%26issue%3D1%26spage%3D122%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jorge  Garcia Fortanet</span>, <span class="hlFld-ContribAuthor ">Christine Hiu-Tung  Chen</span>, <span class="hlFld-ContribAuthor ">Ying-Nan P.  Chen</span>, <span class="hlFld-ContribAuthor ">Zhouliang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhan  Deng</span>, <span class="hlFld-ContribAuthor ">Brant  Firestone</span>, <span class="hlFld-ContribAuthor ">Peter  Fekkes</span>, <span class="hlFld-ContribAuthor ">Michelle  Fodor</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>, <span class="hlFld-ContribAuthor ">Cary  Fridrich</span>, <span class="hlFld-ContribAuthor ">Denise  Grunenfelder</span>, <span class="hlFld-ContribAuthor ">Samuel  Ho</span>, <span class="hlFld-ContribAuthor ">Zhao B.  Kang</span>, <span class="hlFld-ContribAuthor ">Rajesh  Karki</span>, <span class="hlFld-ContribAuthor ">Mitsunori  Kato</span>, <span class="hlFld-ContribAuthor ">Nick  Keen</span>, <span class="hlFld-ContribAuthor ">Laura R.  LaBonte</span>, <span class="hlFld-ContribAuthor ">Jay  Larrow</span>, <span class="hlFld-ContribAuthor ">Francois  Lenoir</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Shumei  Liu</span>, <span class="hlFld-ContribAuthor ">Franco  Lombardo</span>, <span class="hlFld-ContribAuthor ">Dyuti  Majumdar</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Meyer</span>, <span class="hlFld-ContribAuthor ">Mark  Palermo</span>, <span class="hlFld-ContribAuthor ">Lawrence  Perez</span>, <span class="hlFld-ContribAuthor ">Minying  Pu</span>, <span class="hlFld-ContribAuthor ">Timothy  Ramsey</span>, <span class="hlFld-ContribAuthor ">William R.  Sellers</span>, <span class="hlFld-ContribAuthor ">Michael D.  Shultz</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Christopher  Towler</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Williams</span>, <span class="hlFld-ContribAuthor ">Ji-Hu  Zhang</span>, and <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 7773-7782. <a href="https://doi.org/10.1021/acs.jmedchem.6b00680" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BInhibition%252Bof%252BSHP2%25253A%252BIdentification%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BPhosphatase%252BInhibitor%26aulast%3DGarcia%2BFortanet%26aufirst%3DJorge%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03052016%26date%3D12072016%26date%3D08092016%26date%3D27062016%26volume%3D59%26issue%3D17%26spage%3D7773%26epage%3D7782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cynthia M.  Chio</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Lim</span>, and <span class="hlFld-ContribAuthor ">Anthony C.  Bishop</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2015,</strong> <em>54 </em>
                                    (2)
                                     , 497-504. <a href="https://doi.org/10.1021/bi5013595" title="DOI URL">https://doi.org/10.1021/bi5013595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi5013595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi5013595%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DTargeting%252Ba%252BCryptic%252BAllosteric%252BSite%252Bfor%252BSelective%252BInhibition%252Bof%252Bthe%252BOncogenic%252BProtein%252BTyrosine%252BPhosphatase%252BShp2%26aulast%3DChio%26aufirst%3DCynthia%2BM.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D01112014%26date%3D09122014%26date%3D02012015%26date%3D20012015%26date%3D17122014%26volume%3D54%26issue%3D2%26spage%3D497%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Kangshuai  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Yu</span>, <span class="hlFld-ContribAuthor ">Jin-Peng  Sun</span>, and <span class="hlFld-ContribAuthor ">Hao  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Fast Identification of Novel Lymphoid Tyrosine Phosphatase Inhibitors Using Target–Ligand Interaction-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (22)
                                     , 9309-9322. <a href="https://doi.org/10.1021/jm500692u" title="DOI URL">https://doi.org/10.1021/jm500692u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500692u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500692u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFast%252BIdentification%252Bof%252BNovel%252BLymphoid%252BTyrosine%252BPhosphatase%252BInhibitors%252BUsing%252BTarget%2525E2%252580%252593Ligand%252BInteraction-Based%252BVirtual%252BScreening%26aulast%3DHou%26aufirst%3DXuben%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D27032014%26date%3D12112014%26date%3D26112014%26date%3D05112014%26volume%3D57%26issue%3D22%26spage%3D9309%26epage%3D9322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Nian</span>, <span class="hlFld-ContribAuthor ">Jinhao  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  He</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fernando  Rodrigues-Lima</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuanlin  Feng</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 1645-1652. <a href="https://doi.org/10.1016/j.cclet.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bsmall%252Bmolecule%252Binhibitor%252Btargeting%252BSHP2%252Bmutations%252Bfor%252Bthe%252Blung%252Bcarcinoma%26aulast%3DNian%26aufirst%3DQing%26date%3D2021%26volume%3D32%26issue%3D5%26spage%3D1645%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Buesking</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Combs</span>. </span><span class="cited-content_cbyCitation_article-title">Immuno‐Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1002/0471266949.bmc272" title="DOI URL">https://doi.org/10.1002/0471266949.bmc272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc272%26sid%3Dliteratum%253Aachs%26atitle%3DImmuno%2525E2%252580%252590Oncology%26aulast%3DBuesking%26aufirst%3DAndrew%2BW.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingwei  Wu</span>, <span class="hlFld-ContribAuthor ">Weiya  Li</span>, <span class="hlFld-ContribAuthor ">Zhihui  Zheng</span>, <span class="hlFld-ContribAuthor ">Xinhua  Lu</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Runling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, common feature pharmacophore model and molecular dynamics simulation studies of ethyl 4-(phenoxymethyl)-2-phenylthiazole-5-carboxylate as Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1174-1188. <a href="https://doi.org/10.1080/07391102.2020.1726817" title="DOI URL">https://doi.org/10.1080/07391102.2020.1726817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1726817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1726817%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Bcommon%252Bfeature%252Bpharmacophore%252Bmodel%252Band%252Bmolecular%252Bdynamics%252Bsimulation%252Bstudies%252Bof%252Bethyl%252B4-%252528phenoxymethyl%252529-2-phenylthiazole-5-carboxylate%252Bas%252BSrc%252Bhomology-2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DWu%26aufirst%3DJingwei%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1174%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Sarah  Libring</span>, <span class="hlFld-ContribAuthor ">Kasi Viswanatharaju  Ruddraraju</span>, <span class="hlFld-ContribAuthor ">Jinmin  Miao</span>, <span class="hlFld-ContribAuthor ">Luis  Solorio</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael K.  Wendt</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (49)
                                     , 7166-7180. <a href="https://doi.org/10.1038/s41388-020-01488-5" title="DOI URL">https://doi.org/10.1038/s41388-020-01488-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-020-01488-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-020-01488-5%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DSHP2%252Bis%252Ba%252Bmultifunctional%252Btherapeutic%252Btarget%252Bin%252Bdrug%252Bresistant%252Bmetastatic%252Bbreast%252Bcancer%26aulast%3DChen%26aufirst%3DHao%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D49%26spage%3D7166%26epage%3D7180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Hao-Xin  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-based selective SHP2 inhibitors design using core hopping, molecular docking, biological evaluation and molecular simulation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104391. <a href="https://doi.org/10.1016/j.bioorg.2020.104391" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104391%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DScaffold-based%252Bselective%252BSHP2%252Binhibitors%252Bdesign%252Busing%252Bcore%252Bhopping%25252C%252Bmolecular%252Bdocking%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bsimulation%26aulast%3DLi%26aufirst%3DWei-Ya%26date%3D2020%26volume%3D105%26spage%3D104391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjie  Guo</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacological Sciences</span><span> <strong>2020,</strong> <em>144 </em>
                                    (3)
                                     , 139-146. <a href="https://doi.org/10.1016/j.jphs.2020.06.002" title="DOI URL">https://doi.org/10.1016/j.jphs.2020.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphs.2020.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphs.2020.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacological%2520Sciences%26atitle%3DPhosphatase-independent%252Bfunctions%252Bof%252BSHP2%252Band%252Bits%252Bregulation%252Bby%252Bsmall%252Bmolecule%252Bcompounds%26aulast%3DGuo%26aufirst%3DWenjie%26date%3D2020%26volume%3D144%26issue%3D3%26spage%3D139%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Pardella</span>, <span class="hlFld-ContribAuthor ">Erica  Pranzini</span>, <span class="hlFld-ContribAuthor ">Angela  Leo</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Taddei</span>, <span class="hlFld-ContribAuthor ">Paolo  Paoli</span>, <span class="hlFld-ContribAuthor ">Giovanni  Raugei</span>. </span><span class="cited-content_cbyCitation_article-title">Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 2799. <a href="https://doi.org/10.3390/cancers12102799" title="DOI URL">https://doi.org/10.3390/cancers12102799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12102799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12102799%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DOncogenic%252BTyrosine%252BPhosphatases%25253A%252BNovel%252BTherapeutic%252BTargets%252Bfor%252BMelanoma%252BTreatment%26aulast%3DPardella%26aufirst%3DElisa%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D2799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Bing  Yang</span>, <span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103875. <a href="https://doi.org/10.1016/j.bioorg.2020.103875" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103875%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyridine%252Bderivatives%252Bas%252Bselective%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DWen-Shan%26date%3D2020%26volume%3D100%26spage%3D103875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendran  Satheeshkumar</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Ting-Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Long  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen-Long  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 127170. <a href="https://doi.org/10.1016/j.bmcl.2020.127170" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127170%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bheterocyclic%252Bbis-aryl%252Bamides%252Bas%252Bnovel%252BSrc%252Bhomology%252B2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DSatheeshkumar%26aufirst%3DRajendran%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D127170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soobin  Wang</span>, <span class="hlFld-ContribAuthor ">Alessia  Battigelli</span>, <span class="hlFld-ContribAuthor ">Dahlia  Alkekhia</span>, <span class="hlFld-ContribAuthor ">Alexis  Fairman</span>, <span class="hlFld-ContribAuthor ">Valentin  Antoci</span>, <span class="hlFld-ContribAuthor ">Wentian  Yang</span>, <span class="hlFld-ContribAuthor ">Douglas  Moore</span>, <span class="hlFld-ContribAuthor ">Anita  Shukla</span>. </span><span class="cited-content_cbyCitation_article-title">Controlled delivery of a protein tyrosine phosphatase inhibitor, SHP099, using cyclodextrin-mediated host–guest interactions in polyelectrolyte multilayer films for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (34)
                                     , 20073-20082. <a href="https://doi.org/10.1039/D0RA03864D" title="DOI URL">https://doi.org/10.1039/D0RA03864D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03864D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03864D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DControlled%252Bdelivery%252Bof%252Ba%252Bprotein%252Btyrosine%252Bphosphatase%252Binhibitor%25252C%252BSHP099%25252C%252Busing%252Bcyclodextrin-mediated%252Bhost%2525E2%252580%252593guest%252Binteractions%252Bin%252Bpolyelectrolyte%252Bmultilayer%252Bfilms%252Bfor%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DSoobin%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D34%26spage%3D20073%26epage%3D20082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Qu</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a promising strategy for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104595. <a href="https://doi.org/10.1016/j.phrs.2019.104595" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104595%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DLiu%26aufirst%3DQianqian%26date%3D2020%26volume%3D152%26spage%3D104595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Cerulli</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Kritzer</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphotyrosine isosteres: past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 583-605. <a href="https://doi.org/10.1039/C9OB01998G" title="DOI URL">https://doi.org/10.1039/C9OB01998G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01998G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01998G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPhosphotyrosine%252Bisosteres%25253A%252Bpast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DCerulli%26aufirst%3DRobert%2BA.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D583%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Matthew  Rhett</span>, <span class="hlFld-ContribAuthor ">Imran  Khan</span>, <span class="hlFld-ContribAuthor ">John P.  O’Bryan</span>. </span><span class="cited-content_cbyCitation_article-title">Biology, pathology, and therapeutic targeting of RAS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 69-146. <a href="https://doi.org/10.1016/bs.acr.2020.05.002" title="DOI URL">https://doi.org/10.1016/bs.acr.2020.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.acr.2020.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.acr.2020.05.002%26sid%3Dliteratum%253Aachs%26atitle%3DBiology%25252C%252Bpathology%25252C%252Band%252Btherapeutic%252Btargeting%252Bof%252BRAS%26aulast%3DRhett%26aufirst%3DJ.%2BMatthew%26date%3D2020%26spage%3D69%26epage%3D146%26pub%3DElsevier%26date%3D2020%26volume%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshihito  Kano</span>, <span class="hlFld-ContribAuthor ">Teklab  Gebregiworgis</span>, <span class="hlFld-ContribAuthor ">Christopher B.  Marshall</span>, <span class="hlFld-ContribAuthor ">Nikolina  Radulovich</span>, <span class="hlFld-ContribAuthor ">Betty P. K.  Poon</span>, <span class="hlFld-ContribAuthor ">Jonathan  St-Germain</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Cook</span>, <span class="hlFld-ContribAuthor ">Ivette  Valencia-Sama</span>, <span class="hlFld-ContribAuthor ">Benjamin M. M.  Grant</span>, <span class="hlFld-ContribAuthor ">Silvia Gabriela  Herrera</span>, <span class="hlFld-ContribAuthor ">Jinmin  Miao</span>, <span class="hlFld-ContribAuthor ">Brian  Raught</span>, <span class="hlFld-ContribAuthor ">Meredith S.  Irwin</span>, <span class="hlFld-ContribAuthor ">Jeffrey E.  Lee</span>, <span class="hlFld-ContribAuthor ">Jen Jen  Yeh</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming-Sound  Tsao</span>, <span class="hlFld-ContribAuthor ">Mitsuhiko  Ikura</span>, <span class="hlFld-ContribAuthor ">Michael  Ohh</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-08115-8" title="DOI URL">https://doi.org/10.1038/s41467-018-08115-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-08115-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-08115-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DTyrosyl%252Bphosphorylation%252Bof%252BKRAS%252Bstalls%252BGTPase%252Bcycle%252Bvia%252Balteration%252Bof%252Bswitch%252BI%252Band%252BII%252Bconformation%26aulast%3DKano%26aufirst%3DYoshihito%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sitaram</span>, <span class="hlFld-ContribAuthor ">Uyemura</span>, <span class="hlFld-ContribAuthor ">Malarkannan</span>, <span class="hlFld-ContribAuthor ">Riese</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (23)
                                     , 5821. <a href="https://doi.org/10.3390/ijms20235821" title="DOI URL">https://doi.org/10.3390/ijms20235821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20235821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20235821%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBeyond%252Bthe%252BCell%252BSurface%25253A%252BTargeting%252BIntracellular%252BNegative%252BRegulators%252Bto%252BEnhance%252BT%252Bcell%252BAnti-Tumor%252BActivity%26aulast%3DSitaram%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D23%26spage%3D5821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlène  Niogret</span>, <span class="hlFld-ContribAuthor ">Walter  Birchmeier</span>, <span class="hlFld-ContribAuthor ">Greta  Guarda</span>. </span><span class="cited-content_cbyCitation_article-title">SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.02468" title="DOI URL">https://doi.org/10.3389/fimmu.2019.02468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.02468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.02468%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSHP-2%252Bin%252BLymphocytes%252527%252BCytokine%252Band%252BInhibitory%252BReceptor%252BSignaling%26aulast%3DNiogret%26aufirst%3DCharl%25C3%25A8ne%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana Tannús  Ruckert</span>, <span class="hlFld-ContribAuthor ">Pamela Viani  de Andrade</span>, <span class="hlFld-ContribAuthor ">Verena Silva  Santos</span>, <span class="hlFld-ContribAuthor ">Vanessa Silva  Silveira</span>. </span><span class="cited-content_cbyCitation_article-title">Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2019,</strong> <em>76 </em>
                                    (13)
                                     , 2571-2592. <a href="https://doi.org/10.1007/s00018-019-03095-4" title="DOI URL">https://doi.org/10.1007/s00018-019-03095-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-019-03095-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-019-03095-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DProtein%252Btyrosine%252Bphosphatases%25253A%252Bpromising%252Btargets%252Bin%252Bpancreatic%252Bductal%252Badenocarcinoma%26aulast%3DRuckert%26aufirst%3DMariana%2BTann%25C3%25BAs%26date%3D2019%26date%3D2019%26volume%3D76%26issue%3D13%26spage%3D2571%26epage%3D2592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Motohiro  Sonoda</span>, <span class="hlFld-ContribAuthor ">Ayu  Ikeda</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Shinohara</span>, <span class="hlFld-ContribAuthor ">Naoya  Hayagane</span>, <span class="hlFld-ContribAuthor ">Akiya  Ogawa</span>, <span class="hlFld-ContribAuthor ">Shinji  Tanimori</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic study of silica-gel or FeCl3-promoted ring-opening aromatization of 7-oxanorborna-2,5-dienes affording 2-bromo-3-hydroxybenzoate derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2019,</strong> <em>45 </em>
                                    (1)
                                     , 13-21. <a href="https://doi.org/10.1007/s11164-018-3627-2" title="DOI URL">https://doi.org/10.1007/s11164-018-3627-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-018-3627-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-018-3627-2%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DMechanistic%252Bstudy%252Bof%252Bsilica-gel%252Bor%252BFeCl3-promoted%252Bring-opening%252Baromatization%252Bof%252B7-oxanorborna-2%25252C5-dienes%252Baffording%252B2-bromo-3-hydroxybenzoate%252Bderivatives%26aulast%3DSonoda%26aufirst%3DMotohiro%26date%3D2019%26date%3D2018%26volume%3D45%26issue%3D1%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariella  Zehender</span>, <span class="hlFld-ContribAuthor ">Jingang  Huang</span>, <span class="hlFld-ContribAuthor ">Andrea-Hermina  Györfi</span>, <span class="hlFld-ContribAuthor ">Alexandru-Emil  Matei</span>, <span class="hlFld-ContribAuthor ">Thuong  Trinh-Minh</span>, <span class="hlFld-ContribAuthor ">Xiaohan  Xu</span>, <span class="hlFld-ContribAuthor ">Yi-Nan  Li</span>, <span class="hlFld-ContribAuthor ">Chih-Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Jianping  Lin</span>, <span class="hlFld-ContribAuthor ">Clara  Dees</span>, <span class="hlFld-ContribAuthor ">Christian  Beyer</span>, <span class="hlFld-ContribAuthor ">Kolja  Gelse</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Christina  Bergmann</span>, <span class="hlFld-ContribAuthor ">Andreas  Ramming</span>, <span class="hlFld-ContribAuthor ">Walter  Birchmeier</span>, <span class="hlFld-ContribAuthor ">Oliver  Distler</span>, <span class="hlFld-ContribAuthor ">Georg  Schett</span>, <span class="hlFld-ContribAuthor ">Jörg H. W.  Distler</span>. </span><span class="cited-content_cbyCitation_article-title">The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-05768-3" title="DOI URL">https://doi.org/10.1038/s41467-018-05768-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-05768-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-05768-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DThe%252Btyrosine%252Bphosphatase%252BSHP2%252Bcontrols%252BTGF%2525CE%2525B2-induced%252BSTAT3%252Bsignaling%252Bto%252Bregulate%252Bfibroblast%252Bactivation%252Band%252Bfibrosis%26aulast%3DZehender%26aufirst%3DAriella%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan R.  LaRochelle</span>, <span class="hlFld-ContribAuthor ">Michelle  Fodor</span>, <span class="hlFld-ContribAuthor ">Vidyasiri  Vemulapalli</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Rajiv  Chopra</span>, <span class="hlFld-ContribAuthor ">Michael G.  Acker</span>, <span class="hlFld-ContribAuthor ">Stephen C.  Blacklow</span>. </span><span class="cited-content_cbyCitation_article-title">Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-06823-9" title="DOI URL">https://doi.org/10.1038/s41467-018-06823-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-06823-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-06823-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructural%252Breorganization%252Bof%252BSHP2%252Bby%252Boncogenic%252Bmutations%252Band%252Bimplications%252Bfor%252Boncoprotein%252Bresistance%252Bto%252Ballosteric%252Binhibition%26aulast%3DLaRochelle%26aufirst%3DJonathan%2BR.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryouhei  Tsutsumi</span>, <span class="hlFld-ContribAuthor ">Hao  Ran</span>, <span class="hlFld-ContribAuthor ">Benjamin G.  Neel</span>. </span><span class="cited-content_cbyCitation_article-title">Off‐target inhibition by active site‐targeting
              SHP
              2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2018,</strong> <em>8 </em>
                                    (9)
                                     , 1405-1411. <a href="https://doi.org/10.1002/2211-5463.12493" title="DOI URL">https://doi.org/10.1002/2211-5463.12493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.12493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.12493%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DOff%2525E2%252580%252590target%252Binhibition%252Bby%252Bactive%252Bsite%2525E2%252580%252590targeting%252BSHP%252B2%252Binhibitors%26aulast%3DTsutsumi%26aufirst%3DRyouhei%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D9%26spage%3D1405%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Thaiwong</span>, <span class="hlFld-ContribAuthor ">S.  Sirivisoot</span>, <span class="hlFld-ContribAuthor ">M.  Takada</span>, <span class="hlFld-ContribAuthor ">V.  Yuzbasiyan-Gurkan</span>, <span class="hlFld-ContribAuthor ">M.  Kiupel</span>. </span><span class="cited-content_cbyCitation_article-title">Gain-of-function mutation in
              PTPN11
              in histiocytic sarcomas of Bernese Mountain Dogs. </span><span class="cited-content_cbyCitation_journal-name">Veterinary and Comparative Oncology</span><span> <strong>2018,</strong> <em>16 </em>
                                    (2)
                                     , 220-228. <a href="https://doi.org/10.1111/vco.12357" title="DOI URL">https://doi.org/10.1111/vco.12357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/vco.12357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fvco.12357%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520and%2520Comparative%2520Oncology%26atitle%3DGain-of-function%252Bmutation%252Bin%252BPTPN11%252Bin%252Bhistiocytic%252Bsarcomas%252Bof%252BBernese%252BMountain%252BDogs%26aulast%3DThaiwong%26aufirst%3DT.%26date%3D2018%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D220%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan Y.  Hsu</span>, <span class="hlFld-ContribAuthor ">Theodore  Gurol</span>, <span class="hlFld-ContribAuthor ">Tiago J. P.  Sobreira</span>, <span class="hlFld-ContribAuthor ">Sheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Natalie  Moore</span>, <span class="hlFld-ContribAuthor ">Chufan  Cai</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Characterization of an Endotoxemia Model in Zebra Fish. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fimmu.2018.00607" title="DOI URL">https://doi.org/10.3389/fimmu.2018.00607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2018.00607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2018.00607%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DDevelopment%252Band%252BCharacterization%252Bof%252Ban%252BEndotoxemia%252BModel%252Bin%252BZebra%252BFish%26aulast%3DHsu%26aufirst%3DAlan%2BY.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-(Hetero)Arylindoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 321-355. <a href="https://doi.org/10.1002/9781118686263.ch9" title="DOI URL">https://doi.org/10.1002/9781118686263.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch9%26sid%3Dliteratum%253Aachs%26atitle%3D2-%252528Hetero%252529Arylindoles%26date%3D2018%26date%3D2018%26spage%3D321%26epage%3D355%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Kelley E.  McQueeney</span>, <span class="hlFld-ContribAuthor ">James C.  Burnett</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule targeting of PTPs in cancer. </span><span class="cited-content_cbyCitation_journal-name">The International Journal of Biochemistry & Cell Biology</span><span> <strong>2018,</strong> <em>96 </em>, 171-181. <a href="https://doi.org/10.1016/j.biocel.2017.09.011" title="DOI URL">https://doi.org/10.1016/j.biocel.2017.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biocel.2017.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biocel.2017.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520International%2520Journal%2520of%2520Biochemistry%2520%2526%2520Cell%2520Biology%26atitle%3DSmall%252Bmolecule%252Btargeting%252Bof%252BPTPs%252Bin%252Bcancer%26aulast%3DLazo%26aufirst%3DJohn%2BS.%26date%3D2018%26volume%3D96%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rochelle  Frankson</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Bai</span>, <span class="hlFld-ContribAuthor ">Qinglin  Li</span>, <span class="hlFld-ContribAuthor ">Ruo-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of Oncogenic Tyrosine Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2017,</strong> <em>77 </em>
                                    (21)
                                     , 5701-5705. <a href="https://doi.org/10.1158/0008-5472.CAN-17-1510" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-17-1510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-17-1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-17-1510%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DTherapeutic%252BTargeting%252Bof%252BOncogenic%252BTyrosine%252BPhosphatases%26aulast%3DFrankson%26aufirst%3DRochelle%26date%3D2017%26date%3D2017%26volume%3D77%26issue%3D21%26spage%3D5701%26epage%3D5705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhidong  Gu</span>, <span class="hlFld-ContribAuthor ">Xuqian  Fang</span>, <span class="hlFld-ContribAuthor ">Chang  Li</span>, <span class="hlFld-ContribAuthor ">Changqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Guangshu  Liang</span>, <span class="hlFld-ContribAuthor ">Xinming  Zheng</span>, <span class="hlFld-ContribAuthor ">Qishi  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oncology</span><span> <strong>2017,</strong> <em>51 </em>
                                    (2)
                                     , 489-497. <a href="https://doi.org/10.3892/ijo.2017.4055" title="DOI URL">https://doi.org/10.3892/ijo.2017.4055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijo.2017.4055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijo.2017.4055%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oncology%26atitle%3DIncreased%252BPTPRA%252Bexpression%252Bleads%252Bto%252Bpoor%252Bprognosis%252Bthrough%252Bc-Src%252Bactivation%252Band%252BG1%252Bphase%252Bprogression%252Bin%252Bsquamous%252Bcell%252Blung%252Bcancer%26aulast%3DGu%26aufirst%3DZhidong%26date%3D2017%26date%3D2017%26volume%3D51%26issue%3D2%26spage%3D489%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie M.  Stanford</span>, <span class="hlFld-ContribAuthor ">Nunzio  Bottini</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Tyrosine Phosphatases: Time to End the Stigma. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2017,</strong> <em>38 </em>
                                    (6)
                                     , 524-540. <a href="https://doi.org/10.1016/j.tips.2017.03.004" title="DOI URL">https://doi.org/10.1016/j.tips.2017.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2017.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTargeting%252BTyrosine%252BPhosphatases%25253A%252BTime%252Bto%252BEnd%252Bthe%252BStigma%26aulast%3DStanford%26aufirst%3DStephanie%2BM.%26date%3D2017%26volume%3D38%26issue%3D6%26spage%3D524%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fengzhi  Yang</span>, <span class="hlFld-ContribAuthor ">Fangzhou  Xie</span>, <span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Xia</span>, <span class="hlFld-ContribAuthor ">Wenlu  Liu</span>, <span class="hlFld-ContribAuthor ">Faqin  Jiang</span>, <span class="hlFld-ContribAuthor ">Celine  Lam</span>, <span class="hlFld-ContribAuthor ">Yixue  Qiao</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Xie</span>, <span class="hlFld-ContribAuthor ">Jianqi  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (10)
                                     , 2166-2170. <a href="https://doi.org/10.1016/j.bmcl.2017.03.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DY-shaped%252Bbis-arylethenesulfonic%252Bacid%252Besters%25253A%252BPotential%252Bpotent%252Band%252Bmembrane%252Bpermeable%252Bprotein%252Btyrosine%252Bphosphatase%252B1B%252Binhibitors%26aulast%3DYang%26aufirst%3DFengzhi%26date%3D2017%26volume%3D27%26issue%3D10%26spage%3D2166%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasi Viswanatharaju  Ruddraraju</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent inhibition of protein tyrosine phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2017,</strong> <em>13 </em>
                                    (7)
                                     , 1257-1279. <a href="https://doi.org/10.1039/C7MB00151G" title="DOI URL">https://doi.org/10.1039/C7MB00151G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MB00151G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MB00151G%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DCovalent%252Binhibition%252Bof%252Bprotein%252Btyrosine%252Bphosphatases%26aulast%3DRuddraraju%26aufirst%3DKasi%2BViswanatharaju%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D7%26spage%3D1257%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Qi</span>, <span class="hlFld-ContribAuthor ">Tao  Han</span>, <span class="hlFld-ContribAuthor ">Hua  Tang</span>, <span class="hlFld-ContribAuthor ">Kenan  Huang</span>, <span class="hlFld-ContribAuthor ">Jie  Min</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xinyu  Ding</span>, <span class="hlFld-ContribAuthor ">Zhifei  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     , 134. <a href="https://doi.org/10.3390/ijms18010134" title="DOI URL">https://doi.org/10.3390/ijms18010134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18010134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18010134%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DShp2%252BInhibits%252BProliferation%252Bof%252BEsophageal%252BSquamous%252BCell%252BCancer%252Bvia%252BDephosphorylation%252Bof%252BStat3%26aulast%3DQi%26aufirst%3DChen%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruo-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Lifan  Zeng</span>, <span class="hlFld-ContribAuthor ">Sheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Bai</span>, <span class="hlFld-ContribAuthor ">Jinmin  Miao</span>, <span class="hlFld-ContribAuthor ">Lan  Chen</span>, <span class="hlFld-ContribAuthor ">Jingwu  Xie</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 phosphatase as a novel therapeutic target for melanoma treatment. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (45)
                                     , 73817-73829. <a href="https://doi.org/10.18632/oncotarget.12074" title="DOI URL">https://doi.org/10.18632/oncotarget.12074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12074%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DSHP2%252Bphosphatase%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bfor%252Bmelanoma%252Btreatment%26aulast%3DZhang%26aufirst%3DRuo-Yu%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D45%26spage%3D73817%26epage%3D73829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shoumei  Bai</span>, <span class="hlFld-ContribAuthor ">Patrick  Ingram</span>, <span class="hlFld-ContribAuthor ">Yu-Chih  Chen</span>, <span class="hlFld-ContribAuthor ">Ning  Deng</span>, <span class="hlFld-ContribAuthor ">Alex  Pearson</span>, <span class="hlFld-ContribAuthor ">Yashar S.  Niknafs</span>, <span class="hlFld-ContribAuthor ">Patrick  O'Hayer</span>, <span class="hlFld-ContribAuthor ">Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Elisa  Boscolo</span>, <span class="hlFld-ContribAuthor ">Joyce  Bischoff</span>, <span class="hlFld-ContribAuthor ">Euisik  Yoon</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Buckanovich</span>. </span><span class="cited-content_cbyCitation_article-title">EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH
              +
              Ovarian Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2016,</strong> <em>76 </em>
                                    (21)
                                     , 6396-6409. <a href="https://doi.org/10.1158/0008-5472.CAN-16-0225" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-16-0225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-16-0225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-16-0225%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DEGFL6%252BRegulates%252Bthe%252BAsymmetric%252BDivision%25252C%252BMaintenance%25252C%252Band%252BMetastasis%252Bof%252BALDH%252B%25252B%252BOvarian%252BCancer%252BCells%26aulast%3DBai%26aufirst%3DShoumei%26date%3D2016%26date%3D2016%26volume%3D76%26issue%3D21%26spage%3D6396%26epage%3D6409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gyun Jee  Song</span>, <span class="hlFld-ContribAuthor ">Jaehong  Kim</span>, <span class="hlFld-ContribAuthor ">Jong-Heon  Kim</span>, <span class="hlFld-ContribAuthor ">Seungeun  Song</span>, <span class="hlFld-ContribAuthor ">Hana  Park</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Kyoungho  Suk</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Analysis of Protein Tyrosine Phosphatases Regulating Microglial Activation. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurobiology</span><span> <strong>2016,</strong> <em>25 </em>
                                    (5)
                                     , 252-261. <a href="https://doi.org/10.5607/en.2016.25.5.252" title="DOI URL">https://doi.org/10.5607/en.2016.25.5.252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5607/en.2016.25.5.252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5607%2Fen.2016.25.5.252%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurobiology%26atitle%3DComparative%252BAnalysis%252Bof%252BProtein%252BTyrosine%252BPhosphatases%252BRegulating%252BMicroglial%252BActivation%26aulast%3DSong%26aufirst%3DGyun%2BJee%26date%3D2016%26volume%3D25%26issue%3D5%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Guiquan  Xia</span>, <span class="hlFld-ContribAuthor ">Qi  Guo</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Shizhen  Chen</span>, <span class="hlFld-ContribAuthor ">Zhigang  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhong-Xing  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel
              19
              F magnetic resonance sensitive protein tyrosine phosphatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (8)
                                     , 1672-1680. <a href="https://doi.org/10.1039/C6MD00277C" title="DOI URL">https://doi.org/10.1039/C6MD00277C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00277C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00277C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B19%252BF%252Bmagnetic%252Bresonance%252Bsensitive%252Bprotein%252Btyrosine%252Bphosphatase%252Binhibitors%26aulast%3DLi%26aufirst%3DYu%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D8%26spage%3D1672%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Nan P.  Chen</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Ho Man  Chan</span>, <span class="hlFld-ContribAuthor ">Peter  Fekkes</span>, <span class="hlFld-ContribAuthor ">Jorge  Garcia-Fortanet</span>, <span class="hlFld-ContribAuthor ">Michael G.  Acker</span>, <span class="hlFld-ContribAuthor ">Brandon  Antonakos</span>, <span class="hlFld-ContribAuthor ">Christine Hiu-Tung  Chen</span>, <span class="hlFld-ContribAuthor ">Zhouliang  Chen</span>, <span class="hlFld-ContribAuthor ">Vesselina G.  Cooke</span>, <span class="hlFld-ContribAuthor ">Jason R.  Dobson</span>, <span class="hlFld-ContribAuthor ">Zhan  Deng</span>, <span class="hlFld-ContribAuthor ">Feng  Fei</span>, <span class="hlFld-ContribAuthor ">Brant  Firestone</span>, <span class="hlFld-ContribAuthor ">Michelle  Fodor</span>, <span class="hlFld-ContribAuthor ">Cary  Fridrich</span>, <span class="hlFld-ContribAuthor ">Hui  Gao</span>, <span class="hlFld-ContribAuthor ">Denise  Grunenfelder</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>, <span class="hlFld-ContribAuthor ">Jaison  Jacob</span>, <span class="hlFld-ContribAuthor ">Samuel  Ho</span>, <span class="hlFld-ContribAuthor ">Kathy  Hsiao</span>, <span class="hlFld-ContribAuthor ">Zhao B.  Kang</span>, <span class="hlFld-ContribAuthor ">Rajesh  Karki</span>, <span class="hlFld-ContribAuthor ">Mitsunori  Kato</span>, <span class="hlFld-ContribAuthor ">Jay  Larrow</span>, <span class="hlFld-ContribAuthor ">Laura R.  La Bonte</span>, <span class="hlFld-ContribAuthor ">Francois  Lenoir</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Shumei  Liu</span>, <span class="hlFld-ContribAuthor ">Dyuti  Majumdar</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Meyer</span>, <span class="hlFld-ContribAuthor ">Mark  Palermo</span>, <span class="hlFld-ContribAuthor ">Lawrence  Perez</span>, <span class="hlFld-ContribAuthor ">Minying  Pu</span>, <span class="hlFld-ContribAuthor ">Edmund  Price</span>, <span class="hlFld-ContribAuthor ">Christopher  Quinn</span>, <span class="hlFld-ContribAuthor ">Subarna  Shakya</span>, <span class="hlFld-ContribAuthor ">Michael D.  Shultz</span>, <span class="hlFld-ContribAuthor ">Joanna  Slisz</span>, <span class="hlFld-ContribAuthor ">Kavitha  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Markus  Warmuth</span>, <span class="hlFld-ContribAuthor ">Sarah  Williams</span>, <span class="hlFld-ContribAuthor ">Guizhi  Yang</span>, <span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Ji-Hu  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Zhu</span>, <span class="hlFld-ContribAuthor ">Timothy  Ramsey</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Keen</span>, <span class="hlFld-ContribAuthor ">William R.  Sellers</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2016,</strong> <em>535 </em>
                                    (7610)
                                     , 148-152. <a href="https://doi.org/10.1038/nature18621" title="DOI URL">https://doi.org/10.1038/nature18621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnature18621%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DAllosteric%252Binhibition%252Bof%252BSHP2%252Bphosphatase%252Binhibits%252Bcancers%252Bdriven%252Bby%252Breceptor%252Btyrosine%252Bkinases%26aulast%3DChen%26aufirst%3DYing-Nan%2BP.%26date%3D2016%26date%3D2016%26volume%3D535%26issue%3D7610%26spage%3D148%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keisuke  Maeshima</span>, <span class="hlFld-ContribAuthor ">Stephanie M.  Stanford</span>, <span class="hlFld-ContribAuthor ">Deepa  Hammaker</span>, <span class="hlFld-ContribAuthor ">Cristiano  Sacchetti</span>, <span class="hlFld-ContribAuthor ">Li-fan  Zeng</span>, <span class="hlFld-ContribAuthor ">Rizi  Ai</span>, <span class="hlFld-ContribAuthor ">Vida  Zhang</span>, <span class="hlFld-ContribAuthor ">David L.  Boyle</span>, <span class="hlFld-ContribAuthor ">German R.  Aleman Muench</span>, <span class="hlFld-ContribAuthor ">Gen-Sheng  Feng</span>, <span class="hlFld-ContribAuthor ">John W.  Whitaker</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Nunzio  Bottini</span>, <span class="hlFld-ContribAuthor ">Gary S.  Firestein</span>. </span><span class="cited-content_cbyCitation_article-title">Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2016,</strong> <em>1 </em>
                                    (7)
                                     <a href="https://doi.org/10.1172/jci.insight.86580" title="DOI URL">https://doi.org/10.1172/jci.insight.86580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.86580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.86580%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DAbnormal%252BPTPN11%252Benhancer%252Bmethylation%252Bpromotes%252Brheumatoid%252Barthritis%252Bfibroblast-like%252Bsynoviocyte%252Baggressiveness%252Band%252Bjoint%252Binflammation%26aulast%3DMaeshima%26aufirst%3DKeisuke%26date%3D2016%26volume%3D1%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianxun  Wang</span>, <span class="hlFld-ContribAuthor ">Masayuki  Mizui</span>, <span class="hlFld-ContribAuthor ">Li-Fan  Zeng</span>, <span class="hlFld-ContribAuthor ">Roderick  Bronson</span>, <span class="hlFld-ContribAuthor ">Michele  Finnell</span>, <span class="hlFld-ContribAuthor ">Cox  Terhorst</span>, <span class="hlFld-ContribAuthor ">Vasileios C.  Kyttaris</span>, <span class="hlFld-ContribAuthor ">George C.  Tsokos</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Maria I.  Kontaridis</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2016,</strong> <em>126 </em>
                                    (6)
                                     , 2077-2092. <a href="https://doi.org/10.1172/JCI87037" title="DOI URL">https://doi.org/10.1172/JCI87037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI87037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI87037%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DInhibition%252Bof%252BSHP2%252Bameliorates%252Bthe%252Bpathogenesis%252Bof%252Bsystemic%252Blupus%252Berythematosus%26aulast%3DWang%26aufirst%3DJianxun%26date%3D2016%26volume%3D126%26issue%3D6%26spage%3D2077%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Yi-Ming  Shi</span>, <span class="hlFld-ContribAuthor ">Zhe  Qiang</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Shan-Zhai  Shang</span>, <span class="hlFld-ContribAuthor ">Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Bao-Wen  Du</span>, <span class="hlFld-ContribAuthor ">Hui-Pan  Peng</span>, <span class="hlFld-ContribAuthor ">Xu  Ji</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Lie  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Plasiatine, an Unprecedented Indole–Phenylpropanoid Hybrid from Plantago asiatica as a Potent Activator of the Nonreceptor Protein Tyrosine Phosphatase Shp2. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep24945" title="DOI URL">https://doi.org/10.1038/srep24945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep24945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep24945%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPlasiatine%25252C%252Ban%252BUnprecedented%252BIndole%2525E2%252580%252593Phenylpropanoid%252BHybrid%252Bfrom%252BPlantago%252Basiatica%252Bas%252Ba%252BPotent%252BActivator%252Bof%252Bthe%252BNonreceptor%252BProtein%252BTyrosine%252BPhosphatase%252BShp2%26aulast%3DGao%26aufirst%3DZhong-Hua%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging Undruggable Molecular Cancer Targets. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2016,</strong> <em>56 </em>
                                    (1)
                                     , 23-40. <a href="https://doi.org/10.1146/annurev-pharmtox-010715-103440" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010715-103440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010715-103440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010715-103440%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DDrugging%252BUndruggable%252BMolecular%252BCancer%252BTargets%26aulast%3DLazo%26aufirst%3DJohn%2BS.%26date%3D2016%26volume%3D56%26issue%3D1%26spage%3D23%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Cao</span>, <span class="hlFld-ContribAuthor ">Siyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Cuicui  Wang</span>, <span class="hlFld-ContribAuthor ">Fan  Liang</span>, <span class="hlFld-ContribAuthor ">Leilei  Yan</span>, <span class="hlFld-ContribAuthor ">Duqiang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep17626" title="DOI URL">https://doi.org/10.1038/srep17626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep17626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep17626%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BInhibitor%252Bof%252Bthe%252BProtein%252BTyrosine%252BPhosphatase%252BShp2%26aulast%3DChen%26aufirst%3DChuan%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen He  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Luo</span>, <span class="hlFld-ContribAuthor ">Kaiqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Cui</span>, <span class="hlFld-ContribAuthor ">Huifang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhongzhong  Ji</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Jufang  Yao</span>, <span class="hlFld-ContribAuthor ">Lifan  Zeng</span>, <span class="hlFld-ContribAuthor ">Kaihong  Ji</span>, <span class="hlFld-ContribAuthor ">Wei-Qiang  Gao</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Gen-Sheng  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2015,</strong> <em>112 </em>
                                    (43)
                                     , 13342-13347. <a href="https://doi.org/10.1073/pnas.1507599112" title="DOI URL">https://doi.org/10.1073/pnas.1507599112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1507599112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1507599112%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DShp2%252Band%252BPten%252Bhave%252Bantagonistic%252Broles%252Bin%252Bmyeloproliferation%252Bbut%252Bcooperate%252Bto%252Bpromote%252Berythropoiesis%252Bin%252Bmammals%26aulast%3DZhu%26aufirst%3DHelen%2BHe%26date%3D2015%26date%3D2015%26volume%3D112%26issue%3D43%26spage%3D13342%26epage%3D13347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah M.  Lewis</span>, <span class="hlFld-ContribAuthor ">Ya  Li</span>, <span class="hlFld-ContribAuthor ">Michael J.  Catalano</span>, <span class="hlFld-ContribAuthor ">Adrian R.  Laciak</span>, <span class="hlFld-ContribAuthor ">Harkewal  Singh</span>, <span class="hlFld-ContribAuthor ">Derrick R.  Seiner</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Reilly</span>, <span class="hlFld-ContribAuthor ">John J.  Tanner</span>, <span class="hlFld-ContribAuthor ">Kent S.  Gates</span>. </span><span class="cited-content_cbyCitation_article-title">Inactivation of protein tyrosine phosphatases by dietary isothiocyanates. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4549-4552. <a href="https://doi.org/10.1016/j.bmcl.2015.08.065" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.065%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInactivation%252Bof%252Bprotein%252Btyrosine%252Bphosphatases%252Bby%252Bdietary%252Bisothiocyanates%26aulast%3DLewis%26aufirst%3DSarah%2BM.%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4549%26epage%3D4552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yantao  He</span>, <span class="hlFld-ContribAuthor ">Xing  Guo</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Andrea M.  Gunawan</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jack E.  Dixon</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A potent and selective inhibitor for the UBLCP1 proteasome phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (12)
                                     , 2798-2809. <a href="https://doi.org/10.1016/j.bmc.2015.03.066" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bpotent%252Band%252Bselective%252Binhibitor%252Bfor%252Bthe%252BUBLCP1%252Bproteasome%252Bphosphatase%26aulast%3DHe%26aufirst%3DYantao%26date%3D2015%26volume%3D23%26issue%3D12%26spage%3D2798%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lutz  Tautz</span>, <span class="hlFld-ContribAuthor ">Yotis A.  Senis</span>, <span class="hlFld-ContribAuthor ">Cécile  Oury</span>, <span class="hlFld-ContribAuthor ">Souad  Rahmouni</span>. </span><span class="cited-content_cbyCitation_article-title">Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (12)
                                     , 2786-2797. <a href="https://doi.org/10.1016/j.bmc.2015.03.075" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPerspective%25253A%252BTyrosine%252Bphosphatases%252Bas%252Bnovel%252Btargets%252Bfor%252Bantiplatelet%252Btherapy%26aulast%3DTautz%26aufirst%3DLutz%26date%3D2015%26volume%3D23%26issue%3D12%26spage%3D2786%26epage%3D2797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Shinohara</span>, <span class="hlFld-ContribAuthor ">Motohiro  Sonoda</span>, <span class="hlFld-ContribAuthor ">Naoya  Hayagane</span>, <span class="hlFld-ContribAuthor ">Shota  Kita</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Okushima</span>, <span class="hlFld-ContribAuthor ">Shinji  Tanimori</span>, <span class="hlFld-ContribAuthor ">Akiya  Ogawa</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of 3-hydroxyanthranilate derivatives using furans, bromoalkyne, and secondary amines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (19)
                                     , 2500-2503. <a href="https://doi.org/10.1016/j.tetlet.2015.03.098" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.03.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.03.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.03.098%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DOne-pot%252Bsynthesis%252Bof%252B3-hydroxyanthranilate%252Bderivatives%252Busing%252Bfurans%25252C%252Bbromoalkyne%25252C%252Band%252Bsecondary%252Bamines%26aulast%3DShinohara%26aufirst%3DHiroyuki%26date%3D2015%26volume%3D56%26issue%3D19%26spage%3D2500%26epage%3D2503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Target Families: Intractable Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 43-58. <a href="https://doi.org/10.1007/164_2015_28" title="DOI URL">https://doi.org/10.1007/164_2015_28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2015_28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2015_28%26sid%3Dliteratum%253Aachs%26atitle%3DEmerging%252BTarget%252BFamilies%25253A%252BIntractable%252BTargets%26aulast%3DKnapp%26aufirst%3DStefan%26date%3D2015%26spage%3D43%26epage%3D58%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNew%252BApproaches%252Bto%252BDrug%252BDiscovery%26aulast%3DNielsch%26aufirst%3DUlrich%26date%3D2016%26volume%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Hydroxyindole Carboxylic Acid Based Libraries <b>11a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) FmocOSu, THF, reflux, 20 h, 81.4%; (b) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Na<sub>2</sub>CO<sub>3</sub>, DMF, 44%; (c) I<sub>2</sub>, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> or AcCN, rt, 86%; (d) 50% diethylamine in DCM, 3 h, 85%; (e) 5% LiOH/THF = 1:2, 80 °C, 2 h, 97.2%; (f) corresponding acyl chloride, Et<sub>3</sub>N, DMF, 0 °C, 80–90%; (g) 5% LiOH/THF = 1:2, rt, 2 h, 80–90%; (h) 192 amines, HOBT, HBTU, DIPEA, DMF, rt, overnigh,. 60–80%.</p></p></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure of SHP2 in complex with compound <b>11c</b>-<b>9</b>. (A) Overall structure of SHP2 in complex with <b>11c</b>-<b>9</b>. The P-loop is shown in pink, the WPD-loop in blue, the Q-loop in green, the pY-loop in orange, and the β<sub>5</sub>–β<sub>6</sub> loop in cyan. Compound <b>11c</b>-<b>9</b> is shown in stick model with unbiased <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map contoured at 2.5σ calculated before the ligand and water molecules were added to the model. (B) Detailed interactions between compound <b>11c</b>-<b>9</b> and SHP2. Polar interactions or H-bonds are shown by red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SHP2 binding mode by <b>11a</b>-<b>1</b> revealed by molecular docking. (A) The overall binding mode of <b>11a</b>-<b>1</b> (green carbon stick) with SHP2 (represented by transparent surface). The binding modes of II-B08 (cyan carbon stick) and <b>11c</b>-<b>9</b> (purple carbon stick) from the complex structures are shown for comparison. (B) The hydroxyindole carboxylic acid motif (spheres) penetrating deeply into the SHP2 active site along the pY recognition cleft. (C) The α-phenyl ring (spheres) forms strong π–π stack interaction with Y279 (gray carbon stick with dotted surface). (D) The rigid oxalamide linker orients the phenylthiophene (spheres) to be well sandwiched by R362 and K364 (gray carbon stick). (E) The interaction details between <b>11a</b>-<b>1</b> (green carbon stick) with SHP2. Residues within 5 Å distance to <b>11a</b>-<b>1</b> are shown in stick. P-loop is highlighted in red, and the other three loops are in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SHP2 inhibitor <b>11a</b>-<b>1</b> reduced lung cancer cell proliferation and specifically blocked SHP2-dependent signaling. (A) <b>11a</b>-<b>1</b> dose dependently inhibited H1975 proliferation with an IC<sub>50</sub> of 0.17 ± 0.02 μM. (B) <b>11a</b>-<b>1</b> decreased EGF induced Erk1/2 phosphorylation and increased EGF induced paxillin (Y118) phosphorylation in a dose-dependent manner. (C) The structurally related negative control <b>10a</b> failed to block SHP2-dependent signaling at 2 μM. (D) the ability of <b>11a</b>-<b>1</b> to inhibit Erk1/2 activation was blunted in SHP2 knocked down cells, and (E) <b>11a</b>-<b>1</b> had no effect on PMA-stimulated Erk1/2 phosphorylation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>11a</b>-<b>1</b> inhibits Erk1/2 and Akt activity and ErbB2+ breast cancer cell growth in a 3D Matrigel environment. (A) SKBR3 cells were seeded into Matrigel, and their growth was then monitored over 4 days in the presence of vehicle or the indicated concentrations of <b>11a</b>-<b>1</b>. (B) Cells after 4 days of growth in Matrigel were recovered and the levels of the total and phospho forms of Erk1/2 and Akt were measured by immunoblot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/medium/jm-2014-006176_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>11a</b>-<b>1</b> on 32D cells. (A) 32D myeloid cells bearing wild-type (WT) KIT or KITD814V were starved of serum and growth factors for 6 h and subjected to proliferation assay in the presence or absence of indicated concentration of II-B08 or <b>11a</b>-<b>1</b>. Assay was performed in the presence of IL-3 (10 ng/mL) for cells bearing WT KIT and in the absence of growth factors for cells bearing oncogenic KITD814V. Bars denote the mean thymidine incorporation (CPM ± SEM) consolidated from four independent experiments performed in triplicate. *<i>p</i> < 0.05. (B) WT hematopoietic stem and progenitor cells bearing KITD814V were starved of serum and growth factors for 6 h and subjected to proliferation assay in the presence or absence of indicated concentration of II-B08 or <b>11a</b>-<b>1</b>. Bars denote the mean thymidine incorporation (CPM ± SD) performed in triplicate from one experiment. *<i>p</i> < 0.05. (C) 32D myeloid cells bearing KITD814V were starved of serum and growth factors for 6 h and incubated with the indicated concentration of <b>11a</b>-<b>1</b> for 2 h. After treatment, cells were lysed and equal amount of protein lysates were subjected to Western blot analysis using indicated antibodies. Similar results were observed in two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm5006176/20150708/images/large/jm-2014-006176_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006176&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Tyrosine phosphorylation: thirty years and counting</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.ceb.2009.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19269802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=140-146&author=T.+Hunter&title=Tyrosine+phosphorylation%3A+thirty+years+and+counting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine phosphorylation: thirty years and counting</span></div><div class="casAuthors">Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-146</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging.  Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a no. of which were approved for clin. use.  The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozf_yslNwApbVg90H21EOLACvtfcHk0ljToR26y5B7EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D&md5=ef5dbec53a41f9691317cc5b1b47b3cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DTyrosine%2520phosphorylation%253A%2520thirty%2520years%2520and%2520counting%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-846&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0lgl-hRzKsmXfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: prospects for therapeutics</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2FS1367-5931%2800%2900223-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11470605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=416-423&author=Z.-Y.+Zhang&title=Protein+tyrosine+phosphatases%3A+prospects+for+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: prospects for therapeutics</span></div><div class="casAuthors">Zhang, Z.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">416-423</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways.  Recent gene knockout studies in mice identify PTP1B as a promising target for anti-diabetes/obesity drug discovery.  PTPs are also implicated in a wide variety of other disorders, including cancer.  Significant progress has been made in identifying small mols. that simultaneously bind both the active site and a unique adjacent site that enables specific inhibition of individual PTP isoenzymes.  As a consequence, there are compelling reasons to believe that PTP inhibitors may ultimately serve as powerful therapeutic weapons in the authors' arsenal for battling human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgujWWYVWfjbVg90H21EOLACvtfcHk0lgl-hRzKsmXfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D&md5=eee42d18a57b314321cffca4e3892ac1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2800%2900223-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252800%252900223-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520prospects%2520for%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2001%26volume%3D5%26spage%3D416%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Julien, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M. L.</span><span> </span><span class="NLM_article-title">Inside the human cancer tyrosine phosphatome</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fnrc2980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=21179176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WisrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=35-49&author=S.+G.+Julienauthor=N.+Dub%C3%A9author=S.+Hardyauthor=M.+L.+Tremblay&title=Inside+the+human+cancer+tyrosine+phosphatome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inside the human cancer tyrosine phosphatome</span></div><div class="casAuthors">Julien, Sofi G.; Dube, Nadia; Hardy, Serge; Tremblay, Michel L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-49</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Members of the protein tyrosine phosphatase (Ptp) family dephosphorylate target proteins and counter the activities of protein tyrosine kinases that are involved in cellular phosphorylation and signalling.  As such, certain PTPs might be tumor suppressors.  Indeed, PTPs play an important part in the inhibition or control of growth, but accumulating evidence indicates that some PTPs may exert oncogenic functions.  Recent large-scale genetic analyses of various human tumors have highlighted the relevance of PTPs either as putative tumor suppressors or as candidate oncoproteins.  Progress in understanding the regulation and function of PTPs has provided insights into which PTPs might be potential therapeutic targets in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomjWFudpQjhLVg90H21EOLACvtfcHk0lgl-hRzKsmXfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WisrbM&md5=ffd5f76f3d0b2d0ef220e5d398794f2e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2980%26sid%3Dliteratum%253Aachs%26aulast%3DJulien%26aufirst%3DS.%2BG.%26aulast%3DDub%25C3%25A9%26aufirst%3DN.%26aulast%3DHardy%26aufirst%3DS.%26aulast%3DTremblay%26aufirst%3DM.%2BL.%26atitle%3DInside%2520the%2520human%2520cancer%2520tyrosine%2520phosphatome%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D35%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Krause, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinases as targets for cancer therapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1056%2FNEJMra044389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16014887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFClsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=172-187&author=D.+S.+Krauseauthor=R.+A.+Van+Etten&title=Tyrosine+kinases+as+targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinases as targets for cancer therapy</span></div><div class="casAuthors">Krause, Daniela S.; Van Etten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">172-187</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses the mechanisms of aberrant tyrosine kinase signaling and strategies to inhibit TKs in cancer.  It also summarizes the status of TK-directed cancer therapies, and discusses challenges and prospects for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq89QOl9E0UMLVg90H21EOLACvtfcHk0lj2kNzhQH92iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFClsbs%253D&md5=0a98c8840a983300f6b0743673cf480c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMra044389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra044389%26sid%3Dliteratum%253Aachs%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D172%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ventura, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">Protein kinases and phosphatases as therapeutic targets in cancer</span> <span class="citation_source-journal">Clin. Transl. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1007%2Fs12094-006-0005-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16648114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFentb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=153-160&author=J.+J.+Venturaauthor=A.+R.+Nebreda&title=Protein+kinases+and+phosphatases+as+therapeutic+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases and phosphatases as therapeutic targets in cancer</span></div><div class="casAuthors">Ventura, Juan-Jose; Nebreda, Angel R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Translational Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-160</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Instituto de Investigaciones Biomedicas CSIC/UAM</span>)
        </div><div class="casAbstract">A review.  Protein phosphorylation plays key roles in many physiol. processes and is often deregulated in pathol. conditions.  Our current understanding of how protein kinases and phosphatases orchestrate the phosphorylation changes that control cellular functions has made these enzymes potential drug targets for the treatment of many diseases.  The success of the tyrosine kinase inhibitor Gleevec in the treatment of some cancers has further invigorated the development of kinase inhibitors as anti-cancer drugs.  A large no. of these compds. are currently undergoing clin. trials and there is much expectation on the therapeutic potential of these mols., as more specific and less toxic drugs than currently used generic chemotherapeutic agents.  In this manuscript, we review the current status of more than 30 protein kinase inhibitors with proven or potential therapeutic value for cancer treatment.  These include inhibitors of receptor and cytosolic tyrosine kinases as well as compds. that target different families of serine/threonine kinases involved in signalling and cell cycle regulation.  We also briefly touch on the prospects of phosphatase inhibitors.  The combination of kinase inhibitors to target different components of signalling pathways that are found deregulated in tumors is also emerging as an interesting approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdO6Up4gp6n7Vg90H21EOLACvtfcHk0lj2kNzhQH92iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFentb0%253D&md5=57a09f7b6916b45b1154b608cd1f17af</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs12094-006-0005-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-006-0005-0%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DJ.%2BJ.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DProtein%2520kinases%2520and%2520phosphatases%2520as%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2006%26volume%3D8%26spage%3D153%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Kinase Drug Discovery - What’s Next in the Field?</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300610s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=96-104&author=P.+Cohenauthor=D.+R.+Alessi&title=Kinase+Drug+Discovery+-+What%E2%80%99s+Next+in+the+Field%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcb300610s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300610s%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKinase%2520Drug%2520Discovery%2520-%2520What%25E2%2580%2599s%2520Next%2520in%2520the%2520Field%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D96%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podsypanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miliaresis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibshoosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title"><i>PTEN</i>, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1126%2Fscience.275.5308.1943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=9072974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=1943-1947&author=J.+Liauthor=C.+Yenauthor=D.+Liawauthor=K.+Podsypaninaauthor=S.+Boseauthor=S.+I.+Wangauthor=J.+Pucauthor=C.+Miliaresisauthor=L.+Rodgersauthor=R.+McCombieauthor=S.+H.+Bignerauthor=B.+C.+Giovanellaauthor=M.+Ittmannauthor=B.+Tyckoauthor=H.+Hibshooshauthor=M.+H.+Wiglerauthor=R.+Parsons&title=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span></div><div class="casAuthors">Li, Jing; Yen, Clifford; Liaw, Danny; Podsypanina, Katrina; Bose, Shikha; Wang, Steven I.; Puc, Janusz; Miliaresis, Christa; Rodgers, Linda; McCombie, Richard; Bigner, Sandra H.; Giovanella, Beppino C.; Ittmann, Michael; Tycko, Ben; Hibshoosh, Hanina; Wigler, Michael H.; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5308</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.  In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.  The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homol. to tensin, a protein that interacts with actin filaments at focal adhesions.  These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPNCE1bqsPNLVg90H21EOLACvtfcHk0li8IPFp0UV0sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D&md5=9b3810f68cbd7cbb882ff75e98a2f1bf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5308.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5308.1943%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DC.%26aulast%3DLiaw%26aufirst%3DD.%26aulast%3DPodsypanina%26aufirst%3DK.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%2BI.%26aulast%3DPuc%26aufirst%3DJ.%26aulast%3DMiliaresis%26aufirst%3DC.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DMcCombie%26aufirst%3DR.%26aulast%3DBigner%26aufirst%3DS.%2BH.%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DIttmann%26aufirst%3DM.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DHibshoosh%26aufirst%3DH.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%252C%2520a%2520putative%2520protein%2520tyrosine%2520phosphatase%2520gene%2520mutated%2520in%2520human%2520brain%252C%2520breast%252C%2520and%2520prostate%2520cancer%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sager, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijden, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmigiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Mutational analysis of the tyrosine phosphatome in colorectal cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1164</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1126%2Fscience.1096096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=15155950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVyit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1164-1166&author=Z.+Wangauthor=D.+Shenauthor=D.+W.+Parsonsauthor=A.+Bardelliauthor=J.+Sagerauthor=S.+Szaboauthor=J.+Ptakauthor=N.+Sillimanauthor=B.+A.+Petersauthor=M.+S.+van+der+Heijdenauthor=G.+Parmigianiauthor=H.+Yanauthor=T.+L.+Wangauthor=G.+Rigginsauthor=S.+M.+Powellauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=Mutational+analysis+of+the+tyrosine+phosphatome+in+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers</span></div><div class="casAuthors">Wang, Zhenghe; Shen, Dong; Parsons, D. Williams; Bardelli, Alberto; Sager, Jason; Szabo, Steve; Ptak, Janine; Silliman, Natalie; Peters, Brock A.; van der Heijden, Michiel S.; Parmigiani, Giovanni; Yan, Hai; Wang, Tian-Li; Riggins, Greg; Powell, Steven M.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5674</span>),
    <span class="NLM_cas:pages">1164-1167</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Tyrosine phosphorylation, regulated by protein tyrosine phosphatases (PTPs) and kinases (PTKs), is important in signaling pathways underlying tumorigenesis.  A mutational anal. of the tyrosine phosphatase gene superfamily in human cancers identified 83 somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14), affecting 26% of colorectal cancers and a smaller fraction of lung, breast, and gastric cancers.  Fifteen mutations were nonsense, frameshift, or splice-site alterations predicted to result in truncated proteins lacking phosphatase activity.  Five missense mutations in the most commonly altered PTP (PTPRT) were biochem. examd. and found to reduce phosphatase activity.  Expression of wild-type but not a mutant PTPRT in human cancer cells inhibited cell growth.  These observations suggest that the mutated tyrosine phosphatases are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9NQWiEUTTMbVg90H21EOLACvtfcHk0li8IPFp0UV0sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVyit7c%253D&md5=3466921b63561835ad9bf1f2f4f5d81e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096096%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSager%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DB.%2BA.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DM.%2BS.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DRiggins%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DMutational%2520analysis%2520of%2520the%2520tyrosine%2520phosphatome%2520in%2520colorectal%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1164%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span> </span><span class="NLM_article-title">The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span> </span><span class="NLM_article-title">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+first+identified+proto-oncogene+that+encodes+a+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520first%2520identified%2520proto-oncogene%2520that%2520encodes%2520a%2520tyrosine%2520phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Grossmann, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosário, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 in development and cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2FS0065-230X%2810%2906002-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=20399956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2010&pages=53-89&author=K.+S.+Grossmannauthor=M.+Ros%C3%A1rioauthor=C.+Birchmeierauthor=W.+Birchmeier&title=The+tyrosine+phosphatase+Shp2+in+development+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 in development and cancer</span></div><div class="casAuthors">Grossmann, Katja S.; Rosario, Marta; Birchmeier, Carmen; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-89</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Deregulation of signaling pathways, through mutation or other mol. changes, can ultimately result in disease.  The tyrosine phosphatase Shp2 has emerged as a major regulator of receptor tyrosine kinase (RTK) and cytokine receptor signaling.  In the last decade, germline mutations in the human PTPN11 gene, encoding Shp2, were linked to Noonan (NS) and LEOPARD syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation.  Somatic Shp2 mutations are also assocd. with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML).  Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be assocd. with LEOPARD syndrome.  Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2 function in disease, and shed light on the role of Shp2 in signaling pathways that control decisive events during embryonic development or during cellular transformation/tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgraxAD7u8HbVg90H21EOLACvtfcHk0lipSyQMMcr9-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVGjtr4%253D&md5=45bc842913f2ac8e0fec7c6e1ed8576a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2810%2906002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252810%252906002-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DK.%2BS.%26aulast%3DRos%25C3%25A1rio%26aufirst%3DM.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520in%2520development%2520and%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2010%26volume%3D106%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalidas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+encoding+the+protein+tyrosine+phosphatase+SHP-2%2C+cause+Noonan+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lipSyQMMcr9-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520encoding%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNature%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Noonan syndrome and related disorders: genetics and pathogenesis</span> <span class="citation_source-journal">Annu. Rev. Genomics Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1146%2Fannurev.genom.6.080604.162305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16124853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=45-68&author=M.+Tartagliaauthor=B.+D.+Gelb&title=Noonan+syndrome+and+related+disorders%3A+genetics+and+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Noonan syndrome and related disorders: Genetics and pathogenesis</span></div><div class="casAuthors">Tartaglia, Marco; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genomics and Human Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-68</span>CODEN:
                <span class="NLM_cas:coden">ARGHC4</span>;
        ISSN:<span class="NLM_cas:issn">1527-8204</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Noonan syndrome is a pleiomorphic autosomal dominant disorder with short stature, facial dysmorphia, webbed neck, and heart defects.  In the past decade, progress has been made in elucidating the pathogenesis of this disorder using a positional cloning approach.  Noonan syndrome is now known to be a genetically heterogeneous disorder with nearly one half of cases caused by gain-of-function mutations in PTPN11, the gene encoding the protein tyrosine phosphatase SHP-2.  Similar germ line mutations cause two related genetic disorders, Noonan-like disorder with multiple giant cell lesion syndrome and LEOPARD syndrome, and somatic PTPN11 mutations can underlie certain pediatric hematopoietic malignancies, including juvenile myelomonocytic, acute lymphoblastic, and acute myelogenous leukemias.  A mouse model of PTPN11-related Noonan syndrome was recently generated, providing a reagent for studying disease pathogenesis in greater depth as well as experimenting with novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXWUnHrGyprVg90H21EOLACvtfcHk0lgab6txx0DVoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWisrrN&md5=6a16672446873326cc05a1d732e6bfb5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1146%2Fannurev.genom.6.080604.162305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.genom.6.080604.162305%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DNoonan%2520syndrome%2520and%2520related%2520disorders%253A%2520genetics%2520and%2520pathogenesis%26jtitle%3DAnnu.%2520Rev.%2520Genomics%2520Hum.%2520Genet.%26date%3D2005%26volume%3D6%26spage%3D45%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buechner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahlen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+Hahlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lgab6txx0DVoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DHahlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNature%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzaniga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeddu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pession, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masera, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1182%2Fblood-2003-11-3876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=14982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=307-313&author=M.+Tartagliaauthor=S.+Martinelliauthor=G.+Cazzanigaauthor=V.+Cordedduauthor=I.+Iavaroneauthor=M.+Spinelliauthor=C.+Palmiauthor=C.+Cartaauthor=A.+Pessionauthor=M.+Aricoauthor=G.+Maseraauthor=G.+Bassoauthor=M.+Sorciniauthor=B.+D.+Gelbauthor=A.+Biondi&title=Genetic+evidence+for+lineage-related+and+differentiation+stage-related+contribution+of+somatic+PTPN11+mutations+to+leukemogenesis+in+childhood+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Cazzaniga, Giovanni; Cordeddu, Viviana; Iavarone, Ivano; Spinelli, Monica; Palmi, Chiara; Carta, Claudio; Pession, Andrea; Arico, Maurizio; Masera, Giuseppe; Basso, Giuseppe; Sorcini, Mariella; Gelb, Bruce D.; Biondi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">SHP-2 is a protein tyrosine phosphatase functioning as signal transducer downstream to growth factor and cytokine receptors.  SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.  SHP-2 plays a crucial role in hematopoietic cell development.  We recently demonstrated that somatic PTPN11 mutations are the most frequent lesion in juvenile myelomonocytic leukemia and are obsd. in a smaller percentage of children with other myeloid malignancies.  Here, we report that PTPN11 lesions occur in childhood acute lymphoblastic leukemia (ALL).  Mutations were obsd. in 23 of 317 B-cell precursor ALL cases, but not among 44 children with T-lineage ALL.  In the former, lesions prevalently occurred in TEL-AML1- cases with CD19+/CD10+/cyIgM- immunophenotype.  PTPN11, NRAS, and KRAS2 mutations were largely mutually exclusive and accounted for one third of common ALL cases.  We also show that, among 69 children with acute myeloid leukemia, PTPN11 mutations occurred in 4 of 12 cases with acute monocytic leukemia (FAB-M5).  Leukemia-assocd. PTPN11 mutations were missense and were predicted to result in SHP-2 gain-of-function.  Our findings provide evidence for a wider role of PTPN11 lesions in leukemogenesis, but also suggest a lineage-related and differentiation stage-related contribution of these lesions to clonal expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8ifPYTWa1LVg90H21EOLACvtfcHk0lhjRtAZRg9kZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D&md5=d8a6592845c32adc35c9612bfa1d6a2f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-11-3876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-11-3876%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DIavarone%26aufirst%3DI.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DPalmi%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DArico%26aufirst%3DM.%26aulast%3DMasera%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DBiondi%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520lineage-related%2520and%2520differentiation%2520stage-related%2520contribution%2520of%2520somatic%2520PTPN11%2520mutations%2520to%2520leukemogenesis%2520in%2520childhood%2520acute%2520leukemia%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D307%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieuw, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtiss, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Beau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1182%2Fblood-2003-09-3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=14644997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=2325-2331&author=M.+L.+Lohauthor=S.+Vattikutiauthor=S.+Schubbertauthor=M.+G.+Reynoldsauthor=E.+Carlsonauthor=K.+H.+Lieuwauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=D.+Stokoeauthor=J.+M.+Bonifasauthor=N.+P.+Curtissauthor=J.+Gotlibauthor=S.+Meshinchiauthor=M.+M.+Le+Beauauthor=P.+D.+Emanuelauthor=K.+M.+Shannon&title=Mutations+in+PTPN11+implicate+the+SHP-2+phosphatase+in+leukemogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span></div><div class="casAuthors">Loh, Mignon L.; Vattikuti, Shashaank; Schubbert, Suzanne; Reynolds, Melissa G.; Carlson, Elaine; Lieuw, Kenneth H.; Cheng, Jennifer W.; Lee, Connie M.; Stokoe, David; Bonifas, Jeannette M.; Curtiss, Nicole P.; Gotlib, Jason; Meshinchi, Soheil; Le Beau, Michelle M.; Emanuel, Peter D.; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2325-2331</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2 (Src homol. 2 domain-contg. protein tyrosine Phosphatase), a non-receptor tyrosine protein tyrosine phosphatase (PTPase) that relays signals from activated growth factor receptors to p21Ras (Ras) and other signaling mols.  Mutations in PTPN11 cause Noonan syndrome (NS), a developmental disorder characterized by cardiac and skeletal defects.  NS is also assocd. with a spectrum of hematol. disorders, including juvenile myelomonocytic leukemia (JMML).  To test the hypothesis that PTPN11 mutations might contribute to myeloid leukemogenesis, we screened the entire coding region for mutations in 51 JMML specimens and in selected exons from 60 patients with other myeloid malignancies.  Missense mutations in PTPN11 were detected in 16 of 49 JMML specimens from patients without NS, but they were less common in other myeloid malignancies.  RAS, NF1, and PTPN11 mutations are largely mutually exclusive in JMML, which suggests that mutant SHP-2 proteins deregulate myeloid growth through Ras.  However, although Ba/F3 cells engineered to express leukemia-assocd. SHP-2 proteins cells showed enhanced growth factor-independent survival, biochem. anal. failed to demonstrate hyperactivation of the Ras effectors extracellular-regulated kinase (ERK) or Akt.  We conclude that SHP-2 is an important cellular PTPase that is mutated in myeloid malignancies.  Further investigation is required to clarify how these mutant proteins interact with Ras and other effectors to deregulate myeloid growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwm--W4OxYbVg90H21EOLACvtfcHk0lhjRtAZRg9kZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D&md5=6c64eb186b172aef05f71c5d3dedbc8e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-09-3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-09-3287%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DLieuw%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DCurtiss%26aufirst%3DN.%2BP.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DMutations%2520in%2520PTPN11%2520implicate%2520the%2520SHP-2%2520phosphatase%2520in%2520leukemogenesis%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D2325%26epage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbing, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonzo, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Children’s Cancer Group</span><span> </span><span class="NLM_article-title">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children’s Cancer Group</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1831</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1831-1834&author=M.+L.+Lohauthor=M.+G.+Reynoldsauthor=S.+Vattikutiauthor=R.+B.+Gerbingauthor=T.+A.+Alonzoauthor=E.+Carlsonauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=B.+J.+Langeauthor=S.+Meshinchiauthor=Children%E2%80%99s+Cancer+Group&title=PTPN11+mutations+in+pediatric+patients+with+acute+myeloid+leukemia%3A+results+from+the+Children%E2%80%99s+Cancer+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLange%26aufirst%3DB.%2BJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3D%26atitle%3DPTPN11%2520mutations%2520in%2520pediatric%2520patients%2520with%2520acute%2520myeloid%2520leukemia%253A%2520results%2520from%2520the%2520Children%25E2%2580%2599s%2520Cancer%2520Group%26jtitle%3DLeukemia%26date%3D2004%26volume%3D18%26spage%3D1831%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kratz, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castleberry, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cetin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsträsser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stary, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zecca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span> </span><span class="NLM_article-title">The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2183</span><span class="NLM_x">–</span> <span class="NLM_lpage">2185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=2183-2185&author=C.+P.+Kratzauthor=C.+M.+Niemeyerauthor=R.+P.+Castleberryauthor=M.+Cetinauthor=E.+Bergstr%C3%A4sserauthor=P.+D.+Emanuelauthor=H.+Hasleauthor=G.+Kardosauthor=C.+Kleinauthor=S.+Kojimaauthor=J.+Staryauthor=M.+Treboauthor=M.+Zeccaauthor=B.+D.+Gelbauthor=M.+Tartagliaauthor=M.+L.+Loh&title=The+mutational+spectrum+of+PTPN11+in+juvenile+myelomonocytic+leukemia+and+Noonan+syndrome%2Fmyeloproliferative+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DC.%2BP.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DCastleberry%26aufirst%3DR.%2BP.%26aulast%3DCetin%26aufirst%3DM.%26aulast%3DBergstr%25C3%25A4sser%26aufirst%3DE.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DKardos%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DKojima%26aufirst%3DS.%26aulast%3DStary%26aufirst%3DJ.%26aulast%3DTrebo%26aufirst%3DM.%26aulast%3DZecca%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26atitle%3DThe%2520mutational%2520spectrum%2520of%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%2520and%2520Noonan%2520syndrome%252Fmyeloproliferative%2520disease%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D2183%26epage%3D2185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bentires-Alj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8816</span><span class="NLM_x">–</span> <span class="NLM_lpage">8820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=15604238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span></div><div class="casAuthors">Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.; Keilhack, Heike; Halmos, Balazs; Naoki, Katsuhiko; Maris, John M.; Richardson, Andrea; Bardelli, Alberto; Sugarbaker, David J.; Richards, William G.; Du, Jinyan; Girard, Luc; Minna, John D.; Loh, Mignon L.; Fisher, David E.; Velculescu, Victor E.; Vogelstein, Bert; Meyerson, Matthew; Sellers, William R.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8816-8820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SH2 domain-contg. protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential component of signaling pathways initiated by growth factors, cytokines, and extracellular matrix.  In many of these pathways, Shp2 acts upstream of Ras.  About 50% of patients with Noonan syndrome have germ-line PTPN11 gain of function mutations.  Assocns. between Noonan syndrome and an increased risk of some malignancies, notably leukemia and neuroblastoma, have been reported, and recent data indicate that somatic PTPN11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrome, B-cell acute lymphoblastic leukemia, and acute myelogenous leukemia (AML).  Juvenile myelomonocytic leukemia patients without PTPN11 mutations have either homozygotic NF-1 deletion or activating RAS mutations.  Given the role of Shp2 in Ras activation and the frequent mutation of RAS in human tumors, these data raise the possibility that PTPN11 mutations play a broader role in cancer.  The authors asked whether PTPN11 mutations occur in other malignancies in which activating RAS mutations occur at low but significant frequency.  Sequencing of PTPN11 from 13 different human neoplasms including breast, lung, gastric, and neuroblastoma tumors and adult AML and acute lymphoblastic leukemia revealed 11 missense mutations.  Five are known mutations predicted to result in an activated form of Shp2, whereas six are new mutations.  Biochem. anal. confirmed that several of the new mutations result in increased Shp2 activity.  The data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, esp. neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3taKvDtHXBLVg90H21EOLACvtfcHk0lg6UKlLqJVrLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK&md5=f6f9fb8c6e9d5260901a03081db259c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+distinct+class+of+gain-of-function+SHP-2+mutants+with+oncogenic+RAS-like+transforming+activity+from+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0lg6UKlLqJVrLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520distinct%2520class%2520of%2520gain-of-function%2520SHP-2%2520mutants%2520with%2520oncogenic%2520RAS-like%2520transforming%2520activity%2520from%2520solid%2520tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">The Cancer Genome Atlas Research Network</span><span> </span><span class="NLM_article-title">Comprehensive genomic characterization defines human glioblastoma genes and core pathways</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=1061-1068&author=The+Cancer+Genome+Atlas+Research+Network&title=Comprehensive+genomic+characterization+defines+human+glioblastoma+genes+and+core+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DComprehensive%2520genomic%2520characterization%2520defines%2520human%2520glioblastoma%2520genes%2520and%2520core%2520pathways%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D1061%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Taylor, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hieronymus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reva, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antipin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgalev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socci, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lash, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scardino, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald, W. L.</span><span> </span><span class="NLM_article-title">Integrative genomic profiling of human prostate cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=11-22&author=B.+S.+Taylorauthor=N.+Schultzauthor=H.+Hieronymusauthor=A.+Gopalanauthor=Y.+Xiaoauthor=B.+S.+Carverauthor=V.+K.+Aroraauthor=P.+Kaushikauthor=E.+Ceramiauthor=B.+Revaauthor=Y.+Antipinauthor=N.+Mitsiadesauthor=T.+Landersauthor=I.+Dolgalevauthor=J.+E.+Majorauthor=M.+Wilsonauthor=N.+D.+Socciauthor=A.+E.+Lashauthor=A.+Heguyauthor=J.+A.+Easthamauthor=H.+I.+Scherauthor=V.+E.+Reuterauthor=P.+T.+Scardinoauthor=C.+Sanderauthor=C.+L.+Sawyersauthor=W.+L.+Gerald&title=Integrative+genomic+profiling+of+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DB.%2BS.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DHieronymus%26aufirst%3DH.%26aulast%3DGopalan%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DCarver%26aufirst%3DB.%2BS.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DKaushik%26aufirst%3DP.%26aulast%3DCerami%26aufirst%3DE.%26aulast%3DReva%26aufirst%3DB.%26aulast%3DAntipin%26aufirst%3DY.%26aulast%3DMitsiades%26aufirst%3DN.%26aulast%3DLanders%26aufirst%3DT.%26aulast%3DDolgalev%26aufirst%3DI.%26aulast%3DMajor%26aufirst%3DJ.%2BE.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DSocci%26aufirst%3DN.%2BD.%26aulast%3DLash%26aufirst%3DA.%2BE.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DEastham%26aufirst%3DJ.%2BA.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DReuter%26aufirst%3DV.%2BE.%26aulast%3DScardino%26aufirst%3DP.%2BT.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DGerald%26aufirst%3DW.%2BL.%26atitle%3DIntegrative%2520genomic%2520profiling%2520of%2520human%2520prostate%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D11%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noushmehr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmulevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnholtz-Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vegesna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sougnez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Meir, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacocca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenberger, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TCGA Research Network</span><span> </span><span class="NLM_article-title">The somatic genomic landscape of glioblastoma</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2013&pages=462-477&author=C.+W.+Brennanauthor=R.+G.+Verhaakauthor=A.+McKennaauthor=B.+Camposauthor=H.+Noushmehrauthor=S.+R.+Salamaauthor=S.+Zhengauthor=D.+Chakravartyauthor=J.+Z.+Sanbornauthor=S.+H.+Bermanauthor=R.+Beroukhimauthor=B.+Bernardauthor=C.+J.+Wuauthor=G.+Genoveseauthor=I.+Shmulevichauthor=J.+Barnholtz-Sloanauthor=L.+Zouauthor=R.+Vegesnaauthor=S.+A.+Shuklaauthor=G.+Cirielloauthor=W.+K.+Yungauthor=W.+Zhangauthor=C.+Sougnezauthor=T.+Mikkelsenauthor=K.+Aldapeauthor=D.+D.+Bignerauthor=E.+G.+Van+Meirauthor=M.+Pradosauthor=A.+Sloanauthor=K.+L.+Blackauthor=J.+Eschbacherauthor=G.+Finocchiaroauthor=W.+Friedmanauthor=D.+W.+Andrewsauthor=A.+Guhaauthor=M.+Iacoccaauthor=B.+P.+O%E2%80%99Neillauthor=G.+Foltzauthor=J.+Myersauthor=D.+J.+Weisenbergerauthor=R.+Pennyauthor=R.+Kucherlapatiauthor=C.+M.+Perouauthor=D.+N.+Hayesauthor=R.+Gibbsauthor=M.+Marraauthor=G.+B.+Millsauthor=E.+Landerauthor=P.+Spellmanauthor=R.+Wilsonauthor=C.+Sanderauthor=J.+Weinsteinauthor=M.+Meyersonauthor=S.+Gabrielauthor=P.+W.+Lairdauthor=D.+Hausslerauthor=G.+Getzauthor=L.+Chinauthor=TCGA+Research+Network&title=The+somatic+genomic+landscape+of+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DVerhaak%26aufirst%3DR.%2BG.%26aulast%3DMcKenna%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DNoushmehr%26aufirst%3DH.%26aulast%3DSalama%26aufirst%3DS.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DSanborn%26aufirst%3DJ.%2BZ.%26aulast%3DBerman%26aufirst%3DS.%2BH.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBernard%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DC.%2BJ.%26aulast%3DGenovese%26aufirst%3DG.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DVegesna%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DS.%2BA.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DYung%26aufirst%3DW.%2BK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSougnez%26aufirst%3DC.%26aulast%3DMikkelsen%26aufirst%3DT.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DPrados%26aufirst%3DM.%26aulast%3DSloan%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DK.%2BL.%26aulast%3DEschbacher%26aufirst%3DJ.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DW.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DGuha%26aufirst%3DA.%26aulast%3DIacocca%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BP.%26aulast%3DFoltz%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeisenberger%26aufirst%3DD.%2BJ.%26aulast%3DPenny%26aufirst%3DR.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DHayes%26aufirst%3DD.%2BN.%26aulast%3DGibbs%26aufirst%3DR.%26aulast%3DMarra%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DLander%26aufirst%3DE.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DWeinstein%26aufirst%3DJ.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DHaussler%26aufirst%3DD.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DChin%26aufirst%3DL.%26aulast%3D%26atitle%3DThe%2520somatic%2520genomic%2520landscape%2520of%2520glioblastoma%26jtitle%3DCell%26date%3D2013%26volume%3D155%26spage%3D462%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Aceto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausgruber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhaus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidatzis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martiny-Baron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzarol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balwierz, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachkov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Nimwegen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentires-Alj, M.</span><span> </span><span class="NLM_article-title">Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=529-537&author=N.+Acetoauthor=N.+Sausgruberauthor=H.+Brinkhausauthor=D.+Gaidatzisauthor=G.+Martiny-Baronauthor=G.+Mazzarolauthor=S.+Confalonieriauthor=M.+Quartoauthor=G.+Huauthor=P.+J.+Balwierzauthor=M.+Pachkovauthor=S.+J.+Elledgeauthor=E.+van+Nimwegenauthor=M.+B.+Stadlerauthor=M.+Bentires-Alj&title=Tyrosine+phosphatase+SHP2+promotes+breast+cancer+progression+and+maintains+tumor-initiating+cells+via+activation+of+key+transcription+factors+and+a+positive+feedback+signaling+loop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAceto%26aufirst%3DN.%26aulast%3DSausgruber%26aufirst%3DN.%26aulast%3DBrinkhaus%26aufirst%3DH.%26aulast%3DGaidatzis%26aufirst%3DD.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DMazzarol%26aufirst%3DG.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DBalwierz%26aufirst%3DP.%2BJ.%26aulast%3DPachkov%26aufirst%3DM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3Dvan%2BNimwegen%26aufirst%3DE.%26aulast%3DStadler%26aufirst%3DM.%2BB.%26aulast%3DBentires-Alj%26aufirst%3DM.%26atitle%3DTyrosine%2520phosphatase%2520SHP2%2520promotes%2520breast%2520cancer%2520progression%2520and%2520maintains%2520tumor-initiating%2520cells%2520via%2520activation%2520of%2520key%2520transcription%2520factors%2520and%2520a%2520positive%2520feedback%2520signaling%2520loop%26jtitle%3DNature%2520Med.%26date%3D2012%26volume%3D18%26spage%3D529%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Stommel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmelman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabioullin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponugoti, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedemeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegh, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span> </span><span class="NLM_article-title">Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=287-290&author=J.+M.+Stommelauthor=A.+C.+Kimmelmanauthor=H.+Yingauthor=R.+Nabioullinauthor=A.+H.+Ponugotiauthor=R.+Wiedemeyerauthor=A.+H.+Steghauthor=J.+E.+Bradnerauthor=K.+L.+Ligonauthor=C.+Brennanauthor=L.+Chinauthor=R.+A.+DePinho&title=Coactivation+of+receptor+tyrosine+kinases+affects+the+response+of+tumor+cells+to+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStommel%26aufirst%3DJ.%2BM.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DNabioullin%26aufirst%3DR.%26aulast%3DPonugoti%26aufirst%3DA.%2BH.%26aulast%3DWiedemeyer%26aufirst%3DR.%26aulast%3DStegh%26aufirst%3DA.%2BH.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DCoactivation%2520of%2520receptor%2520tyrosine%2520kinases%2520affects%2520the%2520response%2520of%2520tumor%2520cells%2520to%2520targeted%2520therapies%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D287%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Noren-Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Correa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestweber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiewe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">10606</span><span class="NLM_x">–</span> <span class="NLM_lpage">10611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1073%2Fpnas.0601490103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16809424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10606-10611&author=A.+Noren-Mullerauthor=I.+Reis-Correaauthor=H.+Prinzauthor=C.+Rosenbaumauthor=K.+Saxenaauthor=H.+J.+Schwalbeauthor=D.+Vestweberauthor=G.+Cagnaauthor=S.+Schunkauthor=O.+Schwarzauthor=H.+Schieweauthor=H.+Waldmann&title=Discovery+of+protein+phosphatase+inhibitor+classes+by+biology-oriented+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span></div><div class="casAuthors">Noren-Muller Andrea; Reis-Correa Ivan Jr; Prinz Heino; Rosenbaum Claudia; Saxena Krishna; Schwalbe Harald J; Vestweber Dietmar; Cagna Guiseppe; Schunk Stefan; Schwarz Oliver; Schiewe Hajo; Waldmann Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10606-11</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Protein phosphatases have very recently emerged as important targets for chemical biology and medicinal chemistry research, and new phosphatase inhibitor classes are in high demand.  The underlying frameworks of natural products represent the evolutionarily selected fractions of chemical space explored by nature so far and meet the criteria of relevance to nature and biological prevalidation most crucial to inhibitor development.  We refer to synthesis efforts and compound collection development based on these criteria as biology-oriented synthesis.  For the discovery of phosphatase inhibitor classes by means of this approach, four natural product-derived or -inspired medium-sized compound collections were synthesized and investigated for inhibition of the tyrosine phosphatases VE-PTP, Shp-2, PTP1B, MptpA, and MptpB and the dual-specificity phosphatases Cdc25A and VHR.  The screen yielded four unprecedented and selective phosphatase inhibitor classes for four phosphatases with high hit rates.  For VE-PTP and MptpB the first inhibitors were discovered.  These results demonstrate that biology-oriented synthesis is an efficient approach to the discovery of new compound classes for medicinal chemistry and chemical biology research that opens up new opportunities for the study of phosphatases, which may lead to the development of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNf4ONKii5590Q2ypr7jHkfW6udTcc2eYhnc-NtVynmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D&md5=76f28f79227b8261fd23e7dbf3e2d8e7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601490103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601490103%26sid%3Dliteratum%253Aachs%26aulast%3DNoren-Muller%26aufirst%3DA.%26aulast%3DReis-Correa%26aufirst%3DI.%26aulast%3DPrinz%26aufirst%3DH.%26aulast%3DRosenbaum%26aufirst%3DC.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DSchwalbe%26aufirst%3DH.%2BJ.%26aulast%3DVestweber%26aufirst%3DD.%26aulast%3DCagna%26aufirst%3DG.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DO.%26aulast%3DSchiewe%26aufirst%3DH.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520protein%2520phosphatase%2520inhibitor%2520classes%2520by%2520biology-oriented%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10606%26epage%3D10611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Discovery of a novel shp2 protein tyrosine phosphatase inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=16717135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-570&author=L.+W.+Chenauthor=S.+S.+Sungauthor=M.+L.+R.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+novel+shp2+protein+tyrosine+phosphatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor</span></div><div class="casAuthors">Chen, Liwei; Sung, Shen-Shu; Yip, M. L. Richard; Lawrence, Harshani R.; Ren, Yuan; Guida, Wayne C.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-570</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Shp2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene.  It is involved in growth factor-induced activation of mitogen-activated protein (MAP) kinases Erk1 and Erk2 (Erk1/2) and has been implicated in the pathogenicity of the oncogenic bacterium Helicobacter pylori.  Moreover, gain-of-function Shp2 mutations have been found in childhood leukemias and Noonan syndrome.  Thus, small mol. Shp2 PTP inhibitors are much needed reagents for evaluation of Shp2 as a therapeutic target and for chem. biol. studies of Shp2 function.  By screening the National Cancer Institute (NCI) Diversity Set chem. library, we identified 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877) as a potent Shp2 PTP inhibitor.  Mol. modeling and site-directed mutagenesis studies suggested that NSC-87877 binds to the catalytic cleft of Shp2 PTP.  NSC-87877 cross-inhibited Shp1 in vitro, but it was selective for Shp2 over other PTPs (PTP1B, HePTP, DEP1, CD45, and LAR).  It is noteworthy that NSC-87877 inhibited epidermal growth factor (EGF)-induced activation of Shp2 PTP, Ras, and Erk1/2 in cell cultures but did not block EGF-induced Gab1 tyrosine phosphorylation or Gab1-Shp2 assocn.  Furthermore, NSC-87877 inhibited Erk1/2 activation by a Gab1-Shp2 chimera but did not affect the Shp2-independent Erk1/2 activation by phorbol 12-myristate 13-acetate.  These results identified NSC-87877 as the first PTP inhibitor capable of inhibiting Shp2 PTP in cell cultures without a detectable off-target effect.  Our study also provides the first pharmacol. evidence that Shp2 mediates EGF-induced Erk1/2 MAP kinase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4XVGUjw3W7Vg90H21EOLACvtfcHk0lhOGIASf1JxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D&md5=a2ce03150ecbe6937876bb292ced30dc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520shp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dawson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhuiyan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tautz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waleh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span> </span><span class="NLM_article-title">Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5650</span><span class="NLM_x">–</span> <span class="NLM_lpage">5662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800456k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5650-5662&author=M.+I.+Dawsonauthor=Z.+Xiaauthor=T.+Jiangauthor=M.+Yeauthor=J.+A.+Fontanaauthor=L.+Farhanaauthor=B.+Patelauthor=L.+P.+Xueauthor=M.+Bhuiyanauthor=R.+Pellicciariauthor=A.+Macchiaruloauthor=R.+Nutiauthor=X.+K.+Zhangauthor=Y.+H.+Hanauthor=L.+Tautzauthor=P.+D.+Hobbsauthor=L.+Jongauthor=N.+Walehauthor=W.+R.+Chaoauthor=G.+S.+Fengauthor=Y.+Pangauthor=Y.+Su&title=Adamantyl-substituted+retinoid-derived+molecules+that+interact+with+the+orphan+nuclear+receptor+small+heterodimer+partner%3A+effects+of+replacing+the+1-adamantyl+or+hydroxyl+group+on+inhibition+of+cancer+cell+growth%2C+induction+of+cancer+cell+apoptosis%2C+and+inhibition+of+SRC+homology+2+domain-containing+protein+tyrosine+phosphatase-2+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantyl-Substituted Retinoid-Derived Molecules That Interact with the Orphan Nuclear Receptor Small Heterodimer Partner: Effects of Replacing the 1-Adamantyl or Hydroxyl Group on Inhibition of Cancer Cell Growth, Induction of Cancer Cell Apoptosis, and Inhibition of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Activity</span></div><div class="casAuthors">Dawson, Marcia I.; Xia, Zebin; Jiang, Tao; Ye, Mao; Fontana, Joseph A.; Farhana, Lulu; Patel, Bhaumik; Xue, Li Ping; Bhuiyan, Mohammad; Pellicciari, Roberto; Macchiarulo, Antonio; Nuti, Roberto; Zhang, Xiao-Kun; Han, Young-Hoon; Tautz, Lutz; Hobbs, Peter D.; Jong, Ling; Waleh, Nahid; Chao, Wan-ru; Feng, Gen-Sheng; Pang, Yuhong; Su, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5650-5662</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(E)-4-[3-(1-Adamantyl)-4'-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces the cell-cycle arrest and apoptosis of leukemia and cancer cells.  Studies demonstrated that 3-Cl-AHPC bound to the atypical orphan nuclear receptor small heterodimer partner (SHP).  Although missing a DNA-binding domain, SHP heterodimerizes with the ligand-binding domains of other nuclear receptors to repress their abilities to induce or inhibit gene expression.  3-Cl-AHPC analogs having the 1-adamantyl and phenolic hydroxyl pharmacophoric elements replaced with isosteric groups were designed, synthesized, and evaluated for their inhibition of proliferation and induction of human cancer cell apoptosis.  Structure-anticancer activity relationship studies indicated the importance of both groups to apoptotic activity.  Docking of 3-Cl-AHPC and its analogs to an SHP computational model that was based on the crystal structure of ultraspiracle complexed with 1-stearoyl-2-palmitoylglycero-3-phosphoethanolamine suggested why these 3-Cl-AHPC groups could influence SHP activity.  Inhibitory activity against Src homol. 2 domain-contg. protein tyrosine phosphatase 2 (Shp-2) was also assessed.  The most active Shp-2 inhibitor was found to be the 3'-(3,3-dimethylbutynyl) analog of 3-Cl-AHPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3EhNrmE1CAbVg90H21EOLACvtfcHk0lhOGIASf1JxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtbfE&md5=d083d7bfb6334fe98cf184b59af1dfec</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm800456k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800456k%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BI.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DFontana%26aufirst%3DJ.%2BA.%26aulast%3DFarhana%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DXue%26aufirst%3DL.%2BP.%26aulast%3DBhuiyan%26aufirst%3DM.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DNuti%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DX.%2BK.%26aulast%3DHan%26aufirst%3DY.%2BH.%26aulast%3DTautz%26aufirst%3DL.%26aulast%3DHobbs%26aufirst%3DP.%2BD.%26aulast%3DJong%26aufirst%3DL.%26aulast%3DWaleh%26aufirst%3DN.%26aulast%3DChao%26aufirst%3DW.%2BR.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26atitle%3DAdamantyl-substituted%2520retinoid-derived%2520molecules%2520that%2520interact%2520with%2520the%2520orphan%2520nuclear%2520receptor%2520small%2520heterodimer%2520partner%253A%2520effects%2520of%2520replacing%2520the%25201-adamantyl%2520or%2520hydroxyl%2520group%2520on%2520inhibition%2520of%2520cancer%2520cell%2520growth%252C%2520induction%2520of%2520cancer%2520cell%2520apoptosis%252C%2520and%2520inhibition%2520of%2520SRC%2520homology%25202%2520domain-containing%2520protein%2520tyrosine%2520phosphatase-2%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5650%26epage%3D5662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Geronikaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleftheriou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span> </span><span class="NLM_article-title">2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5221</span><span class="NLM_x">–</span> <span class="NLM_lpage">5228</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8004306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5221-5228&author=A.+Geronikakiauthor=P.+Eleftheriouauthor=P.+Viciniauthor=I.+Alamauthor=A.+Dixitauthor=A.+K.+Saxena&title=2-Thiazolylimino%2Fheteroarylimino-5-arylidene-4-thiazolidinones+as+new+agents+with+SHP-2+inhibitory+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm8004306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8004306%26sid%3Dliteratum%253Aachs%26aulast%3DGeronikaki%26aufirst%3DA.%26aulast%3DEleftheriou%26aufirst%3DP.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DAlam%26aufirst%3DI.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26atitle%3D2-Thiazolylimino%252Fheteroarylimino-5-arylidene-4-thiazolidinones%2520as%2520new%2520agents%2520with%2520SHP-2%2520inhibitory%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5221%26epage%3D5228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymanski, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span> </span><span class="NLM_article-title">Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4948</span><span class="NLM_x">–</span> <span class="NLM_lpage">4956</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8002526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4948-4956&author=H.+R.+Lawrenceauthor=R.+Piredduauthor=L.+W.+Chenauthor=Y.+T.+Luoauthor=S.+S.+Sungauthor=A.+M.+Szymanskiauthor=M.+L.+R.+Yipauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=J.+Wuauthor=N.+J.+Lawrence&title=Inhibitors+of+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28Shp2%29+based+on+oxindole+scaffolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds</span></div><div class="casAuthors">Lawrence, Harshani R.; Pireddu, Roberta; Chen, Liwei; Luo, Yunting; Sung, Shen-Shu; Szymanski, Ann Marie; Yip, M. L. Richard; Guida, Wayne C.; Sebti, Said M.; Wu, Jie; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4948-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the NCI diversity set of compds. has led to the identification of NSC-117199, which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM.  A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities.  Several compds. were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity.  A model for the binding of the active compds. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqLAauyGNBbVg90H21EOLACvtfcHk0lhROLv_OCymLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D&md5=572227c5a8cfffb108388616bd36fdfe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm8002526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002526%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DLuo%26aufirst%3DY.%2BT.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DSzymanski%26aufirst%3DA.%2BM.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DInhibitors%2520of%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528Shp2%2529%2520based%2520on%2520oxindole%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4948%26epage%3D4956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hellmuth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosskopf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kries, J. P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7275</span><span class="NLM_x">–</span> <span class="NLM_lpage">7280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1073%2Fpnas.0710468105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=18480264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7275-7280&author=K.+Hellmuthauthor=S.+Grosskopfauthor=C.+T.+Lumauthor=M.+Wurteleauthor=N.+Roderauthor=J.+P.+V.+Kriesauthor=M.+Rosarioauthor=J.+Rademannauthor=W.+Birchmeier&title=Specific+inhibitors+of+the+protein+tyrosine+phosphatase+Shp2+identified+by+high-throughput+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span></div><div class="casAuthors">Hellmuth, Klaus; Grosskopf, Stefanie; Lum, Ching Tung; Wuertele, Martin; Roeder, Nadine; von Kries, Jens Peter; Rosario, Marta; Rademann, Jorg; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7275-7280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase Shp2 is a pos. regulator of growth factor signaling.  Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene.  We performed a high-throughput in silico screen for small-mol.-wt. compds. that bind the catalytic site of Shp2.  We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1 B.  PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis.  PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin.  Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-assocd. Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.  The PHPS compd. class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGponh1kw_h7jrVg90H21EOLACvtfcHk0lhROLv_OCymLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D&md5=39c7dda94e32134c305e135e4c48b9d1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710468105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710468105%26sid%3Dliteratum%253Aachs%26aulast%3DHellmuth%26aufirst%3DK.%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DWurtele%26aufirst%3DM.%26aulast%3DRoder%26aufirst%3DN.%26aulast%3DKries%26aufirst%3DJ.%2BP.%2BV.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DSpecific%2520inhibitors%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520Shp2%2520identified%2520by%2520high-throughput%2520docking%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D7275%26epage%3D7280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guvench, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKerell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7396</span><span class="NLM_x">–</span> <span class="NLM_lpage">7404</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800229d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7396-7404&author=W.+M.+Yuauthor=O.+Guvenchauthor=A.+D.+MacKerellauthor=C.+K.+Qu&title=Identification+of+small+molecular+weight+inhibitors+of+Src+homology+2+domain-containing+tyrosine+phosphatase+2+%28SHP-2%29+via+in+silico+database+screening+combined+with+experimental+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Small Molecular Weight Inhibitors of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 (SHP-2) via in Silico Database Screening Combined with Experimental Assay</span></div><div class="casAuthors">Yu, Wen-Mei; Guvench, Olgun; MacKerell, Alexander D.; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7396-7404</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual screening methods combined with exptl. assays were used to identify low mol. wt. inhibitors for Src homol. 2 domain-contg. phosphatase 2 (SHP-2) that is mutated and hyperactivated in Noonan syndrome and a significant portion of childhood leukemias.  Virtual screening included multiple conformations of the protein, score normalization procedures, and chem. similarity considerations.  As the catalytic core of SHP-2 shares extremely high homol. to those of the related SHP-1 phosphatase and other tyrosine phosphatases, in order to identify selective inhibitors, we chose to target an adjacent protein surface pocket that is predicted to be important for binding to phosphopeptides and that has structural features unique to SHP-2.  From a database of 1.3 million compds., 9 out of 165 computationally selected compds. were shown to inhibit SHP-2 activity with IC50 values of ≈ 100 μM.  Two of the active compds. were further verified for their ability to inhibit SHP-2-mediated cellular functions.  Fluorescence titrn. expts. confirmed their direct binding to SHP-2.  Because of their simple chem. structures, these small org. compds. have the potential to act as lead compds. for the development of novel anti-SHP-2 drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Kw_2kNl-RbVg90H21EOLACvtfcHk0ljnMII839vmQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI&md5=915691bc2e64243286cf305314b3a470</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm800229d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800229d%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DGuvench%26aufirst%3DO.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520small%2520molecular%2520weight%2520inhibitors%2520of%2520Src%2520homology%25202%2520domain-containing%2520tyrosine%2520phosphatase%25202%2520%2528SHP-2%2529%2520via%2520in%2520silico%2520database%2520screening%2520combined%2520with%2520experimental%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7396%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tautz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustelin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.-S.</span><span> </span><span class="NLM_article-title">A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e4914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e4914&author=D.+Wuauthor=Y.+Pangauthor=Y.+Keauthor=J.+Yuauthor=Z.+Heauthor=L.+Tautzauthor=T.+Mustelinauthor=S.+Dingauthor=Z.+Huangauthor=G.-S.+Feng&title=A+conserved+mechanism+for+control+of+human+and+mouse+embryonic+stem+cell+pluripotency+and+differentiation+by+shp2+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DTautz%26aufirst%3DL.%26aulast%3DMustelin%26aufirst%3DT.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DG.-S.%26atitle%3DA%2520conserved%2520mechanism%2520for%2520control%2520of%2520human%2520and%2520mouse%2520embryonic%2520stem%2520cell%2520pluripotency%2520and%2520differentiation%2520by%2520shp2%2520tyrosine%2520phosphatase%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De4914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Salicylic acid-based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.-X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.-Y.+Zhang&title=Salicylic+acid-based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.-X.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSalicylic%2520acid-based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Fatty acids as natural specific inhibitors of the proto-oncogenic protein Shp2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6833</span><span class="NLM_x">–</span> <span class="NLM_lpage">6837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6833-6837&author=D.+Liuauthor=G.+Kongauthor=Q.+C.+Chenauthor=G.+Wangauthor=J.+Liauthor=Y.+Xuauthor=T.+Linauthor=Y.+Tianauthor=X.+Zhangauthor=X.+Yaoauthor=G.+Fengauthor=Z.+Luauthor=H.+Chen&title=Fatty+acids+as+natural+specific+inhibitors+of+the+proto-oncogenic+protein+Shp2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DKong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DQ.%2BC.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DFatty%2520acids%2520as%2520natural%2520specific%2520inhibitors%2520of%2520the%2520proto-oncogenic%2520protein%2520Shp2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6833%26epage%3D6837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Scott, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs</span> <span class="citation_source-journal">Bioorg. Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.bmcl.2010.11.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=21193311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=730-733&author=L.+M.+Scottauthor=L.+Chenauthor=K.+G.+Danielauthor=W.+H.+Brooksauthor=W.+C.+Guidaauthor=H.+R.+Lawrenceauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Shp2+protein+tyrosine+phosphatase+inhibitor+activity+of+estramustine+phosphate+and+its+triterpenoid+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs</span></div><div class="casAuthors">Scott, Latanya M.; Chen, Liwei; Daniel, Kenyon G.; Brooks, Wesley H.; Guida, Wayne C.; Lawrence, Harshani R.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">730-733</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Shp2 protein tyrosine phosphate (PTP) is a novel target for anticancer drug discovery.  We identified estramustine phosphate as a Shp2 PTP inhibitor from the National Cancer Institute Approved Oncol. Drug set.  A focused structure-activity relationship study indicated that the 17-phosphate group is required for the Shp2 PTP inhibitor activity of estramustine phosphate.  A search for estramustine phosphate analogs led to identification of two triterpenoids, enoxolone, and celastrol, having Shp2 PTP inhibitor activity.  With the previously reported PTP1B inhibitor trodusquemine, our study reveals steroids and triterpenoids with neg. charged phosphate, carboxylate, or sulfonate groups as novel pharmacophores of selective PTP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo41pp4mYsX5rVg90H21EOLACvtfcHk0ljnMII839vmQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOjtA%253D%253D&md5=41e82922b4285fa0d45c9033d1257631</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.117%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDaniel%26aufirst%3DK.%2BG.%26aulast%3DBrooks%26aufirst%3DW.%2BH.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DShp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%2520activity%2520of%2520estramustine%2520phosphate%2520and%2520its%2520triterpenoid%2520analogs%26jtitle%3DBioorg.%2520Bioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D730%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Yu, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4238</span><span class="NLM_x">–</span> <span class="NLM_lpage">4242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4238-4242&author=Z.-H.+Yuauthor=L.+Chenauthor=L.+Wuauthor=S.+Liuauthor=L.+Wangauthor=Z.-Y.+Zhang&title=Small+molecule+inhibitors+of+SHP2+tyrosine+phosphatase+discovered+by+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.-H.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520SHP2%2520tyrosine%2520phosphatase%2520discovered%2520by%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4238%26epage%3D4242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">SHP2 is a target of the immunosuppressant tautomycetin</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.chembiol.2010.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=21276943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=101-110&author=S.+Liuauthor=Z.+Yuauthor=X.+Yuauthor=S.-X.+Huangauthor=Y.+Luoauthor=L.+Wuauthor=W.+Shenauthor=Z.+Yangauthor=L.+Wangauthor=A.+M.+Gunawanauthor=R.+J.+Chanauthor=B.+Shenauthor=Z.-Y.+Zhang&title=SHP2+is+a+target+of+the+immunosuppressant+tautomycetin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 is a Target of the Immunosuppressant Tautomycetin</span></div><div class="casAuthors">Liu, Si-Jiu; Yu, Zhi-Hong; Yu, Xiao; Huang, Sheng-Xiong; Luo, Ying-Gang; Wu, Li; Shen, Wei-Hua; Yang, Zhen-Yun; Wang, Li-Na; Gunawan, Andrea M.; Chan, Rebecca J.; Shen, Ben; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SHP2 phosphatase is a pos. transducer of growth factor and cytokine signaling.  SHP2 is also a bona fide oncogene; gain-of-function SHP2 mutations leading to increased phosphatase activity cause Noonan syndrome, as well as multiple forms of leukemia and solid tumors.  The authors report that tautomycetin (TTN), an immunosuppressor in organ transplantation, and its engineered analog TTN D-1 are potent SHP2 inhibitors.  TTN and TTN D-1 block T cell receptor-mediated tyrosine phosphorylation and ERK activation and gain-of-function mutant SHP2-induced hematopoietic progenitor hyperproliferation and monocytic differentiation.  Crystal structure of the SHP2·TTN D-1 complex reveals that TTN D-1 occupies the SHP2 active site in a manner similar to that of a peptide substrate.  Collectively, the data support the notion that SHP2 is a cellular target for TTN and provide a potential mechanism for the immunosuppressive activity of TTN.  Moreover, the structure furnishes mol. insights upon which therapeutics targeting SHP2 can be developed on the basis of the TTN scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfQx2ElYrqrVg90H21EOLACvtfcHk0li2oWcM_z-IrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaku7c%253D&md5=2ecffe52d66725214426ddee18fe85f5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DS.-X.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSHP2%2520is%2520a%2520target%2520of%2520the%2520immunosuppressant%2520tautomycetin%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7212</span><span class="NLM_x">–</span> <span class="NLM_lpage">7221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400474r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7212-7221&author=W.+Liuauthor=B.+Yuauthor=G.+Xuauthor=W.+R.+Xuauthor=M.+L.+Lohauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Identification+of+cryptotanshinone+as+an+inhibitor+of+oncogenic+protein+tyrosine+phosphatase+SHP2+%28PTPN11%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)</span></div><div class="casAuthors">Liu, Wei; Yu, Bing; Xu, Gang; Xu, Wei-Ren; Loh, Mignon L.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7212-7221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are assocd. with Noonan syndrome, childhood leukemias, and sporadic solid tumors.  Virtual screening combined with exptl. assays was performed to identify inhibitors of SHP2 from a database of natural products.  This effort led to the identification of cryptotanshinone as an inhibitor of SHP2.  Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM.  Fluorescence titrn. expts. confirmed that it directly bound to SHP2.  Enzymic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.  This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions.  Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor.  Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-assocd. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYelS47QYHLVg90H21EOLACvtfcHk0li2oWcM_z-IrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN&md5=3bbbae68159ae4227bbf74d5573ca77a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520cryptotanshinone%2520as%2520an%2520inhibitor%2520of%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520%2528PTPN11%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7212%26epage%3D7221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guvench, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1738</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1158%2F1535-7163.MCT-13-0049-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=23825065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1738-1748&author=B.+Yuauthor=W.+Liuauthor=W.+M.+Yuauthor=M.+L.+Lohauthor=S.+Alterauthor=O.+Guvenchauthor=A.+D.+Mackerellauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Targeting+protein+tyrosine+phosphatase+SHP2+for+the+treatment+of+PTPN11-associated+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11-Associated Malignancies</span></div><div class="casAuthors">Yu, Bing; Liu, Wei; Yu, Wen-Mei; Loh, Mignon L.; Alter, Shawn; Guvench, Olgun; MacKerell, Alexander D., Jr.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1738-1748</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activating mutations in PTPN11 (encoding SHP2), a protein tyrosine phosphatase (PTP) that plays an overall pos. role in growth factor and cytokine signaling, are directly assocd. with the pathogenesis of Noonan syndrome and childhood leukemias.  Identification of SHP2-selective inhibitors could lead to the development of new drugs that ultimately serve as treatments for PTPN11-assocd. diseases.  As the catalytic core of SHP2 shares extremely high homol. to those of SHP1 and other PTPs that play neg. roles in cell signaling, to identify selective inhibitors of SHP2 using computer-aided drug design, we targeted a protein surface pocket that is adjacent to the catalytic site, is predicted to be important for binding to phosphopeptide substrates, and has structural features unique to SHP2.  From computationally selected candidate compds., #220-324 effectively inhibited SHP2 activity with an IC50 of 14 μmol/L.  Fluorescence titrn. expts. confirmed its direct binding to SHP2.  This active compd. was further verified for its ability to inhibit SHP2-mediated cell signaling and cellular function with minimal off-target effects.  Furthermore, mouse myeloid progenitors with the activating mutation (E76K) in PTPN11 and patient leukemic cells with the same mutation were more sensitive to this inhibitor than wild-type cells.  This study provides evidence that SHP2 is a "druggable" target for the treatment of PTPN11-assocd. diseases.  As the small-mol. SHP2 inhibitor identified has a simple chem. structure, it represents an ideal lead compd. for the development of novel anti-SHP2 drugs.  Mol Cancer Ther; 12(9); 1738-48. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj3UZZIk5H7LVg90H21EOLACvtfcHk0li2oWcM_z-IrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7M&md5=645bbea5d54c34844313f638b6fb0b7c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0049-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0049-T%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DAlter%26aufirst%3DS.%26aulast%3DGuvench%26aufirst%3DO.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DTargeting%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520for%2520the%2520treatment%2520of%2520PTPN11-associated%2520malignancies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1738%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Puius, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">13420</span><span class="NLM_x">–</span> <span class="NLM_lpage">13425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1073%2Fpnas.94.25.13420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=9391040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADyaK2sXotVamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=13420-13425&author=Y.+A.+Puiusauthor=Y.+Zhaoauthor=M.+Sullivanauthor=D.+S.+Lawrenceauthor=S.+C.+Almoauthor=Z.-Y.+Zhang&title=Identification+of+a+second+aryl+phosphate-binding+site+in+protein-tyrosine+phosphatase+1B%3A+A+paradigm+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design</span></div><div class="casAuthors">Puius, Yoram A.; Zhao, Yu; Sullivan, Michael; Lawrence, David S.; Almo, Steven C.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">13420-13425</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The structure of the catalytically inactive mutant (C215S) of the human protein-tyrosine phosphatase 1B (PTP1B) has been solved to high resoln. in two complexes.  In the first, crystals were grown in the presence of bis-(para-phosphophenyl) methane (BPPM), a synthetic high-affinity low-mol. wt. nonpeptidic substrate (Km = 16μM), and the structure was refined to an R-factor of 18.2% at 1.9 Å resoln.  In the second, crystals were grown in a satg. concn. of phosphotyrosine (pTyr), and the structure was refined to an R-factor of 18.1% at 1.85 Å.  Difference Fourier maps showed that BPPM binds PTP1B in two mutually exclusive modes, one in which it occupies the canonical pTyr-binding site (the active site), and another in which a phosphophenyl moiety interacts with a set of residues not previously obsd. to bind aryl phosphates.  The identification of a second pTyr mol. at the same site in the PTP1B/C215S-pTyr complex confirms that these residues constitute a low-affinity noncatalytic aryl phosphate-binding site.  Identification of a second aryl phosphate binding site adjacent to the active site provides a paradigm for the design of tight-binding, highly specific PTP1B inhibitors that can span both the active site and the adjacent noncatalytic site.  This design can be achieved by tethering together two small ligands that are individually targeted to the active site and the proximal noncatalytic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXZfTSWJNehLVg90H21EOLACvtfcHk0ljCzNojzf7ZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotVamtbs%253D&md5=663b390ee7851d389f8e045391bfe46b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.25.13420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.25.13420%26sid%3Dliteratum%253Aachs%26aulast%3DPuius%26aufirst%3DY.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DLawrence%26aufirst%3DD.%2BS.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DIdentification%2520of%2520a%2520second%2520aryl%2520phosphate-binding%2520site%2520in%2520protein-tyrosine%2520phosphatase%25201B%253A%2520A%2520paradigm%2520for%2520inhibitor%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D13420%26epage%3D13425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1146%2Fannurev.pharmtox.42.083001.144616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11807171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFKnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=209-234&author=Z.-Y.+Zhang&title=Protein+tyrosine+phosphatases%3A+structure+and+function%2C+substrate+specificity%2C+and+inhibitor+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development</span></div><div class="casAuthors">Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-234</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs) are signaling enzymes that control a diverse array of cellular processes.  Malfunction of PTP activity is assocd. with a no. of human disorders.  Recent genetic and biochem. studies indicate that PTPs represent a novel platform for drug discovery.  Detailed knowledge of PTP substrate specificity and the wealth of structural data on PTPs provide a solid foundation for rational PTP inhibitor design.  This review summarizes a correlation of PTP structure and function from mutagenesis expts.  The mol. basis for PTP1B and MKP3 substrate recognition is discussed.  A powerful strategy is presented for creating specific and high-affinity bidentate PTP inhibitors that simultaneously bind both the active site and a unique adjacent site.  Finally, recent advances in the development of potent and selective inhibitors for PTP1B and Cdc25 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKkHsDd9nAT7Vg90H21EOLACvtfcHk0ljCzNojzf7ZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFKnsbo%253D&md5=eb192ad4d7283c476947af0fbbcfcfb0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.42.083001.144616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.42.083001.144616%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520structure%2520and%2520function%252C%2520substrate%2520specificity%252C%2520and%2520inhibitor%2520development%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2002%26volume%3D42%26spage%3D209%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Small molecule tools for functional interrogation of protein tyrosine phosphatases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1111%2Fj.1742-4658.2012.08718.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=22816879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=731-750&author=R.+Heauthor=L.-F.+Zengauthor=Y.+Heauthor=S.+Zhangauthor=Z.-Y.+Zhang&title=Small+molecule+tools+for+functional+interrogation+of+protein+tyrosine+phosphatases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule tools for functional interrogation of protein tyrosine phosphatases</span></div><div class="casAuthors">He, Rongjun; Zeng, Li-Fan; He, Yantao; Zhang, Sheng; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">731-750</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The importance of protein tyrosine phosphatases (PTPs) in the regulation of cellular signalling is well established.  Malfunction of PTP activity is also known to be assocd. with cancer, metabolic syndromes and autoimmune disorders, as well as neurodegenerative and infectious diseases.  However, a detailed understanding of the roles played by the PTPs in normal physiol. and in pathogenic conditions has been hampered by the absence of PTP-specific small mol. agents.  In addn., the therapeutic benefits of modulating this target class are underexplored as a result of a lack of suitable chem. probes.  Potent and specific PTP inhibitors could significantly facilitate functional anal. of the PTPs in complex cellular signal transduction pathways and may constitute valuable therapeutics in the treatment of several human diseases.  We highlight the current challenges to and opportunities for developing PTP-specific small mol. agents.  We also review available selective small mol. inhibitors developed for a no. of PTPs, including PTP1B, TC-PTP, SHP2, lymphoid-specific tyrosine phosphatase, hematopoietic protein tyrosine phosphatase, CD45, PTPβ, PTPγ, PTPRO, Vaccinia H1-related phosphatase, mitogen-activated protein kinase phosphatase-1, mitogen-activated protein kinase phosphatase-3, Cdc25, YopH, mPTPA and mPTPB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokl-YBrjLX1bVg90H21EOLACvtfcHk0ljCzNojzf7ZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D&md5=a30f63b9e20bcff3b00bf61e77a95bce</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08718.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08718.x%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSmall%2520molecule%2520tools%2520for%2520functional%2520interrogation%2520of%2520protein%2520tyrosine%2520phosphatases%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D731%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudmon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">19767</span><span class="NLM_x">–</span> <span class="NLM_lpage">19772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19767-19772&author=X.+Yuauthor=J.-P.+Sunauthor=Y.+Heauthor=X.-L.+Guoauthor=S.+Liuauthor=B.+Zhouauthor=A.+Hudmonauthor=Z.-Y.+Zhang&title=Structure%2C+inhibitor%2C+and+regulatory+mechanism+of+Lyp%2C+a+lymphoid-specific+tyrosine+phosphatase+implicated+in+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DJ.-P.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.-L.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DHudmon%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DStructure%252C%2520inhibitor%252C%2520and%2520regulatory%2520mechanism%2520of%2520Lyp%252C%2520a%2520lymphoid-specific%2520tyrosine%2520phosphatase%2520implicated%2520in%2520autoimmune%2520diseases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19767%26epage%3D19772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Targeting Mycobacterium Protein Tyrosine Phosphatase B for Anti-Tuberculosis Agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">4573</span><span class="NLM_x">–</span> <span class="NLM_lpage">4578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=4573-4578&author=B.+Zhouauthor=Y.+Heauthor=X.+Zhangauthor=J.+Xuauthor=Y.+Luoauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=Z.+Yangauthor=R.+J.+Chanauthor=Y.+Liuauthor=J.+Zhengauthor=Z.-Y.+Zhang&title=Targeting+Mycobacterium+Protein+Tyrosine+Phosphatase+B+for+Anti-Tuberculosis+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DTargeting%2520Mycobacterium%2520Protein%2520Tyrosine%2520Phosphatase%2520B%2520for%2520Anti-Tuberculosis%2520Agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D4573%26epage%3D4578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">A Facile Hydroxyindole Carboxylic Acid-Based Focused Library Approach for Potent and Selective Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=904-908&author=L.-F.+Zengauthor=J.+Xuauthor=Y.+Heauthor=R.+Heauthor=L.+Wuauthor=A.+M.+Gunawanauthor=Z.-Y.+Zhang&title=A+Facile+Hydroxyindole+Carboxylic+Acid-Based+Focused+Library+Approach+for+Potent+and+Selective+Inhibitors+of+Mycobacterium+Protein+Tyrosine+Phosphatase+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DA%2520Facile%2520Hydroxyindole%2520Carboxylic%2520Acid-Based%2520Focused%2520Library%2520Approach%2520for%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Mycobacterium%2520Protein%2520Tyrosine%2520Phosphatase%2520B%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D904%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Discovery and Evaluation of Novel Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B from the 6-Hydroxy-Benzofuran-5-Carboxylic Acid Scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301781p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Oguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=832-842&author=Y.+Heauthor=J.+Xuauthor=Z.-H.+Yuauthor=A.+M.+Gunawanauthor=L.+Wuauthor=L.+Wangauthor=Z.-Y.+Zhang&title=Discovery+and+Evaluation+of+Novel+Inhibitors+of+Mycobacterium+Protein+Tyrosine+Phosphatase+B+from+the+6-Hydroxy-Benzofuran-5-Carboxylic+Acid+Scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of Novel Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic Acid Scaffold</span></div><div class="casAuthors">He, Yantao; Xu, Jie; Yu, Zhi-Hong; Gunawan, Andrea M.; Wu, Li; Wang, Lina; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">832-842</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis (Mtb) protein tyrosine phosphatase B (mPTPB) is a virulence factor secreted by the pathogen and mediates mycobacterial survival in macrophages by targeting host cell immune responses.  Consequently, mPTPB represents an exciting new target to combat tuberculosis (TB) infection.  We describe a medicinal chem. oriented approach that transforms a benzofuran salicylic acid scaffold into a highly potent (IC50 = 38 nM) and selective mPTPB inhibitor (>50 fold against a large panel of PTPs).  Importantly, the inhibitor is capable of reversing the altered host immune responses induced by the bacterial phosphatase and restoring the macrophage's full capacity to secrete IL-6 and undergo apoptosis in response to interferon-γ stimulation, validating the concept that chem. inhibition of mPTPB may be therapeutically useful for novel TB treatment.  The study further demonstrates that bicyclic salicylic acid pharmacophores can be used to deliver PTP inhibitors with high potency, selectivity, and cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPqxb8o40oqrVg90H21EOLACvtfcHk0lh63QRIRJtXRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Oguw%253D%253D&md5=c9492d72c21adb7be4e74eb2f5d5860a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm301781p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301781p%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DZ.-H.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520and%2520Evaluation%2520of%2520Novel%2520Inhibitors%2520of%2520Mycobacterium%2520Protein%2520Tyrosine%2520Phosphatase%2520B%2520from%2520the%25206-Hydroxy-Benzofuran-5-Carboxylic%2520Acid%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D832%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrios, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cato, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">A potent and selective small molecular inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4990</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400248c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4990-5008&author=Y.+Heauthor=S.+Liuauthor=A.+Menonauthor=S.+Stanfordauthor=E.+Oppongauthor=A.+M.+Gunawanauthor=L.+Wuauthor=D.+J.+Wuauthor=A.+M.+Barriosauthor=N.+Bottiniauthor=A.+C.+Catoauthor=Z.-Y.+Zhang&title=A+potent+and+selective+small+molecular+inhibitor+for+the+lymphoid-specific+tyrosine+phosphatase+%28LYP%29%2C+a+target+associated+with+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm400248c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400248c%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DA.%26aulast%3DStanford%26aufirst%3DS.%26aulast%3DOppong%26aufirst%3DE.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DD.%2BJ.%26aulast%3DBarrios%26aufirst%3DA.%2BM.%26aulast%3DBottini%26aufirst%3DN.%26aulast%3DCato%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DA%2520potent%2520and%2520selective%2520small%2520molecular%2520inhibitor%2520for%2520the%2520lymphoid-specific%2520tyrosine%2520phosphatase%2520%2528LYP%2529%252C%2520a%2520target%2520associated%2520with%2520autoimmune%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4990%26epage%3D5008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Mali, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramdas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munugalavadla, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, R.</span><span> </span><span class="NLM_article-title">Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2669-2678&author=R.+S.+Maliauthor=P.+Maauthor=L.-F.+Zengauthor=H.+Martinauthor=B.+Ramdasauthor=Y.+Heauthor=E.+Simsauthor=J.+Goshauthor=S.+Nabingerauthor=S.+Liauthor=V.+Munugalavadlaauthor=A.+W.+Craigauthor=K.+D.+Buntingauthor=G.-S.+Fengauthor=R.+J.+Chanauthor=Z.-Y.+Zhangauthor=R.+Kapur&title=Role+of+SHP2+phosphatase+in+KIT-induced+transformation%3A+identification+of+SHP2+as+a+druggable+target+in+diseases+involving+oncogenic+KIT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMali%26aufirst%3DR.%2BS.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DMartin%26aufirst%3DH.%26aulast%3DRamdas%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DSims%26aufirst%3DE.%26aulast%3DGosh%26aufirst%3DJ.%26aulast%3DNabinger%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DCraig%26aufirst%3DA.%2BW.%26aulast%3DBunting%26aufirst%3DK.%2BD.%26aulast%3DFeng%26aufirst%3DG.-S.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26aulast%3DKapur%26aufirst%3DR.%26atitle%3DRole%2520of%2520SHP2%2520phosphatase%2520in%2520KIT-induced%2520transformation%253A%2520identification%2520of%2520SHP2%2520as%2520a%2520druggable%2520target%2520in%2520diseases%2520involving%2520oncogenic%2520KIT%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D2669%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turchi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Targeting SHP2 for EGFR inhibitor resistant non small cell lung carcinoma</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">439</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2013&pages=586-590&author=J.+Xuauthor=L.-F.+Zengauthor=W.+Shenauthor=J.+J.+Turchiauthor=Z.-Y.+Zhang&title=Targeting+SHP2+for+EGFR+inhibitor+resistant+non+small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTurchi%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DTargeting%2520SHP2%2520for%2520EGFR%2520inhibitor%2520resistant%2520non%2520small%2520cell%2520lung%2520carcinoma%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D439%26spage%3D586%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Barr, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugochukwu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess-Brown, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Large-scale structural analysis of the classical human protein tyrosine phosphatome</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.cell.2008.11.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19167335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Kiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=352-363&author=A.+J.+Barrauthor=E.+Ugochukwuauthor=W.+H.+Leeauthor=O.+N.+Kingauthor=P.+Filippakopoulosauthor=I.+Alfanoauthor=P.+Savitskyauthor=N.+A.+Burgess-Brownauthor=S.+Mullerauthor=S.+Knapp&title=Large-scale+structural+analysis+of+the+classical+human+protein+tyrosine+phosphatome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Large-scale structural analysis of the classical human protein tyrosine phosphatome</span></div><div class="casAuthors">Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Muller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">352-363</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs) play a crit. role in regulating cellular functions by selectively dephosphorylating their substrates.  Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive anal. of the classical PTP family.  Despite their largely conserved fold, surface properties of PTPs are strikingly diverse.  A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors.  Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure.  Enzymic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases.  We propose a "head-to-toe" dimerization model for RPTPγ/ζ that is distinct from the "inhibitory wedge" model and that provides a mol. basis for inhibitory regulation.  This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0kaabM4U0LLVg90H21EOLACvtfcHk0lhconSYWmu2uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Kiu7o%253D&md5=f47994736342cc0490609596d66fd03e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.11.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.11.038%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26aulast%3DUgochukwu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DKing%26aufirst%3DO.%2BN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DAlfano%26aufirst%3DI.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DBurgess-Brown%26aufirst%3DN.%2BA.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DLarge-scale%2520structural%2520analysis%2520of%2520the%2520classical%2520human%2520protein%2520tyrosine%2520phosphatome%26jtitle%3DCell%26date%3D2009%26volume%3D136%26spage%3D352%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1163-1167&author=R.+Sordellaauthor=D.+W.+Bellauthor=D.+A.+Haberauthor=J.+Settleman&title=Gefitinib-sensitizing+EGFR+mutations+in+lung+cancer+activate+anti-apoptotic+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DGefitinib-sensitizing%2520EGFR%2520mutations%2520in%2520lung%2520cancer%2520activate%2520anti-apoptotic%2520pathways%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1163%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riely, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakowski, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kris, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H.</span><span> </span><span class="NLM_article-title">Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain</span> <span class="citation_source-journal">PLoS Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=e73&author=W.+Paoauthor=V.+A.+Millerauthor=K.+A.+Politiauthor=G.+J.+Rielyauthor=R.+Somwarauthor=M.+F.+Zakowskiauthor=M.+G.+Krisauthor=H.+Varmus&title=Acquired+resistance+of+lung+adenocarcinomas+to+gefitinib+or+erlotinib+is+associated+with+a+second+mutation+in+the+EGFR+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DPoliti%26aufirst%3DK.%2BA.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26aulast%3DSomwar%26aufirst%3DR.%26aulast%3DZakowski%26aufirst%3DM.%2BF.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DAcquired%2520resistance%2520of%2520lung%2520adenocarcinomas%2520to%2520gefitinib%2520or%2520erlotinib%2520is%2520associated%2520with%2520a%2520second%2520mutation%2520in%2520the%2520EGFR%2520kinase%2520domain%26jtitle%3DPLoS%2520Med.%26date%3D2005%26volume%3D2%26spage%3De73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Dance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, P.</span><span> </span><span class="NLM_article-title">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</span> <span class="citation_source-journal">Cell Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2Fj.cellsig.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=17993263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=453-459&author=M.+Danceauthor=A.+Montagnerauthor=J.+P.+Sallesauthor=A.+Yartauthor=P.+Raynal&title=The+molecular+functions+of+Shp2+in+the+Ras%2FMitogen-activated+protein+kinase+%28ERK1%2F2%29+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</span></div><div class="casAuthors">Dance, Marie; Montagner, Alexandra; Salles, Jean-Pierre; Yart, Armelle; Raynal, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">453-459</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Shp2 is a ubiquitous tyrosine phosphatase contg. Src Homol. 2 domains which plays major biol. functions in response to various growth factors, hormones or cytokines.  This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway.  Recent progresses have been made in the understanding of the mol. mechanisms involved in this regulation.  We review here, and discuss the physiol. relevance, of the following mol. functions of Shp2 that have been proposed to couple the phosphatase to Ras activation: promoter of Grb2/Sos recruitment through direct binding to Grb2, binding partner and regulator of SHPS-1, neg. regulator of Sprouty, neg. regulator of RasGAP recruitment, and activator of Src through dephosphorylation of Src-regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF2Kpmuyw1urVg90H21EOLACvtfcHk0livONYRryeGIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D&md5=a512a7f588e669c4ea4bb8fcc3d872db</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDance%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DSalles%26aufirst%3DJ.%2BP.%26aulast%3DYart%26aufirst%3DA.%26aulast%3DRaynal%26aufirst%3DP.%26atitle%3DThe%2520molecular%2520functions%2520of%2520Shp2%2520in%2520the%2520Ras%252FMitogen-activated%2520protein%2520kinase%2520%2528ERK1%252F2%2529%2520pathway%26jtitle%3DCell%2520Signalling%26date%3D2008%26volume%3D20%26spage%3D453%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">(2004) Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">8497</span><span class="NLM_x">–</span> <span class="NLM_lpage">8505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=8497-8505&author=Y.+Renauthor=S.+Mengauthor=L.+Meiauthor=Z.+J.+Zhaoauthor=R.+Joveauthor=J.+Wu&title=%282004%29+Roles+of+Gab1+and+SHP2+in+paxillin+tyrosine+dephosphorylation+and+Src+activation+in+response+to+epidermal+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3D%25282004%2529%2520Roles%2520of%2520Gab1%2520and%2520SHP2%2520in%2520paxillin%2520tyrosine%2520dephosphorylation%2520and%2520Src%2520activation%2520in%2520response%2520to%2520epidermal%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D8497%26epage%3D8505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Yamauchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milarski, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltiel, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessin, J. E.</span><span> </span><span class="NLM_article-title">Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=664-668&author=K.+Yamauchiauthor=K.+L.+Milarskiauthor=A.+R.+Saltielauthor=J.+E.+Pessin&title=Protein-tyrosine-phosphatase+SHPTP2+is+a+required+positive+effector+for+insulin+downstream+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DK.%26aulast%3DMilarski%26aufirst%3DK.%2BL.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26aulast%3DPessin%26aufirst%3DJ.%2BE.%26atitle%3DProtein-tyrosine-phosphatase%2520SHPTP2%2520is%2520a%2520required%2520positive%2520effector%2520for%2520insulin%2520downstream%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D664%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Marquardt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stabel, S.</span><span> </span><span class="NLM_article-title">Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3213</span><span class="NLM_x">–</span> <span class="NLM_lpage">3218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=3213-3218&author=B.+Marquardtauthor=D.+Frithauthor=S.+Stabel&title=Signalling+from+TPA+to+MAP+kinase+requires+protein+kinase+C%2C+raf+and+MEK%3A+reconstitution+of+the+signalling+pathway+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarquardt%26aufirst%3DB.%26aulast%3DFrith%26aufirst%3DD.%26aulast%3DStabel%26aufirst%3DS.%26atitle%3DSignalling%2520from%2520TPA%2520to%2520MAP%2520kinase%2520requires%2520protein%2520kinase%2520C%252C%2520raf%2520and%2520MEK%253A%2520reconstitution%2520of%2520the%2520signalling%2520pathway%2520in%2520vitro%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D3213%26epage%3D3218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span> </span><span class="NLM_article-title">Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent of Raf</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">23512</span><span class="NLM_x">–</span> <span class="NLM_lpage">23519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23512-23519&author=Y.+Uedaauthor=S.+Hiraiauthor=S.+Osadaauthor=A.+Suzukiauthor=K.+Mizunoauthor=S.+Ohno&title=Protein+kinase+C+activates+the+MEK-ERK+pathway+in+a+manner+independent+of+Ras+and+dependent+of+Raf"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DOsada%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DOhno%26aufirst%3DS.%26atitle%3DProtein%2520kinase%2520C%2520activates%2520the%2520MEK-ERK%2520pathway%2520in%2520a%2520manner%2520independent%2520of%2520Ras%2520and%2520dependent%2520of%2520Raf%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23512%26epage%3D23519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Weigelt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissell, M. J.</span><span> </span><span class="NLM_article-title">HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1007%2Fs10549-009-0502-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19701706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2010&pages=35-43&author=B.+Weigeltauthor=A.+T.+Loauthor=C.+C.+Parkauthor=J.+W.+Grayauthor=M.+J.+Bissell&title=HER2+signaling+pathway+activation+and+response+of+breast+cancer+cells+to+HER2-targeting+agents+is+dependent+strongly+on+the+3D+microenvironment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment</span></div><div class="casAuthors">Weigelt, Britta; Lo, Alvin T.; Park, Catherine C.; Gray, Joe W.; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-43</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Development of effective and durable breast cancer treatment strategies requires a mechanistic understanding of the influence of the microenvironment on response.  Previous work has shown that cellular signaling pathways and cell morphol. are dramatically influenced by three-dimensional (3D) cultures as opposed to traditional two-dimensional (2D) monolayers.  Here, we compared 2D and 3D culture models to det. the impact of 3D architecture and extracellular matrix (ECM) on HER2 signaling and on the response of HER2-amplified breast cancer cell lines to the HER2-targeting agents Trastuzumab, Pertuzumab and Lapatinib.  We show that the response of the HER2-amplified AU565, SKBR3 and HCC1569 cells to these anti-HER2 agents was highly dependent on whether the cells were cultured in 2D monolayer or 3D laminin-rich ECM gels.  Inhibition of β1 integrin, a major cell-ECM receptor subunit, significantly increased the sensitivity of the HER2-amplified breast cancer cell lines to the humanized monoclonal antibodies Trastuzumab and Pertuzumab when grown in a 3D environment.  Finally, in the absence of inhibitors, 3D cultures had substantial impact on HER2 downstream signaling and induced a switch between PI3K-AKT- and RAS-MAPK-pathway activation in all cell lines studied, including cells lacking HER2 amplification and overexpression.  Our data provide direct evidence that breast cancer cells are able to rapidly adapt to different environments and signaling cues by activating alternative pathways that regulate proliferation and cell survival, events that may play a significant role in the acquisition of resistance to targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxkScWl2PzgrVg90H21EOLACvtfcHk0livONYRryeGIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKlsr0%253D&md5=7f49c4af3b9f1ef0c5633e81f66368ff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2Fs10549-009-0502-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-009-0502-2%26sid%3Dliteratum%253Aachs%26aulast%3DWeigelt%26aufirst%3DB.%26aulast%3DLo%26aufirst%3DA.%2BT.%26aulast%3DPark%26aufirst%3DC.%2BC.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26atitle%3DHER2%2520signaling%2520pathway%2520activation%2520and%2520response%2520of%2520breast%2520cancer%2520cells%2520to%2520HER2-targeting%2520agents%2520is%2520dependent%2520strongly%2520on%2520the%25203D%2520microenvironment%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2010%26volume%3D122%26spage%3D35%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Muthuswamy, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, B.</span><span> </span><span class="NLM_article-title">Cell polarity as a regulator of cancer cell behavior plasticity</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=599-625&author=S.+K.+Muthuswamyauthor=B.+Xue&title=Cell+polarity+as+a+regulator+of+cancer+cell+behavior+plasticity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuthuswamy%26aufirst%3DS.%2BK.%26aulast%3DXue%26aufirst%3DB.%26atitle%3DCell%2520polarity%2520as%2520a%2520regulator%2520of%2520cancer%2520cell%2520behavior%2520plasticity%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2012%26volume%3D28%26spage%3D599%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isozaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad Tunio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span> </span><span class="NLM_article-title">Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=577-580&author=S.+Hirotaauthor=K.+Isozakiauthor=Y.+Moriyamaauthor=K.+Hashimotoauthor=T.+Nishidaauthor=S.+Ishiguroauthor=K.+Kawanoauthor=M.+Hanadaauthor=A.+Kurataauthor=M.+Takedaauthor=G.+Muhammad+Tunioauthor=Y.+Matsuzawaauthor=Y.+Kanakuraauthor=Y.+Shinomuraauthor=Y.+Kitamura&title=Gain-of-function+mutations+of+c-kit+in+human+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DIsozaki%26aufirst%3DK.%26aulast%3DMoriyama%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DHanada%26aufirst%3DM.%26aulast%3DKurata%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DMuhammad%2BTunio%26aufirst%3DG.%26aulast%3DMatsuzawa%26aufirst%3DY.%26aulast%3DKanakura%26aufirst%3DY.%26aulast%3DShinomura%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DY.%26atitle%3DGain-of-function%2520mutations%2520of%2520c-kit%2520in%2520human%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D577%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Longley, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reguera, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span> </span><span class="NLM_article-title">Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1016%2FS0145-2126%2801%2900028-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=11377682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslSisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=571-576&author=B.+J.+Longleyauthor=M.+J.+Regueraauthor=Y.+Ma&title=Classes+of+c-KIT+activating+mutations%3A+proposed+mechanisms+of+action+and+implications+for+disease+classification+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy</span></div><div class="casAuthors">Longley, B. J.; Reguera, M. J.; Ma, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">571-576</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Mutations causing constitutive activation of KIT have been shown to be causative in some forms of mastocytosis, and several types of mutations have been assocd. with myeloproliferative disorders (MPDs), acute myelogenous leukemia (AML), sinonasal lymphomas, and gastrointestinal stromal tumors (GIST).  We divide these activating mutation into two types - 'regulatory type' mutations, which affect regulation of the kinase mol., and 'enzymic pocket type' mutations, which alter the amino acid sequence directly forming the enzymic site.  KIT inhibitors have been suggested as therapeutic drugs for these conditions, but different types of activating mutations respond differentially to KIT inhibitors, so classification of individuals on the basis of specific mutations is necessary to guide therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCZqOKdaiUV7Vg90H21EOLACvtfcHk0ljlAlPOqJhoGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslSisbg%253D&md5=d902f401a5919da6bc558ccf100fd6d3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0145-2126%2801%2900028-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0145-2126%252801%252900028-5%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DB.%2BJ.%26aulast%3DReguera%26aufirst%3DM.%2BJ.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DClasses%2520of%2520c-KIT%2520activating%2520mutations%253A%2520proposed%2520mechanisms%2520of%2520action%2520and%2520implications%2520for%2520disease%2520classification%2520and%2520therapy%26jtitle%3DLeuk.%2520Res.%26date%3D2001%26volume%3D25%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cymborowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chruszcz, M.</span><span> </span><span class="NLM_article-title">HKL-3000: the integration of data reduction and structure solution–from diffraction images to an initial model in minutes</span> <span class="citation_source-journal">Acta. Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+integration+of+data+reduction+and+structure+solution%E2%80%93from+diffraction+images+to+an+initial+model+in+minutes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520integration%2520of%2520data%2520reduction%2520and%2520structure%2520solution%25E2%2580%2593from%2520diffraction%2520images%2520to%2520an%2520initial%2520model%2520in%2520minutes%26jtitle%3DActa.%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A.</span><span> </span><span class="NLM_article-title">MOLREP: an automated program for molecular replacement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1107%2FS0021889897006766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=1022-1025&author=A.+Vaginauthor=A.+Teplyakov&title=MOLREP%3A+an+automated+program+for+molecular+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">MOLREP: an automated program for molecular replacement</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement which uses effective new approaches in data processing and rotational and translational searching.  These include an automatic choice of all parameters, scaling by Patterson origin peaks and soft resoln. cutoff.  One of the cornerstones of the program is an original full-symmetry translation function combined with a packing function.  Information from the model already placed in the cell is incorporated in both translation and packing functions.  A no. of tests using exptl. data proved the ability of the program to find the correct soln. in difficult cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGXdZ-nTKxLVg90H21EOLACvtfcHk0ljlAlPOqJhoGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D&md5=96af64aedd8a8f018c3c18b57a6b4b21</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1107%2FS0021889897006766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897006766%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMOLREP%253A%2520an%2520automated%2520program%2520for%2520molecular%2520replacement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D1022%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Brünger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLano, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography and NMR system: a new software suite for macro-molecular structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Br%C3%BCngerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+DeLanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+and+NMR+system%3A+a+new+software+suite+for+macro-molecular+structure+determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520and%2520NMR%2520system%253A%2520a%2520new%2520software%2520suite%2520for%2520macro-molecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Brünger, A. T.</span><span> </span><span class="NLM_article-title">The free <i>R</i> value: a novel statistical quantity for assessing the accuracy of crystal structures</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1992&pages=472-475&author=A.+T.+Br%C3%BCnger&title=The+free+R+value%3A+a+novel+statistical+quantity+for+assessing+the+accuracy+of+crystal+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26atitle%3DThe%2520free%2520R%2520value%253A%2520a%2520novel%2520statistical%2520quantity%2520for%2520assessing%2520the%2520accuracy%2520of%2520crystal%2520structures%26jtitle%3DNature%26date%3D1992%26volume%3D355%26spage%3D472%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljpVTbJ1FXXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm5006176&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljpVTbJ1FXXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span> </span><span class="NLM_article-title">Python: A programming language for software integration and development</span> <span class="citation_source-journal">Journal Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm5006176&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm5006176&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+A+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0ljpVTbJ1FXXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520A%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJournal%2520Mol.%2520Graphics%2520Modell.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B7O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B7O','PDB','3B7O'); return false;">PDB: 3B7O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O5X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O5X','PDB','3O5X'); return false;">PDB: 3O5X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PVG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PVG','PDB','4PVG'); return false;">PDB: 4PVG</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a href="/doi/suppl/10.1021/jm5006176">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_10215"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H and <sup>13</sup>C NMR spectra for all of the intermediates (compounds <b>2</b>, <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b>) and final compounds (<b>10a</b>–<b>d</b>, <b>11a</b>-<b>1</b> to <b>11a</b>-<b>26</b> and <b>11c</b>-<b>1</b> to <b>11c</b>-<b>11</b>) tested for biological activity. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5006176/suppl_file/jm5006176_si_001.pdf">jm5006176_si_001.pdf (11.48 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates for the structure of the SHP2·<b>11c</b>-<b>9</b> complex (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PVG">4PVG</a>) have been deposited in the Protein Data Bank.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5006176&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm5006176%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-15%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5006176" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993659392c3d76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
